≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Rash and other nonspecific skin eruption

DOID Endpoint Browser

R18_RASH_OTHER_NONSPECIFIC_SKIN_ERUPT

exanthem: a widespread rash usually occurring in children but can occur in adults. An exanthem can be caused by toxins, drugs, or microorganisms, or can result from autoimmune disease. It can be contrasted with an enanthem.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — R21
  • Cause of death: ICD-10 — R21

2 out of 7 registries used, show all original rules.

4319

4. Check minimum number of events

None

4319

5. Include endpoints

None

4319

6. Filter based on genotype QC (FinnGen only)

4160

Control definitions (FinnGen only)

Control exclude
R18_SYMPTOMS_SIGNS_INVOLVI_SKIN_SUBCU_TISSUE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
R2[0-3]
Name in latin
Exanthema et aliae eruptiones cutis non specificae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 4160 2760 1400
Unadjusted period prevalence (%) 0.87 0.98 0.64
Median age at first event (years) 55.34 52.67 60.61

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4319
Matched controls
43190
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4503599627370496.0
307.7
4317
684
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
11.4
307.7
1448
1832
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.0
225.0
1396
5958
D07AB08
ATC
desonide; topical
3.2
165.3
755
2657
D07AC01
ATC
betamethasone; topical
2.4
160.9
1961
11239
R20.2
ICD-10 Finland
Paraesthesia of skin
5.4
156.6
324
639
H02AB06
ATC
prednisolone; systemic
2.3
150.9
2419
15428
E0000UV, ,
ATC
2.3
149.8
2202
13536
Z2221
NOMESCO Finland
Medical doctor
2.4
148.4
1518
8000
E000001, ,
ATC
2.4
118.3
1086
5375
D07AD01
ATC
clobetasol; topical
2.4
117.8
973
4593
D07AC13
ATC
mometasone; topical
2.1
108.8
1468
8447
D07AB02
ATC
hydrocortisone butyrate; topical
2.0
99.8
1474
8714
R06AE07
ATC
cetirizine; oral
1.9
97.2
2130
14400
R4110
NOMESCO Finland
Physiotherapy
2.0
91.9
1387
8214
Z3231
NOMESCO Finland
Registered nurse
2.0
89.2
1346
7954
XQ802
NOMESCO Finland
Epicutan test
3.7
88.0
289
813
L57.0
ICD-10 Finland
Actinic keratosis
2.6
87.8
552
2267
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.6
87.2
547
2243
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
85.1
1765
11566
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.3
84.5
717
3379
XQ800
NOMESCO Finland
Prick test
2.8
84.2
454
1721
L04AX01
ATC
azathioprine; systemic
3.5
78.7
280
830
H02AB07
ATC
prednisone; oral
2.3
77.2
700
3384
Z71.8
ICD-10 Finland
Other specified counselling
1.8
72.2
1625
10778
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
71.4
1340
8398
ZXE00
NOMESCO Finland
One hour or less
1.8
71.1
1770
12082
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
70.9
680
3356
R06AX27
ATC
desloratadine; oral
1.8
68.9
1375
8762
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
68.9
1615
10804
Z3226
NOMESCO Finland
Physiotherapist
2.0
68.5
894
4952
S29
ICPC
Skin symptom/complaint other
1.9
68.0
1017
5904
J01MA02
ATC
ciprofloxacin; systemic
1.8
67.8
1701
11590
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.6
66.0
425
1755
J01DB01
ATC
cefalexin; oral
2.0
65.1
3598
30679
J01FF01
ATC
clindamycin; systemic
1.8
63.5
1221
7659
ZXA05
NOMESCO Finland
Left side
1.8
61.0
1095
6709
D07AA02
ATC
hydrocortisone; topical
2.1
61.0
697
3665
N02AX02
ATC
tramadol; systemic, rectal
1.7
59.2
1847
13225
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.9
59.1
953
5639
T78.4
ICD-10 Finland
Allergy, unspecified
3.0
58.6
270
935
D02AX
ATC
Other emollients and protectives
3.5
57.8
204
600
ZX120
NOMESCO Finland
Intravenous
2.3
57.8
476
2194
J02AC01
ATC
fluconazole; systemic
1.7
57.6
1803
12895
A02BC05
ATC
esomeprazole; systemic
1.7
57.4
1774
12643
TQW99
NOMESCO Finland
Other minor procedure on skin
3.0
57.3
268
935
N03AX16
ATC
[U] pregabalin
1.8
57.3
1031
6304
L30.8
ICD-10 Finland
Other specified dermatitis
3.7
57.1
188
528
P01BA02
ATC
hydroxychloroquine; oral
2.4
56.2
439
1977
R06AE09
ATC
levocetirizine; oral
2.0
56.1
696
3761
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
55.8
1551
10724
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
55.0
1649
11622
A02BC02
ATC
pantoprazole; systemic
1.7
54.8
2949
24130
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
53.3
811
4691
M79.6
ICD-10 Finland
Pain in limb
1.6
52.5
1943
14396
L04AD01
ATC
ciclosporin; systemic
4.5
52.3
128
289
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
52.3
1242
8199
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
51.7
842
4972
R50.9
ICD-10 Finland
Fever, unspecified
1.9
51.7
718
4026
E000002, ,
ATC
2.1
51.6
530
2666
J01DA01
ATC
[U] cefalexin
1.6
51.3
2620
20963
Z2446
NOMESCO Finland
Social worker
2.5
51.2
346
1457
UJF32
NOMESCO Finland
Coloscopy
1.7
51.1
1132
7320
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
5.3
51.1
104
201
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
50.8
2019
15182
L93.0
ICD-10 Finland
Discoid lupus erythematosus
9.1
50.7
62
69
S18
ICPC
Laceration/cut
1.6
50.7
2007
15074
S21
ICPC
Skin texture symptom/complaint
1.9
50.3
724
4106
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
49.9
1121
7270
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.2
49.9
204
658
R51.80
ICD-10 Finland
Headache
1.9
48.1
735
4243
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.5
47.3
311
1292
ZXA00
NOMESCO Finland
Right side
1.7
46.7
1113
7317
J01FA10
ATC
azithromycin; systemic
1.6
45.7
2445
19527
L04AA01
ATC
[U] ciclosporin
5.0
45.7
99
202
L50.9
ICD-10 Finland
Urticaria, unspecified
2.9
45.7
221
785
L04AA06
ATC
mycophenolic acid; systemic
4.2
44.8
120
291
E000006, ,
ATC
2.4
44.1
337
1499
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.5
43.9
151
437
L50.3
ICD-10 Finland
Dermatographic urticaria
4.1
43.6
120
297
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.1
43.3
472
2421
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.8
43.1
220
804
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
8.9
42.8
53
60
R03DC03
ATC
montelukast; oral
1.8
42.7
765
4624
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
42.5
1324
9279
J04BA02
ATC
dapsone; oral
8.2
42.3
56
69
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
4.4
41.6
105
243
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
41.6
819
5086
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
40.8
615
3522
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.3
40.7
318
1426
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
40.7
1146
7819
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.0
40.4
519
2818
A46
ICD-10 Finland
Erysipelas
1.9
40.2
628
3636
D86.3
ICD-10 Finland
Sarcoidosis of skin
15.3
40.0
35
23
WX002
NOMESCO Finland
Sedation and analgesia
1.7
39.6
818
5139
L17
ICPC
Foot/toe symptom/complaint
1.6
39.3
1335
9511
J05AB01
ATC
aciclovir; systemic
1.7
39.3
975
6433
R4120
NOMESCO Finland
Occupational therapy
2.3
38.7
319
1463
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
38.3
654
3885
XQ848
NOMESCO Finland
Dermatological photography
3.3
38.3
145
446
D02AE01
ATC
carbamide; topical
2.3
38.2
301
1355
D06BX01
ATC
metronidazole; topical
1.9
38.1
499
2724
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
37.8
1823
14005
C01CA24
ATC
epinephrine; parenteral
2.3
37.8
309
1412
R60.0
ICD-10 Finland
Localized oedema
1.9
37.8
569
3251
R03BA02
ATC
budesonide; inhalant
1.7
37.7
784
4929
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.2
37.5
323
1509
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.9
37.4
83
173
R52.9
ICD-10 Finland
Pain, unspecified
2.0
37.2
470
2535
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
37.2
838
5382
J05AB11
ATC
valaciclovir; oral
1.8
37.1
652
3904
A02BC03
ATC
lansoprazole; oral
1.6
37.1
1165
8128
ZXD20
NOMESCO Finland
Day surgery
1.9
37.1
560
3203
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
36.9
545
3095
M25.5
ICD-10 Finland
Pain in joint
1.5
36.8
1424
10418
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
12.6
35.8
35
28
D69.0
ICD-10 Finland
Allergic purpura
6.6
35.7
57
87
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.6
35.6
212
839
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
35.5
406
2113
P01AB01
ATC
metronidazole; oral, rectal
1.5
35.3
1668
12704
L04AX03
ATC
methotrexate; systemic
2.0
35.3
444
2389
D07CC01
ATC
betamethasone and antibiotics; topical
1.8
35.3
541
3106
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
35.1
834
5421
L30.3
ICD-10 Finland
Infective dermatitis
2.8
35.1
180
660
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.6
34.9
114
319
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
34.8
421
2235
L29.9
ICD-10 Finland
Pruritus, unspecified
2.9
34.7
162
564
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
34.7
484
2695
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
34.6
468
2579
C07AB07
ATC
bisoprolol; oral
1.5
34.5
1935
15244
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
34.4
950
6409
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
34.4
953
6437
R06AX22
ATC
ebastine; oral
1.7
34.3
743
4711
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
34.3
559
3269
J01AA02
ATC
doxycycline; systemic
1.6
34.2
3218
28151
L20.0
ICD-10 Finland
Besnier prurigo
2.1
34.2
358
1804
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
3.5
34.2
121
357
S01GX01
ATC
cromoglicic acid; ophthalmic
1.6
34.1
871
5762
J01FA06
ATC
roxithromycin; oral
1.5
34.0
1630
12428
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.1
33.9
361
1830
N06AX21
ATC
duloxetine; oral
1.8
33.7
520
2989
E000003, ,
ATC
2.5
33.6
215
881
A07AA02
ATC
nystatin; oral
2.3
33.6
276
1264
J01MA12
ATC
levofloxacin; systemic
1.7
33.6
752
4809
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
33.3
761
4891
A02BC01
ATC
omeprazole; systemic
1.6
33.2
1117
7886
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
33.1
2100
16898
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.4
32.8
224
946
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
7.8
32.7
45
58
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.3
32.7
259
1167
L95.8
ICD-10 Finland
Other vasculitis limited to skin
11.4
32.7
34
30
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
32.5
1140
8116
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
32.5
909
6142
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.6
32.2
107
303
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
32.2
266
1221
H02AB04
ATC
methylprednisolone; systemic
1.7
32.1
612
3740
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
3.1
32.0
139
465
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
5.6
31.9
60
108
D07AC14
ATC
methylprednisolone aceponate; topical
2.4
31.8
216
909
R01AD09
ATC
mometasone; nasal
1.5
31.7
1866
14758
E000007, ,
ATC
2.3
31.6
251
1132
J01MA14
ATC
moxifloxacin; systemic
2.0
31.6
385
2047
R06.0
ICD-10 Finland
Dyspnoea
1.5
31.5
1125
8032
TQW80
NOMESCO Finland
Local dermatologic skincare
3.1
31.4
136
454
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
3.0
31.2
137
461
R03AC02
ATC
salbutamol; inhalant
1.5
30.9
2284
18828
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
30.8
844
5664
L50.8
ICD-10 Finland
Other urticaria
3.5
30.7
106
308
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
30.6
696
4460
R53
ICD-10 Finland
Malaise and fatigue
1.5
30.5
1066
7564
L50.0
ICD-10 Finland
Allergic urticaria
2.9
29.7
145
518
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.9
29.5
431
2430
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
6.3
29.5
49
78
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.1
29.5
290
1426
M54.5
ICD-10 Finland
Low back pain
1.5
29.3
1505
11545
L28
ICPC
Limited function/disability (L)
1.6
29.2
797
5339
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
29.1
1037
7380
G44.2
ICD-10 Finland
Tension-type headache
1.7
29.1
580
3585
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
28.9
357
1906
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
28.8
1202
8841
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
28.7
995
7035
ZXA10
NOMESCO Finland
Bilateral
1.6
28.7
752
4985
J45.1
ICD-10 Finland
Nonallergic asthma
2.0
28.7
323
1669
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
28.5
415
2337
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
28.3
1748
13858
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
28.1
758
5059
XX9XE
NOMESCO Finland
Other ultrasound examination
5.1
27.9
59
118
B01AB05
ATC
enoxaparin; parenteral
1.5
27.8
1256
9370
L73.8
ICD-10 Finland
Other specified follicular disorders
4.8
27.8
63
134
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
4.2
27.5
72
172
L12
ICPC
Hand/finger symptom/complaint
1.6
27.4
733
4877
127
Kela drug reimbursment
Transplant complication
3.9
27.4
82
216
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
27.4
411
2336
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.3
27.3
207
915
L92.0
ICD-10 Finland
Granuloma annulare
6.5
27.2
44
68
D07XC01
ATC
betamethasone; topical
1.8
27.1
486
2912
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
27.0
345
1861
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.4
27.0
191
819
J01AA07
ATC
tetracycline; systemic
1.7
27.0
595
3771
D06AX01
ATC
fusidic acid; topical
1.9
27.0
385
2153
ZXC20
NOMESCO Finland
Use of chemical agents
3.4
26.9
98
295
J01AA04
ATC
lymecycline; systemic
1.7
26.8
528
3247
K30
ICD-10 Finland
Functional dyspepsia
1.7
26.7
487
2931
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.6
26.7
162
647
R42
ICD-10 Finland
Dizziness and giddiness
1.5
26.7
930
6569
J31.0
ICD-10 Finland
Chronic rhinitis
1.9
26.6
370
2052
UJH02
NOMESCO Finland
Anoscopy
2.4
26.6
181
763
A01AB09
ATC
miconazole; local oral
1.9
26.5
360
1981
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
26.5
375
2091
L82
ICD-10 Finland
Seborrhoeic keratosis
1.6
26.4
767
5199
C03CA01
ATC
furosemide; systemic
1.5
26.4
1151
8510
J02AC02
ATC
itraconazole; systemic
1.6
25.9
719
4823
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
3.2
25.8
103
328
J45.8
ICD-10 Finland
Mixed asthma
2.6
25.7
148
576
N05CF01
ATC
zopiclone; oral
1.5
25.7
1265
9568
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
25.5
336
1831
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
2.7
25.5
135
504
ZXC50
NOMESCO Finland
Cryotherapy
2.7
25.4
136
510
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
4.7
25.4
59
128
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
7.1
25.4
38
54
AA1AD
NOMESCO Finland
CT of head and brain
1.5
25.4
1119
8283
R23.3
ICD-10 Finland
Spontaneous ecchymoses
3.3
25.3
95
291
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
25.3
906
6427
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
25.3
198
888
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
25.2
474
2875
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
25.0
434
2574
M03BX02
ATC
tizanidine; oral
1.4
25.0
2459
20971
B07.9
ICD-10 Finland
Verruca simplex
2.5
24.9
164
681
L01BA01
ATC
methotrexate; systemic
2.4
24.8
172
731
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
24.8
764
5242
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.6
24.7
145
570
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
24.7
1507
11838
ZQZ00
NOMESCO Finland
Treatment of several skin areas
6.7
24.6
39
59
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.8
24.6
123
445
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.0
24.6
294
1551
R01AD08
ATC
fluticasone; nasal
1.5
24.6
1132
8442
D06BB10
ATC
imiquimod; topical
2.1
24.4
224
1072
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.3
24.4
179
781
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
24.3
1022
7482
M01AH01
ATC
celecoxib; oral
1.6
24.3
699
4720
N03AX12
ATC
[U] gabapentin; oral
1.6
24.3
627
4128
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
24.3
203
936
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
24.2
874
6206
R05
ICD-10 Finland
Cough
1.5
24.1
892
6362
ZXD05
NOMESCO Finland
Urgent procedure
1.5
24.1
1167
8778
L43.9
ICD-10 Finland
Lichen planus, unspecified
3.0
24.1
108
368
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
9.7
24.1
28
29
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
24.1
556
3560
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.2
23.9
218
1041
A97
ICPC
No disease
1.5
23.8
840
5931
R21
ICPC
Throat symptom/complaint
1.5
23.8
862
6121
L30.0
ICD-10 Finland
Nummular dermatitis
2.4
23.8
170
733
N06AX11
ATC
mirtazapine; oral
1.4
23.6
1358
10537
A28
ICPC
Limited function/disability NOS
1.6
23.6
712
4859
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.6
23.5
138
543
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.4
23.5
169
731
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
23.4
206
969
WX402
NOMESCO Finland
General anaesthesia
1.5
23.3
893
6409
A01
ICPC
Pain general/multiple sites
1.7
23.3
430
2593
A07EC02
ATC
mesalazine; oral, rectal
2.1
23.3
221
1071
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
23.2
427
2573
A01AB04
ATC
amphotericin B; local oral
2.2
23.1
197
915
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
23.0
1686
13618
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.7
23.0
516
3278
Z50.1
ICD-10 Finland
Other physical therapy
2.1
23.0
229
1131
K50.1
ICD-10 Finland
Crohn disease of large intestine
4.1
23.0
63
156
H02AB09
ATC
hydrocortisone; systemic
2.7
23.0
123
462
L53.9
ICD-10 Finland
Erythematous condition, unspecified
3.7
22.9
71
192
N05BB01
ATC
hydroxyzine; systemic
2.0
22.9
260
1347
L12.0
ICD-10 Finland
Bullous pemphigoid
5.7
22.9
42
74
L04AB04
ATC
adalimumab; parenteral
2.8
22.8
112
402
D01
ICPC
Abdominal pain/cramps general
1.6
22.8
529
3390
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.1
22.6
95
312
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
22.6
721
4978
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
22.5
213
1031
N02BE01
ATC
paracetamol; systemic, rectal
1.6
22.5
3712
34388
Z01.7
ICD-10 Finland
Laboratory examination
1.6
22.5
686
4688
ZY010
NOMESCO Finland
Hospital outpatient
2.1
22.4
219
1074
L43.8
ICD-10 Finland
Other lichen planus
3.1
22.3
93
304
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
22.3
296
1617
ZZR00
NOMESCO Finland
Flap of skin
3.0
22.2
100
342
XA402
NOMESCO Finland
ENMG
2.8
22.0
114
421
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
22.0
772
5436
J45
ICD-10 Finland
Asthma
1.7
21.9
432
2653
M01AG02
ATC
tolfenamic acid; oral, rectal
1.6
21.8
602
4018
M13.9
ICD-10 Finland
Arthritis, unspecified
1.9
21.8
309
1722
J01FA09
ATC
clarithromycin; systemic
1.4
21.8
1220
9391
A02BA02
ATC
ranitidine; systemic
1.5
21.8
723
5031
A29
ICPC
General symptom/complaint other
1.6
21.7
552
3614
H53.1
ICD-10 Finland
Subjective visual disturbances
1.9
21.7
292
1602
N30.0
ICD-10 Finland
Acute cystitis
1.5
21.7
729
5086
N05BA01
ATC
diazepam; systemic, rectal
1.6
21.5
500
3202
JN4BD
NOMESCO Finland
Extensive body CT
1.7
21.4
388
2327
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
21.4
2903
25765
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
21.4
248
1294
R74
ICPC
Upper respiratory infection acute
1.4
21.3
1311
10248
RD210, ,
NOMESCO Finland
3.0
21.3
95
323
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
21.2
713
4973
X57
ICD-10 Finland
Unspecified privation
2.8
21.1
106
385
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
2.9
21.1
102
363
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
21.1
386
2322
R11
ICD-10 Finland
Nausea and vomiting
1.7
21.0
369
2192
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
3.9
21.0
62
162
R35
ICD-10 Finland
Polyuria
1.9
21.0
267
1438
D07BC01
ATC
betamethasone and antiseptics; topical
1.7
20.8
460
2907
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.4
20.8
141
594
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
5.4
20.7
40
74
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
20.6
418
2585
XF404
NOMESCO Finland
Ambulatory ECG
1.8
20.6
333
1933
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
20.5
389
2362
R60.9
ICD-10 Finland
Oedema, unspecified
2.0
20.5
241
1264
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.4
20.4
135
562
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.9
20.4
95
331
J01CA04
ATC
amoxicillin; systemic
1.4
20.4
3377
30844
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.1
20.3
186
890
UKC02
NOMESCO Finland
Cystoscopy
1.6
20.3
559
3728
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
20.2
615
4193
R05
ICPC
Cough
1.4
20.2
1012
7621
D05BB02
ATC
acitretin; oral
2.8
20.2
102
372
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.4
20.2
139
590
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
5.0
20.2
43
87
D19
ICPC
Teeth/gum symptom/complaint
1.4
20.2
1226
9549
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.7
20.1
421
2624
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.0
20.1
231
1202
A04AA01
ATC
ondansetron; systemic, rectal
1.8
20.0
344
2033
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
3.2
19.9
80
256
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
3.1
19.8
81
262
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
4.5
19.8
48
108
XX9XT
NOMESCO Finland
Other radiological intervention
35.9
19.8
25
7
N06AA09
ATC
amitriptyline; systemic
1.7
19.8
374
2268
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
19.7
512
3367
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
19.5
254
1377
R07.0
ICD-10 Finland
Pain in throat
1.8
19.5
295
1677
M02AA07
ATC
piroxicam; topical
1.4
19.5
1356
10786
L71.8
ICD-10 Finland
Other rosacea
3.0
19.4
84
281
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.9
19.3
252
1368
N02AA05
ATC
oxycodone; systemic
1.5
19.3
690
4866
L88
ICPC
Rheumatoid/seropositive arthritis
2.1
19.3
183
888
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.4
19.3
131
553
A04
ICPC
Weakness/tiredness general
1.5
19.2
645
4490
L03
ICPC
Low back symptom/complaint
1.4
19.1
1165
9062
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.3
19.1
152
687
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
19.1
329
1944
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
19.0
2068
17586
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
19.0
535
3581
J01EA01
ATC
trimethoprim; systemic
1.4
18.9
1033
7884
R03AC03
ATC
terbutaline; inhalant
1.6
18.8
534
3582
R03BA01
ATC
beclometasone; inhalant
1.6
18.7
535
3593
D11
ICPC
Diarrhoea
1.6
18.7
482
3161
U02
ICPC
Urinary frequency/urgency
1.5
18.7
613
4243
N05BA04
ATC
oxazepam; oral
1.4
18.7
1024
7818
KMAK, ,
NOMESCO Finland
1.3
18.7
1945
16421
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
7.7
18.7
26
34
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
18.6
224
1184
S97
ICPC
Chronic ulcer skin
1.9
18.6
243
1320
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
2.6
18.5
107
418
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
18.5
1368
10969
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.8
18.4
274
1551
L71.9
ICD-10 Finland
Rosacea, unspecified
2.4
18.3
125
529
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.6
18.2
526
3539
A08
ICPC
Swelling
1.9
18.2
238
1294
C84.0
ICD-10 Finland
Mycosis fungoides
21.8
18.1
26
12
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
18.1
240
1310
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.1
18.0
176
863
XW000
NOMESCO Finland
Bone marrow biopsy
2.1
18.0
162
770
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.0
18.0
205
1064
Z01.2
ICD-10 Finland
Dental examination
1.3
17.9
1850
15566
A06AD11
ATC
lactulose; oral
1.5
17.8
544
3705
XKD00
NOMESCO Finland
Uroflowmetry
1.6
17.8
487
3236
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.9
17.8
224
1201
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.7
17.8
313
1859
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
17.8
1603
13220
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
2.1
17.8
161
767
WW200
NOMESCO Finland
Immunization
2.4
17.8
117
487
L29.8
ICD-10 Finland
Other pruritus
3.2
17.7
68
212
XQ820
NOMESCO Finland
Exposure to medicinal substance
5.6
17.7
33
59
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
17.7
818
6054
A07EA06
ATC
budesonide; oral, local oral
2.2
17.6
155
730
R02
ICPC
Shortness of breath/dyspnoea
1.5
17.6
530
3599
K50.8
ICD-10 Finland
Other Crohn disease
3.2
17.5
70
224
QDH00
NOMESCO Finland
Avulsion of toe nail
7.8
17.4
24
31
R06AX13
ATC
loratadine; oral
1.5
17.4
568
3926
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.4
17.4
114
474
S02
ICPC
Pruritus
2.2
17.3
155
735
L40.9
ICD-10 Finland
Psoriasis, unspecified
3.0
17.3
77
262
Z71.9
ICD-10 Finland
Counselling, unspecified
1.7
17.3
327
1982
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.0
17.2
202
1058
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
17.2
412
2655
EB1AA, ,
SPAT
1.8
17.1
261
1487
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
17.1
342
2103
L51.9
ICD-10 Finland
Erythema multiforme, unspecified
6.6
17.0
27
41
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
16.9
486
3267
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
3.1
16.8
69
224
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
16.8
1025
7944
J01MA06
ATC
norfloxacin; oral
1.5
16.7
495
3346
D01AC02
ATC
miconazole; topical
1.8
16.7
275
1603
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
16.7
331
2033
L03AA02
ATC
filgrastim; parenteral
2.3
16.6
121
527
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.2
16.6
141
655
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
4.7
16.6
38
82
R13
ICD-10 Finland
Dysphagia
1.8
16.5
276
1616
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.7
16.5
301
1808
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.2
16.4
144
678
J01DA06
ATC
[U] cefuroxime
1.5
16.4
533
3676
SAA04
NOMESCO Finland
Special examination of mouth
1.9
16.4
210
1133
L52
ICD-10 Finland
Erythema nodosum
4.3
16.4
42
99
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
3.3
16.4
60
182
RS221, ,
NOMESCO Finland
3.1
16.4
69
228
R83
ICPC
Respiratory infection other
1.4
16.4
979
7561
N06AB04
ATC
citalopram; systemic
1.4
16.3
777
5769
R52.0
ICD-10 Finland
Acute pain
2.2
16.3
143
673
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.7
16.3
277
1630
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
16.3
1003
7783
N03AX09
ATC
lamotrigine; oral
2.0
16.2
181
933
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.1
16.2
156
762
WYA10
NOMESCO Finland
Emergency care or similar visit
1.7
16.2
277
1634
L30.4
ICD-10 Finland
Erythema intertrigo
3.0
16.2
70
235
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
16.1
507
3473
XQ845
NOMESCO Finland
Dermatoscopy
3.0
16.1
71
241
M79.1
ICD-10 Finland
Myalgia
1.5
16.0
573
4029
TAB00
NOMESCO Finland
Lumbar puncture
2.0
16.0
163
813
H01.0
ICD-10 Finland
Blepharitis
1.7
16.0
273
1609
A92
ICPC
Allergy/allergic reaction NOS
2.2
15.9
137
640
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.3
15.9
126
569
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.5
15.9
95
378
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
3.6
15.9
51
142
L04AB01
ATC
etanercept; parenteral
2.8
15.9
76
270
A07EC01
ATC
sulfasalazine; oral, rectal
1.7
15.8
305
1858
L40.5
ICD-10 Finland
Arthropathic psoriasis
2.8
15.8
77
276
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
15.8
525
3638
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
3.0
15.7
70
239
L04AA13
ATC
[U] leflunomide
2.4
15.7
107
453
R4190
NOMESCO Finland
Nutritional therapy
2.0
15.7
169
860
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
15.6
249
1439
F29
ICPC
Eye symptom/complaint other
1.6
15.6
417
2756
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
15.5
1114
8842
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.9
15.5
71
246
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.6
15.5
371
2388
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
4.3
15.4
39
91
R06AX26
ATC
fexofenadine; oral
1.7
15.4
264
1557
R2110
NOMESCO Finland
Giving the first information
1.7
15.3
266
1574
A07EA02
ATC
hydrocortisone; rectal
2.6
15.3
88
344
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
11.3
15.2
28
25
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
15.2
394
2583
R29
ICPC
Respiratory symptom/complaint other
1.7
15.2
268
1593
A12AA04
ATC
calcium carbonate; oral
2.9
15.2
69
238
U07
ICPC
Urine symptom/complaint other
1.6
15.1
334
2107
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
15.1
522
3643
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
15.1
256
1505
A11
ICPC
Chest pain NOS
1.6
15.1
324
2030
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.4
15.1
98
406
J01DA09
ATC
[U] cefadroxil
1.4
15.1
967
7538
H57.1
ICD-10 Finland
Ocular pain
2.0
15.0
159
804
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
4.0
15.0
42
106
ZXC15
NOMESCO Finland
Use of photodynamic technique
3.3
15.0
55
167
K07.60
ICD-10 Finland
Snapping jaw
1.9
15.0
200
1095
L60.0
ICD-10 Finland
Ingrowing nail
1.9
14.9
193
1046
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.3
14.9
111
489
R07.3
ICD-10 Finland
Other chest pain
1.6
14.8
385
2526
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.6
14.8
330
2088
Z2445
NOMESCO Finland
Psychologist
2.0
14.8
152
761
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
5.5
14.8
28
51
D01BA02
ATC
terbinafine; oral
1.4
14.7
900
6961
D05AX52
ATC
calcipotriol, combinations; topical
1.9
14.7
196
1073
M04AA01
ATC
allopurinol; systemic
1.5
14.7
433
2924
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.6
14.6
374
2444
R96
ICPC
Asthma
1.6
14.6
386
2543
N01
ICPC
Headache
1.5
14.6
442
3002
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.9
14.6
67
233
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
14.5
348
2240
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.8
14.5
72
261
R00.2
ICD-10 Finland
Palpitations
1.7
14.5
304
1894
DHB00
NOMESCO Finland
Excision of lesion of external nose
3.8
14.5
44
118
C08CA05
ATC
nifedipine; systemic
1.8
14.5
215
1217
L13.9
ICD-10 Finland
Bullous disorder, unspecified
4.6
14.4
34
75
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.4
14.4
101
433
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
14.4
712
5311
N06AX16
ATC
venlafaxine; oral
1.5
14.4
535
3786
J01FA01
ATC
erythromycin; systemic
1.5
14.4
498
3475
S76
ICPC
Skin infection other
1.8
14.4
205
1145
M01AH02
ATC
rofecoxib; oral
1.5
14.4
444
3027
WVA20
NOMESCO Finland
Medicine administration
2.3
14.3
112
504
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
14.3
594
4295
D01AE15
ATC
terbinafine; topical
1.7
14.3
250
1483
K90.0
ICD-10 Finland
Coeliac disease
2.2
14.3
120
556
L02
ICPC
Back symptom/complaint
1.6
14.3
397
2645
R01AD12
ATC
fluticasone furoate; nasal
1.3
14.2
1197
9701
H92.0
ICD-10 Finland
Otalgia
1.7
14.2
256
1531
U13
ICPC
Bladder symptom/complaint other
2.2
14.2
125
590
M79.7
ICD-10 Finland
Fibromyalgia
2.0
14.2
144
718
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.9
14.1
169
892
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
14.1
341
2199
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
14.1
265
1603
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.7
14.0
273
1667
EB1WA, ,
NOMESCO Finland
4.4
14.0
34
77
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
14.0
137
674
C08CA01
ATC
amlodipine; oral
1.3
14.0
1389
11514
L29
ICPC
Musculoskeletal sympt/complt other
1.6
14.0
346
2245
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
4.1
13.9
37
90
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
3.1
13.9
57
186
A03
ICPC
Fever
1.4
13.8
647
4779
L04AC05
ATC
ustekinumab; parenteral
5.0
13.8
29
58
K50.0
ICD-10 Finland
Crohn disease of small intestine
2.9
13.7
65
230
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
3.7
13.7
43
118
R5599
NOMESCO Finland
Other rehabilitation service
2.2
13.7
113
520
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
13.7
1747
14948
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
13.6
410
2778
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
5.1
13.6
28
55
C03DA01
ATC
spironolactone; oral
1.5
13.6
440
3028
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
13.6
149
764
G50.1
ICD-10 Finland
Atypical facial pain
2.6
13.5
75
288
N03AF01
ATC
carbamazepine; oral, rectal
1.9
13.5
182
999
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.8
13.5
30
63
M35.7
ICD-10 Finland
Hypermobility syndrome
2.8
13.5
65
232
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
3.1
13.4
54
174
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
13.4
418
2854
N05BA12
ATC
alprazolam; oral
1.6
13.4
361
2388
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.6
13.4
76
296
D06
ICPC
Abdominal pain localized other
1.6
13.3
347
2280
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
13.2
2087
18301
N05BE01
ATC
buspirone; oral
2.2
13.2
106
482
U01
ICPC
Dysuria/painful urination
1.6
13.2
314
2017
N03AG01
ATC
valproic acid; systemic, rectal
1.8
13.2
216
1258
L04
ICPC
Chest symptom/complaint
1.7
13.2
246
1486
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.0
13.2
138
696
M54.6
ICD-10 Finland
Pain in thoracic spine
1.7
13.2
274
1703
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.0
13.1
136
683
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.1
13.1
131
649
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
2.5
13.1
84
346
XCK00
NOMESCO Finland
Perimetry
1.7
13.1
218
1275
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.6
13.1
300
1909
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.2
13.1
50
156
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
13.1
349
2302
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
13.1
218
1276
WX110, ,
SPAT
1.7
13.1
217
1269
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.4
13.1
86
359
L30
ICD-10 Finland
Other dermatitis
2.3
13.1
102
459
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.7
13.1
220
1292
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
13.1
517
3702
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.3
13.1
99
440
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
5.9
13.0
23
39
A03FA02
ATC
cisapride; oral, rectal
1.7
13.0
264
1630
R03DC01
ATC
zafirlukast; oral
2.7
13.0
66
243
R49.01
ICD-10 Finland
Functional dysphonia
2.1
12.9
122
592
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.8
12.9
64
232
Z01.9
ICD-10 Finland
Special examination, unspecified
1.7
12.9
229
1364
R31
ICD-10 Finland
Unspecified haematuria
1.6
12.9
333
2181
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
12.9
1480
12469
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
3.0
12.8
55
184
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
4.9
12.8
28
58
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.7
12.8
231
1383
ZXC10
NOMESCO Finland
Use of laser
2.4
12.8
87
369
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.1
12.7
118
569
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
12.7
315
2043
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.0
12.7
55
185
Z94.0
ICD-10 Finland
Kidney transplant status
3.2
12.7
49
154
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.8
12.6
180
1006
S04
ICPC
Lump/swelling localized
1.5
12.6
405
2781
N05AH04
ATC
quetiapine; oral
1.4
12.6
634
4737
N03AE01
ATC
clonazepam; systemic
1.8
12.6
204
1185
RJ420, ,
NOMESCO Finland
4.8
12.6
28
59
M48.0
ICD-10 Finland
Spinal stenosis
1.5
12.6
425
2950
TGC00
NOMESCO Finland
Bronchial lavation
2.3
12.6
95
422
B01AB10
ATC
tinzaparin; parenteral
1.5
12.5
402
2760
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
12.5
216
1277
H01
ICPC
Ear pain/earache
1.5
12.5
456
3212
D10AF01
ATC
clindamycin; topical
1.9
12.5
165
901
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
6.2
12.5
21
34
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.4
12.4
44
131
H93.1
ICD-10 Finland
Tinnitus
1.7
12.4
253
1565
M05BA04
ATC
alendronic acid; oral
1.6
12.4
325
2137
M01AH05
ATC
etoricoxib; oral
1.3
12.3
2383
21331
K59.09
ICD-10 Finland
Constipation, unspecified
1.6
12.3
256
1591
C10AC01
ATC
colestyramine; oral
2.1
12.3
108
510
XA420
NOMESCO Finland
Extensive sleep examination
3.2
12.3
47
147
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
12.3
249
1538
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
12.2
2828
25844
J01CF05
ATC
flucloxacillin; systemic
1.6
12.2
259
1617
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
2.4
12.2
85
364
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.3
12.2
95
427
R04.0
ICD-10 Finland
Epistaxis
1.6
12.2
269
1696
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
12.2
217
1294
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
12.2
450
3178
EB1SA, ,
SPAT
1.8
12.2
197
1144
A11CC03
ATC
alfacalcidol; systemic
2.3
12.2
93
415
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
3.2
12.2
46
143
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
4.8
12.1
27
57
ZXC12
NOMESCO Finland
Pulse colorlaser
5.5
12.1
23
42
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.8
12.1
165
911
N02BF02
ATC
pregabalin; oral
1.6
12.0
252
1569
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.8
12.0
191
1103
M01AB05
ATC
diclofenac; systemic, rectal
1.3
12.0
2515
22688
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
12.0
390
2684
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.6
12.0
258
1617
G04CA02
ATC
tamsulosin; oral
1.4
12.0
658
4985
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
12.0
288
1855
1XC02, ,
NOMESCO Finland
3.8
12.0
36
96
G72.9
ICD-10 Finland
Myopathy, unspecified
3.6
12.0
39
110
L01
ICPC
Neck symptom/complaint
1.4
11.9
618
4637
D06BB03
ATC
aciclovir; topical
1.8
11.9
172
966
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
11.9
297
1930
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.2
11.9
101
471
R20.0
ICD-10 Finland
Anaesthesia of skin
4.8
11.9
26
54
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
3.3
11.9
43
130
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.6
11.9
297
1931
TK800
NOMESCO Finland
Hemodialysis
2.4
11.9
77
320
A10AB05
ATC
insulin aspart; parenteral
1.6
11.9
271
1725
M54.8
ICD-10 Finland
Other dorsalgia
1.8
11.8
177
1005
DAB00
NOMESCO Finland
Excision of lesion of auricle
3.5
11.8
39
111
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
3.7
11.8
36
97
R23
ICD-10 Finland
Other skin changes
3.0
11.8
52
177
PA6AD
NOMESCO Finland
CT of neck arteries
1.9
11.8
135
704
SBB10
NOMESCO Finland
Dental impressions
1.6
11.7
253
1588
L28.2
ICD-10 Finland
Other prurigo
4.6
11.6
27
59
K02.1
ICD-10 Finland
Caries of dentine
1.3
11.6
2243
20015
WW500
NOMESCO Finland
Blood transfusion
1.9
11.6
149
807
D86.0
ICD-10 Finland
Sarcoidosis of lung
3.0
11.6
49
163
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
11.6
725
5607
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.4
11.5
77
324
H03AA01
ATC
levothyroxine sodium; systemic
1.3
11.5
883
7031
A07DA03
ATC
loperamide; oral
2.0
11.5
118
591
A41.9
ICD-10 Finland
Sepsis, unspecified
2.0
11.5
130
674
ZX112
NOMESCO Finland
Subcutaneous
2.3
11.5
85
374
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
11.5
390
2708
T78.3
ICD-10 Finland
Angioneurotic oedema
2.7
11.5
58
213
M79.3
ICD-10 Finland
Panniculitis, unspecified
5.7
11.5
21
37
K92.1
ICD-10 Finland
Melaena
1.8
11.5
184
1067
SFA30
NOMESCO Finland
Three-surface restoration
1.3
11.4
1544
13218
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
11.4
2251
20114
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.1
11.4
103
492
LCA06
NOMESCO Finland
Biopsy of endometrium
1.5
11.4
438
3115
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.6
11.4
257
1630
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.4
11.4
458
3286
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.8
11.4
155
855
-60
ICPC
Result test/procedure
1.7
11.4
203
1212
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.8
11.4
173
987
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
3.7
11.4
35
95
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
5.4
11.3
22
41
C07AA05
ATC
propranolol; systemic
1.3
11.3
728
5650
N03AF02
ATC
oxcarbazepine; oral
2.0
11.3
120
609
Z00.0
ICD-10 Finland
General medical examination
1.4
11.3
693
5340
N03AX11
ATC
topiramate; oral
2.2
11.3
95
442
R01AD05
ATC
budesonide; nasal
1.6
11.3
264
1691
D11AH01
ATC
tacrolimus; topical
3.1
11.2
45
145
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
2.6
11.2
64
250
J02AB02
ATC
ketoconazole; oral
2.1
11.2
104
502
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
11.2
1014
8255
L56.8
ICD-10 Finland
Other specified acute skin changes due to ultraviolet radiation
9.6
11.2
22
23
C05AA08
ATC
fluocortolone; rectal, topical
1.4
11.2
469
3390
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
11.2
463
3340
L04AA11
ATC
[U] etanercept
4.7
11.2
25
53
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.8
11.2
162
912
L21.0
ICD-10 Finland
Seborrhoea capitis
3.1
11.1
46
151
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.2
11.1
88
399
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.0
11.1
123
634
G47.3
ICD-10 Finland
Sleep apnoea
1.3
11.1
771
6051
L08.0
ICD-10 Finland
Pyoderma
3.1
11.1
44
141
K80
ICPC
Cardiac arrhythmia NOS
1.5
11.1
317
2125
U71
ICPC
Cystitis/urinary infection other
1.6
11.1
270
1746
M01AX17
ATC
nimesulide; oral
1.3
11.0
827
6564
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
10.9
1155
9587
R25.2
ICD-10 Finland
Cramp and spasm
2.2
10.9
92
428
J20
ICD-10 Finland
Acute bronchitis
1.5
10.9
374
2602
S99
ICPC
Skin disease other
2.3
10.9
84
377
B01AB04
ATC
dalteparin; parenteral
1.7
10.9
180
1053
L01BC02
ATC
fluorouracil; systemic, topical
4.1
10.9
29
71
UJF30, ,
SPAT
3.1
10.8
44
143
S01
ICPC
Pain/tenderness of skin
1.7
10.8
178
1040
M10.9
ICD-10 Finland
Gout, unspecified
1.6
10.8
220
1361
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
2.4
10.8
70
291
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
10.8
460
3335
C09CA06
ATC
candesartan; oral
1.3
10.8
870
6973
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.2
10.7
90
418
XG460
NOMESCO Finland
Short time oxymetry
2.7
10.7
57
215
L13.0
ICD-10 Finland
Dermatitis herpetiformis
4.6
10.7
25
55
N02BF01
ATC
gabapentin; oral
1.5
10.7
372
2597
RS222, ,
NOMESCO Finland
2.8
10.7
51
182
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
10.7
187
1112
N18.0
ICD-10 Finland
End-stage renal disease
3.2
10.7
41
129
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.7
10.7
201
1219
R03BA08
ATC
ciclesonide; inhalant
1.5
10.7
313
2110
A99
ICPC
Disease/condition unspecnature/site
1.5
10.6
388
2733
R52.2
ICD-10 Finland
Other chronic pain
1.9
10.6
139
758
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
10.6
286
1892
R03BA05
ATC
fluticasone; inhalant
1.3
10.6
660
5094
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
4.1
10.6
28
68
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.2
10.6
91
427
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.1
10.6
99
480
A60
ICPC
General and Unspecified, Result test/procedure
1.8
10.6
158
897
ZXD35
NOMESCO Finland
Usual procedure
2.0
10.6
116
596
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
10.6
423
3032
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
10.5
353
2445
C07AB02
ATC
metoprolol; systemic
1.3
10.5
672
5205
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.9
10.5
134
724
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
10.5
501
3703
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.6
10.5
228
1433
F45.0
ICD-10 Finland
Somatization disorder
4.4
10.5
26
60
R30.0
ICD-10 Finland
Dysuria
1.8
10.5
164
944
L01BB01, ,
ATC
10.0
10.5
20
20
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
9.2
10.5
21
23
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic
2.1
10.5
100
489
A03CA02
ATC
clidinium and psycholeptics; oral
1.7
10.5
195
1179
WW200, ,
SPAT
0.8
10.5
732
9181
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.0
10.4
115
592
ZX108
NOMESCO Finland
Inhalation
3.5
10.4
35
101
B35.3
ICD-10 Finland
Tinea pedis
1.8
10.4
166
961
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.6
10.4
217
1351
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.5
10.4
357
2485
S80.0
ICD-10 Finland
Contusion of knee
1.6
10.4
276
1820
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
3.4
10.4
37
111
N06AB06
ATC
sertraline; oral
1.4
10.4
411
2940
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
3.3
10.4
38
116
D68.8
ICD-10 Finland
Other specified coagulation defects
2.9
10.4
47
163
B02.9
ICD-10 Finland
Zoster without complication
1.6
10.4
250
1613
F51.0
ICD-10 Finland
Nonorganic insomnia
1.4
10.3
621
4765
D05AX02
ATC
calcipotriol; topical
1.9
10.3
129
693
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.2
10.3
80
360
D07AC03
ATC
desoximetasone; topical
2.5
10.3
63
255
N17
ICPC
Vertigo/dizziness
1.4
10.3
474
3484
R39.1
ICD-10 Finland
Other difficulties with micturition
2.0
10.3
102
506
N05BA06
ATC
lorazepam; systemic, sublingual
1.7
10.3
174
1025
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.5
10.2
277
1834
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.2
10.2
87
407
XF402
NOMESCO Finland
ECG with work load test
1.5
10.2
343
2377
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.1
10.2
91
434
R03AC12
ATC
salmeterol; inhalant
1.8
10.2
153
871
K07
ICPC
Swollen ankles/oedema
1.7
10.2
173
1021
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
13.1
10.1
17
13
ZX100
NOMESCO Finland
Oral
2.6
10.1
55
210
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.6
10.1
248
1605
J46
ICD-10 Finland
Status asthmaticus
2.0
10.1
107
543
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.3
10.1
37
113
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.7
10.1
193
1175
I78.9
ICD-10 Finland
Disease of capillaries, unspecified
5.3
10.1
20
38
R03BB04
ATC
tiotropium bromide; inhalant
1.5
10.1
332
2291
K59.0
ICD-10 Finland
Constipation
1.7
10.1
202
1245
H15.1
ICD-10 Finland
Episcleritis
2.5
10.1
59
234
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
1.7
10.1
163
948
K96
ICPC
Haemorrhoids
2.0
10.1
109
558
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
10.0
905
7351
WX892
NOMESCO Finland
Monitored bed care
1.6
10.0
252
1642
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
4.8
10.0
22
46
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.5
10.0
328
2263
L01.1
ICD-10 Finland
Impetiginization of other dermatoses
3.7
10.0
31
85
J01CA08
ATC
pivmecillinam; oral
1.2
9.9
1599
13901
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
9.9
218
1375
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
9.9
209
1305
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.1
9.9
93
452
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
2.2
9.9
81
373
M54.2
ICD-10 Finland
Cervicalgia
1.5
9.9
285
1913
S06.0
ICD-10 Finland
Concussion
1.4
9.8
375
2663
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
1.9
9.8
112
584
G43.9
ICD-10 Finland
Migraine, unspecified
1.6
9.8
221
1403
L98.6
ICD-10 Finland
Other infiltrative disorders of skin and subcutaneous tissue
20.1
9.8
14
7
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
1.6
9.8
197
1216
S12
ICPC
Insect bite/sting
1.5
9.8
309
2115
UJF92
NOMESCO Finland
Capsular endoscopy
2.2
9.8
81
375
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.9
9.8
113
592
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.9
9.8
121
649
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
9.8
532
4020
L04AD02
ATC
tacrolimus; systemic
2.9
9.7
43
147
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.4
9.7
66
281
N06
ICPC
Sensation disturbance other
3.0
9.7
41
137
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
3.0
9.7
41
137
N76.0
ICD-10 Finland
Acute vaginitis
1.6
9.7
233
1503
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.6
9.6
250
1640
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
2.9
9.6
43
148
L29.0
ICD-10 Finland
Pruritus ani
2.8
9.6
45
159
N05CF02
ATC
zolpidem; oral
1.3
9.6
609
4709
WZA10
NOMESCO Finland
Extensive medical or dental certificate
2.6
9.6
55
216
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.0
9.6
96
478
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
3.5
9.6
32
92
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.8
9.6
136
761
H02.4
ICD-10 Finland
Ptosis of eyelid
2.0
9.6
104
533
R01AD11
ATC
triamcinolone; nasal
1.5
9.6
298
2034
RS220, ,
NOMESCO Finland
2.6
9.6
52
199
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
9.5
407
2951
SXC03
NOMESCO Finland
Other oral or dental procedure
2.9
9.5
43
149
SFA10
NOMESCO Finland
One-surface restoration
1.2
9.5
2069
18533
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
9.5
2557
23405
D10AX03
ATC
azelaic acid; topical
1.6
9.5
233
1510
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
3.8
9.5
28
74
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
1.9
9.5
121
656
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
9.4
931
7643
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
2.8
9.4
47
172
E66.8
ICD-10 Finland
Other obesity
1.6
9.4
198
1237
M01AC06
ATC
meloxicam; systemic, rectal
1.2
9.4
1297
11076
S10
ICPC
Boil/carbuncle
1.6
9.4
204
1285
F61.0
ICD-10 Finland
Mixed personality disorders
2.5
9.3
57
231
L04AB06
ATC
golimumab; parenteral
3.2
9.3
36
114
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
4.9
9.3
20
41
B02AA02
ATC
tranexamic acid; systemic
1.4
9.3
536
4085
NHQ40
NOMESCO Finland
Amputation of toe
2.6
9.3
53
208
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.5
9.3
54
214
K11.2
ICD-10 Finland
Sialoadenitis
1.9
9.3
117
632
L72.1
ICD-10 Finland
Trichilemmal cyst
1.6
9.3
232
1511
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
9.2
261
1746
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.3
9.2
67
294
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
3.5
9.2
30
85
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
2.7
9.2
48
180
XX9LA
NOMESCO Finland
Complementary kinetic X-ray examination without contrast
3.1
9.2
37
120
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
1.9
9.2
113
605
R03AC13
ATC
formoterol; inhalant
1.7
9.2
175
1066
A10AE05
ATC
insulin detemir; parenteral
1.7
9.2
175
1066
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
13.7
9.2
15
11
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.4
9.2
368
2639
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
9.2
291
1995
J30.3
ICD-10 Finland
Other allergic rhinitis
1.8
9.1
127
707
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.7
9.1
164
983
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
2.4
9.1
60
252
K08.80
ICD-10 Finland
Toothache NOS
1.5
9.1
316
2206
A23
ICPC
Risk factor NOS
1.4
9.1
347
2467
L04AA17
ATC
[U] adalimumab
4.8
9.1
20
42
R03AK08
ATC
formoterol and beclometasone; inhalant
1.7
9.0
158
940
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
9.0
506
3838
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.4
9.0
61
260
B34.9
ICD-10 Finland
Viral infection, unspecified
1.9
9.0
104
546
N06AB10
ATC
escitalopram; oral
1.3
9.0
715
5708
H29
ICPC
Ear symptom/complaint other
1.4
8.9
433
3208
B01AA03
ATC
warfarin; systemic
1.3
8.9
589
4578
J01DC02
ATC
cefuroxime; systemic
1.6
8.9
189
1182
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.1
8.9
79
376
GD1AA, ,
SPAT
1.3
8.9
565
4366
Z00.8
ICD-10 Finland
Other general examinations
1.5
8.9
279
1907
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
8.9
793
6422
R20.8
ICD-10 Finland
Other and unspecified disturbances of skin sensation
3.4
8.9
31
92
R03BC03
ATC
nedocromil; inhalant
1.6
8.9
230
1510
L73.9
ICD-10 Finland
Follicular disorder, unspecified
3.9
8.9
25
64
R5110, ,
SPAT
1.5
8.8
310
2167
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
8.8
358
2571
S01BA01
ATC
dexamethasone; ophthalmic
1.8
8.8
119
656
S06
ICPC
Rash localized
1.6
8.8
195
1233
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.8
8.8
130
737
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
6.8
8.8
21
31
K03.00
ICD-10 Finland
Approximal wear
1.5
8.8
274
1871
K02.0
ICD-10 Finland
Caries limited to enamel
1.3
8.8
720
5767
K04.08
ICD-10 Finland
Other specified pulpit
1.5
8.8
255
1716
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.6
8.8
187
1172
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
1.6
8.8
182
1133
RS230, ,
NOMESCO Finland
3.8
8.8
26
69
S20.2
ICD-10 Finland
Contusion of thorax
1.6
8.8
180
1118
R60.1
ICD-10 Finland
Generalized oedema
3.2
8.8
34
108
L26
ICD-10 Finland
Exfoliative dermatitis
9.5
8.8
17
18
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
3.4
8.8
30
88
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
8.7
1435
12462
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.5
8.7
228
1500
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
8.7
209
1348
L86
ICPC
Back syndrome with radiating pain
1.6
8.7
217
1412
D12
ICPC
Constipation
1.8
8.7
134
770
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.6
8.6
48
186
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
4.2
8.6
22
52
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.5
8.6
243
1624
R52.1
ICD-10 Finland
Chronic intractable pain
2.9
8.6
38
130
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
2.6
8.6
49
192
L18
ICPC
Muscle pain
1.7
8.6
148
877
SFA20
NOMESCO Finland
Two-surface restoration
1.2
8.6
2187
19814
AN1
HP
Coronary angiography
1.4
8.6
328
2330
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.2
8.6
71
329
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.6
8.6
213
1384
6BA02, ,
NOMESCO Finland
4.8
8.6
19
40
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.6
8.6
184
1156
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
1.6
8.6
175
1086
M03BX01
ATC
baclofen; systemic
2.2
8.5
67
304
J01XC01
ATC
fusidic acid; systemic
2.6
8.5
49
193
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.4
8.5
499
3809
L41.1
ICD-10 Finland
Pityriasis lichenoides chronica
16.3
8.5
13
8
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
2.8
8.5
42
153
D10BA01
ATC
isotretinoin; oral
1.6
8.5
196
1252
R01AD01
ATC
beclometasone; nasal
1.3
8.5
526
4050
Z53.8
ICD-10 Finland
Procedure not carried out for other reasons
3.8
8.5
25
66
XLA10, ,
NOMESCO Finland
1.6
8.5
171
1057
M07.3
ICD-10 Finland
Other psoriatic arthropathies
2.7
8.5
43
159
F01
ICPC
Eye pain
1.9
8.5
106
571
E000004, ,
ATC
2.1
8.5
73
344
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.9
8.5
111
607
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.7
8.5
157
950
L94.9
ICD-10 Finland
Localized connective tissue disorder, unspecified
20.1
8.5
12
6
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
2.2
8.5
66
299
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.7
8.5
155
935
D06BB04
ATC
podophyllotoxin; topical
1.7
8.4
153
920
D02
ICPC
Abdominal pain epigastric
1.5
8.4
226
1495
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
2.8
8.4
40
143
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
1.8
8.4
112
616
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.0
8.4
87
440
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.7
8.4
162
991
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
2.1
8.3
77
373
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.7
8.3
135
787
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
4.7
8.3
19
41
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.6
8.3
168
1039
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
3.0
8.3
36
122
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
2.2
8.3
66
301
D29
ICPC
Digestive symptom/complaint other
1.9
8.3
93
483
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
8.3
249
1687
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
2.8
8.3
40
144
Z00.6
ICD-10 Finland
Examination for normal comparison and control in clinical research programme
2.6
8.3
47
184
-1, ,
NOMESCO Finland
1.2
8.3
1169
9977
ZZA00
NOMESCO Finland
Split skin graft
2.0
8.3
87
442
S87
ICPC
Dermatitis/atopic eczema
2.0
8.3
89
456
R03BB01
ATC
ipratropium bromide; inhalant
1.8
8.3
124
707
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.0
8.3
82
408
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.7
8.3
145
865
XQ899
NOMESCO Finland
Other assessment of skin
4.1
8.2
22
54
L50.1
ICD-10 Finland
Idiopathic urticaria
3.1
8.2
33
107
Z71.1
ICD-10 Finland
Person with feared complaint in whom no diagnosis is made
2.9
8.2
36
123
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.6
8.2
173
1082
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
3.2
8.2
31
97
P06
ICPC
Sleep disturbance
1.4
8.2
446
3367
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.7
8.2
142
844
L99
ICPC
Musculoskeletal disease other
2.0
8.2
86
437
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.4
8.2
338
2437
K03.28
ICD-10 Finland
Other erosion of teeth
2.0
8.2
90
465
-54
ICPC
Repair/fix-suture/cast/prosth device
2.1
8.2
74
356
-59
ICPC
Other therap proced/minor surg NEC
1.9
8.2
92
479
SPAT1336
SPAT
Request for examination
1.8
8.2
126
725
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.4
8.2
307
2176
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.3
8.2
566
4430
D01AA02
ATC
natamycin; topical
2.1
8.2
75
363
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
3.9
8.1
23
59
K10.3
ICD-10 Finland
Alveolitis of jaws
1.6
8.1
162
999
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.6
8.1
207
1354
R04.2
ICD-10 Finland
Haemoptysis
1.8
8.1
108
594
RJ411, ,
NOMESCO Finland
3.6
8.1
26
73
L28.1
ICD-10 Finland
Prurigo nodularis
2.9
8.1
36
124
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
8.1
675
5416
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
3.5
8.1
27
78
L50
ICD-10 Finland
Urticaria
2.2
8.1
66
305
137
Kela drug reimbursment
Uraemia requiring dialysis
3.0
8.1
35
119
A06AC51
ATC
ispaghula, combinations; oral
1.6
8.1
160
986
R01AC01
ATC
cromoglicic acid; nasal
1.8
8.1
122
698
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.6
8.1
195
1261
RS121, ,
NOMESCO Finland
3.2
8.1
30
93
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.4
8.1
383
2829
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.2
8.1
1168
9994
RS313, ,
NOMESCO Finland
6.8
8.0
19
28
RJ412, ,
NOMESCO Finland
6.8
8.0
19
28
R55
ICD-10 Finland
Syncope and collapse
1.4
8.0
367
2692
207
Kela drug reimbursment
Chronic arrhythmias
1.3
8.0
504
3888
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
3.0
8.0
34
114
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
8.9
8.0
16
18
SDA03
NOMESCO Finland
Periodontal treatment
1.2
8.0
1488
13053
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.6
8.0
161
996
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.4
8.0
317
2269
S16
ICPC
Bruise/contusion
1.8
8.0
107
590
D72.1
ICD-10 Finland
Eosinophilia
4.1
8.0
21
51
N05CD07
ATC
temazepam; oral
1.4
8.0
374
2756
D04
ICPC
Rectal/anal pain
2.3
8.0
57
249
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.6
8.0
163
1012
XA800
NOMESCO Finland
Neuropsychological investigation
1.7
8.0
141
843
GX1E5, ,
SPAT
2.4
8.0
50
206
C08DB01
ATC
diltiazem; oral
1.6
8.0
161
997
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.5
7.9
267
1853
A98
ICPC
Health maint/preventive medicine
1.4
7.9
4050
39396
HA1AE, ,
SPAT
1.7
7.9
129
754
L71
ICD-10 Finland
Rosacea
1.9
7.9
97
520
R12
ICD-10 Finland
Heartburn
1.4
7.9
287
2021
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.7
7.9
137
815
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.1
7.9
71
341
K50
ICD-10 Finland
Crohn disease [regional enteritis]
4.4
7.9
19
43
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
2.7
7.9
41
154
L08
ICPC
Shoulder symptom/complaint
1.3
7.9
816
6723
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
7.9
2569
23738
P29
ICPC
Psychological sympt/compl other
1.5
7.9
261
1806
S01AD03
ATC
aciclovir; ophthalmic
1.8
7.9
121
696
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
2.3
7.8
57
251
R41.3
ICD-10 Finland
Other amnesia
1.8
7.8
107
594
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
2.3
7.8
56
245
C10AA03
ATC
pravastatin; oral
1.5
7.8
227
1529
S07
ICPC
Rash generalized
3.5
7.8
26
75
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.4
7.8
373
2758
WX890
NOMESCO Finland
Intesive care monitoring
3.2
7.8
29
90
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
3.0
7.8
33
111
HA1AA, ,
SPAT
1.9
7.8
92
488
L05
ICPC
Flank/axilla symptom/complaint
1.5
7.7
223
1499
TQW40
NOMESCO Finland
Remowal of suture of skin
1.5
7.7
233
1581
L20
ICPC
Joint symptom/complaint NOS
1.7
7.7
136
812
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.1
7.7
70
337
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
2.4
7.7
50
209
XX2XW
NOMESCO Finland
Other teleradiological consultation
3.7
7.7
24
66
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
1.5
7.7
202
1330
L84
ICD-10 Finland
Corns and callosities
1.8
7.7
117
670
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.0
7.7
82
419
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.9
7.7
92
489
S01GX02
ATC
levocabastine; ophthalmic
1.6
7.7
195
1275
R51
ICD-10 Finland
Headache
1.6
7.7
192
1251
R49.08
ICD-10 Finland
Other specified dysphonia
2.0
7.7
79
399
WX290, ,
SPAT
1.8
7.7
116
664
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
3.1
7.7
30
96
J01FA15
ATC
telithromycin; oral
1.4
7.7
328
2380
R06.4
ICD-10 Finland
Hyperventilation
2.3
7.7
55
241
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
7.4
7.7
17
23
WZA90
NOMESCO Finland
Other medical or dental certificate
1.3
7.7
813
6716
DAB10
NOMESCO Finland
Partial excision of auricle
4.5
7.6
18
40
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
2.3
7.6
54
235
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
2.8
7.6
37
134
K85
ICPC
Elevated blood pressure
1.3
7.6
583
4623
TFP20
NOMESCO Finland
Cardiodefibrillation
1.5
7.6
216
1448
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.0
7.6
76
380
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
7.6
410
3091
A07AA09
ATC
vancomycin; oral
2.4
7.6
51
217
K04
ICPC
Palpitations/awareness of heart
1.6
7.6
186
1207
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
7.6
743
6079
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
1.8
7.6
110
622
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.3
7.6
57
255
A10AE04
ATC
insulin glargine; parenteral
1.4
7.6
311
2241
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.6
7.6
166
1050
N05AN01
ATC
lithium; oral
2.0
7.5
76
381
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
7.5
920
7719
L93.1
ICD-10 Finland
Subacute cutaneous lupus erythematosus
10.0
7.5
14
14
M30.0
ICD-10 Finland
Polyarteritis nodosa
10.0
7.5
14
14
L56.4
ICD-10 Finland
Polymorphous light eruption
3.8
7.5
22
58
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
7.5
579
4597
M54.3
ICD-10 Finland
Sciatica
1.5
7.5
196
1291
A02BA04
ATC
nizatidine; systemic
1.5
7.5
239
1642
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
2.5
7.5
46
188
VALMI, ,
NOMESCO Finland
1.3
7.5
845
7030
Z02.7
ICD-10 Finland
Issue of medical certificate
1.5
7.5
253
1759
S01KA02
ATC
hypromellose; ophthalmic
2.2
7.5
62
289
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.4
7.4
270
1903
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.0
7.4
74
370
K60.0
ICD-10 Finland
Acute anal fissure
2.4
7.4
46
189
N05AX08
ATC
risperidone; systemic
1.4
7.4
279
1980
C09CA01
ATC
losartan; oral
1.2
7.4
872
7289
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
1.6
7.4
146
900
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
1.9
7.4
82
426
R51.81
ICD-10 Finland
Facial pain NOS
1.9
7.4
84
440
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.8
7.4
34
120
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
1.7
7.4
115
665
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.8
7.3
104
584
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
7.3
360
2673
RL210, ,
NOMESCO Finland
4.0
7.3
20
50
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.5
7.3
228
1558
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
2.3
7.3
55
246
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.4
7.3
387
2909
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.8
7.3
107
607
SDA01
NOMESCO Finland
Periodontal treatment, very brief
1.2
7.3
1014
8623
N64.4
ICD-10 Finland
Mastodynia
1.7
7.3
115
667
K61.0
ICD-10 Finland
Anal abscess
2.3
7.3
53
234
K12.10
ICD-10 Finland
Stomatitis NOS
3.1
7.3
29
94
D01AE16
ATC
amorolfine; topical
1.4
7.3
380
2851
D10
ICPC
Vomiting
1.5
7.2
199
1325
S63.6
ICD-10 Finland
Sprain and strain of finger(s)
1.7
7.2
124
736
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
2.5
7.2
44
179
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
7.2
600
4808
M01AE02
ATC
naproxen; oral, rectal
1.2
7.2
2118
19317
-62
ICPC
Administrative procedure
1.8
7.2
95
522
H20.1
ICD-10 Finland
Chronic iridocyclitis
2.7
7.2
38
144
NH1FA, ,
SPAT
4.3
7.2
18
42
B35.1
ICD-10 Finland
Tinea unguium
1.5
7.2
217
1474
L03AA13
ATC
pegfilgrastim; parenteral
1.6
7.2
152
953
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
2.4
7.2
46
192
WX213
NOMESCO Finland
Lower leg blockade
2.8
7.1
34
122
L15
ICPC
Knee symptom/complaint
1.2
7.1
908
7649
B02
ICD-10 Finland
Zoster [herpes zoster]
1.6
7.1
159
1010
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.4
7.1
344
2549
S15
ICPC
Foreign body in skin
1.5
7.1
217
1478
N30
ICD-10 Finland
Cystitis
1.4
7.1
301
2181
R39.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the urinary system
2.8
7.1
33
117
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
7.1
194
1291
R01AD58
ATC
fluticasone, combinations; nasal
1.2
7.1
879
7383
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.0
7.1
74
377
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
5.6
7.0
19
34
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
1.7
7.0
119
704
L98.1
ICD-10 Finland
Factitial dermatitis
8.8
7.0
14
16
J01MA01
ATC
ofloxacin; systemic
1.4
7.0
252
1771
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
2.3
7.0
48
206
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.7
7.0
134
819
L53.8
ICD-10 Finland
Other specified erythematous conditions
4.2
7.0
18
43
SBA10
NOMESCO Finland
Measurement of salivary flow rate
2.5
7.0
40
158
N48.1
ICD-10 Finland
Balanoposthitis
2.0
7.0
76
392
UJD02
NOMESCO Finland
Gastroscopy
1.6
7.0
151
952
V03AE01
ATC
polystyrene sulfonate; oral
2.5
7.0
42
170
ELA30
NOMESCO Finland
Biopsy of salivary gland
7.0
7.0
16
23
M19.8
ICD-10 Finland
Other specified arthrosis
1.6
7.0
142
882
C82.1
ICD-10 Finland
Follicular lymphoma grade II
3.5
7.0
23
66
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
3.2
7.0
27
86
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
2.1
7.0
60
284
F03
ICPC
Eye discharge
1.5
7.0
240
1675
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.1
6.9
61
291
SFA00
NOMESCO Finland
Small restoration
1.3
6.9
479
3745
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
2.3
6.9
50
220
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
6.9
867
7288
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
6.9
1499
13295
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
1.8
6.9
94
522
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
6.9
256
1811
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.2
6.9
778
6465
EKA10
NOMESCO Finland
iopsy of buccal mucosa
1.9
6.9
79
415
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
1.9
6.9
76
394
P74
ICPC
Anxiety disorder/anxiety state
1.6
6.9
156
995
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.3
6.9
749
6199
N04BC05
ATC
pramipexole; oral
1.4
6.9
250
1762
S01GX05
ATC
lodoxamide; ophthalmic
2.3
6.9
50
221
M03AX01
ATC
botulinum toxin; parenteral
2.3
6.9
50
221
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
2.3
6.9
50
221
G01AA10
ATC
clindamycin; vaginal
1.3
6.8
500
3940
S11
ICPC
Skin infection post-traumatic
2.4
6.8
43
178
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
2.1
6.8
61
293
B37.0
ICD-10 Finland
Candidal stomatitis
2.5
6.8
42
172
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
2.5
6.8
41
166
SBA00
NOMESCO Finland
Microbiological examinations
1.8
6.8
89
488
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
8.3
6.8
14
17
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.4
6.8
332
2464
A10AC01
ATC
insulin (human); parenteral
1.5
6.8
234
1633
B37.2
ICD-10 Finland
Candidiasis of skin and nail
2.8
6.8
33
120
S02.51
ICD-10 Finland
Fracture of tooth, open
1.4
6.8
310
2276
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.6
6.8
165
1071
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.8
6.8
87
475
J01DA08
ATC
[U] cefaclor
1.4
6.8
354
2657
QAE99, ,
SPAT
2.6
6.8
38
149
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
2.4
6.8
43
179
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
2.5
6.7
40
161
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
5.6
6.7
18
32
L02.0
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of face
2.2
6.7
53
242
K91.9
ICD-10 Finland
Postprocedural disorder of digestive system, unspecified
16.7
6.7
10
6
M02AA15
ATC
diclofenac; topical
1.5
6.7
235
1644
S01BA04
ATC
prednisolone; ophthalmic
2.0
6.7
69
349
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
3.1
6.7
27
88
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.1
6.7
58
275
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.7
6.7
107
623
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
6.7
270
1939
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
1.7
6.7
124
752
B01AC04
ATC
clopidogrel; oral
1.3
6.7
496
3914
A02BC04
ATC
rabeprazole; oral
1.4
6.7
289
2101
L71.0
ICD-10 Finland
Perioral dermatitis
2.1
6.7
62
302
A12AA12
ATC
[U] calcium acetate
7.2
6.7
15
21
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
6.7
668
5473
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
2.7
6.7
33
121
XG405
NOMESCO Finland
Education on PEF monitoring
2.2
6.7
51
230
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.1
6.7
63
309
XA421
NOMESCO Finland
Nocturnal polygraphy
3.4
6.7
23
68
L09
ICPC
Arm symptom/complaint
1.6
6.7
168
1099
SCA01
NOMESCO Finland
Preventive oral health care, short
1.2
6.6
1037
8913
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.8
6.6
102
588
I20.09
ICD-10 Finland
Unstable angina
1.6
6.6
165
1076
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
2.8
6.6
32
116
R05FB02
ATC
cough suppressants and expectorants; systemic
1.2
6.6
1301
11427
R053, ,
ICD-10 Finland
1.7
6.6
126
770
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.0
6.6
64
317
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
4.0
6.6
18
45
ECA20
NOMESCO Finland
Biopsy of gingiva
2.4
6.6
44
187
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.5
6.6
182
1214
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
2.4
6.6
42
175
L85.3
ICD-10 Finland
Xerosis cutis
2.5
6.6
39
157
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
3.6
6.6
21
59
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
6.6
1776
16038
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
2.9
6.6
29
100
N05AH03
ATC
olanzapine; systemic
1.5
6.6
200
1363
L60.3
ICD-10 Finland
Nail dystrophy
3.3
6.5
24
74
B09
ICD-10 Finland
Unspecified viral infection characterized by skin and mucous membrane lesions
8.7
6.5
13
15
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
4.2
6.5
17
41
M53.9
ICD-10 Finland
Dorsopathy, unspecified
3.0
6.5
28
95
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
2.0
6.5
63
312
X58
ICD-10 Finland
Exposure to other specified factors
1.3
6.5
484
3821
EMAK, ,
NOMESCO Finland
1.7
6.5
114
682
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.4
6.5
238
1681
WX320
NOMESCO Finland
Spinalanesthesy
1.2
6.5
843
7110
TQW40, ,
SPAT
1.4
6.5
333
2492
S02.50
ICD-10 Finland
Fracture of tooth, closed
2.0
6.5
68
347
H00.00
ICD-10 Finland
Hordeolum
1.6
6.5
155
1002
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
1.9
6.5
73
382
H02BX01
ATC
methylprednisolone, combinations; systemic
1.6
6.5
155
1003
QDH05
NOMESCO Finland
Correction of deformity of toe nail
5.3
6.4
18
34
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
5.3
6.4
18
34
F50.9
ICD-10 Finland
Eating disorder, unspecified
2.6
6.4
35
135
F02
ICPC
Red eye
1.6
6.4
147
940
C08CA13
ATC
lercanidipine; oral
1.3
6.4
475
3747
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
3.1
6.4
25
80
A01AB10
ATC
natamycin; local oral
1.8
6.4
98
564
L41.2
ICD-10 Finland
Lymphomatoid papulosis
70.0
6.4
7
*
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
6.4
1745
15756
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.7
6.4
104
609
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.6
6.4
148
949
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.5
6.4
188
1271
D22
ICD-10 Finland
Melanocytic naevi
1.5
6.4
182
1223
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.6
6.4
137
864
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
2.8
6.4
31
113
R06.2
ICD-10 Finland
Wheezing
1.6
6.4
150
967
R10.2
ICD-10 Finland
Pelvic and perineal pain
1.9
6.4
78
420
Z75.9
ICD-10 Finland
Unspecified problem related to medical facilities and other health care
3.7
6.4
19
51
JN3AD
NOMESCO Finland
Abdominal CT examination
1.3
6.3
436
3406
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
2.1
6.3
54
255
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
1.9
6.3
75
399
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
2.5
6.3
37
148
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
3.0
6.3
26
86
N06AA10
ATC
nortriptyline; systemic
1.9
6.3
69
357
S99.9
ICD-10 Finland
Unspecified injury of ankle and foot
1.8
6.3
81
442
R09.1
ICD-10 Finland
Pleurisy
2.0
6.3
61
302
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.8
6.3
94
537
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
6.5
6.3
15
23
XQ801
NOMESCO Finland
Intracutantest
3.1
6.3
25
81
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.6
6.3
135
851
B37.4
ICD-10 Finland
Candidiasis of other urogenital sites
5.5
6.3
17
31
M05BA07
ATC
risedronic acid; oral
1.8
6.3
95
546
G56.2
ICD-10 Finland
Lesion of ulnar nerve
1.7
6.3
107
636
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
3.8
6.3
18
47
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
2.8
6.2
29
103
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
2.2
6.2
51
237
R5140
NOMESCO Finland
Monitoring the use of the aid
1.4
6.2
341
2578
D05AX03
ATC
calcitriol; topical
2.3
6.2
46
205
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
26.7
6.2
8
*
E87.5
ICD-10 Finland
Hyperkalaemia
2.0
6.2
62
311
S89.9
ICD-10 Finland
Unspecified injury of lower leg
1.7
6.2
117
714
B36.0
ICD-10 Finland
Pityriasis versicolor
2.2
6.2
50
231
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
2.3
6.2
45
199
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.6
6.2
126
784
R43
ICPC
Respiratory, Other diagnostic procedure
2.9
6.2
28
98
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
3.7
6.2
19
52
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
3.7
6.2
19
52
M02AA10
ATC
ketoprofen; topical
1.3
6.2
529
4253
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
6.2
420
3277
D16
ICPC
Rectal bleeding
1.8
6.2
81
446
G04BD08
ATC
solifenacin; oral
1.5
6.2
208
1447
S08
ICPC
Skin colour change
1.5
6.2
183
1241
R20.1
ICD-10 Finland
Hypoaesthesia of skin
4.0
6.2
17
43
Z31.5
ICD-10 Finland
Genetic counselling
1.5
6.2
182
1233
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.1
6.2
24
77
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
6.2
395
3057
ZX114
NOMESCO Finland
Intramuscular
2.2
6.1
50
232
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.6
6.1
126
786
J35.2
ICD-10 Finland
Hypertrophy of adenoids
2.0
6.1
60
299
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.1
6.1
53
252
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
7.7
6.1
13
17
X14
ICPC
Vaginal discharge
1.9
6.1
74
397
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
1.7
6.1
104
618
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
2.7
6.1
30
110
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.4
6.1
246
1769
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.0
6.1
59
293
G47.9
ICD-10 Finland
Sleep disorder, unspecified
1.7
6.1
99
581
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
3.8
6.1
18
48
R76.0
ICD-10 Finland
Raised antibody titre
3.8
6.1
18
48
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
1.7
6.0
95
552
D03
ICPC
Heartburn
1.6
6.0
128
805
GX2C5
NOMESCO Finland
Short-lasting oximetry
3.1
6.0
24
78
L14
ICPC
Leg/thigh symptom/complaint
1.4
6.0
271
1986
J01CE08
ATC
benzathine benzylpenicillin; parenteral
2.4
6.0
38
158
K60.2
ICD-10 Finland
Anal fissure, unspecified
2.0
6.0
57
281

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
1.2e+00
2.0e+00
2.8e+00
9.4e+00
4.5e+00
3.5e+00
1.9e+00
cases:16.49%
controls:5.88%
cases:14.29%
controls:2.29%
cases:6.65%
controls:0.41%
cases:81.08%
controls:0.04%
cases:26.03%
controls:0.38%
cases:42.72%
controls:2.23%
cases:30.02%
controls:6.14%
703
2503
3561
40067
610
974
3660
41640
284
176
3986
42438
3462
15
808
42599
1109
162
3151
42376
1770
926
2373
40663
1128
2309
2629
35275
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
1.6e+00
3.0e+00
4.7e+00
—
4.6e+00
3.7e+00
2.3e+00
cases:2.86%
controls:0.60%
cases:3.21%
controls:0.17%
cases:1.22%
controls:0.01%
—
—
cases:1.38%
controls:0.01%
cases:5.12%
controls:0.14%
cases:5.62%
controls:0.58%
122
257
4142
42313
137
72
4133
42542
52
5
4218
42609
—
59
6
4201
42532
212
57
3931
41532
211
217
3546
37367
Dermatitis, unspecified
L30.9 [45572271]
8.2e-01
2.1e+00
3.6e+00
4.7e+00
3.7e+00
2.3e+00
1.2e+00
cases:3.38%
controls:1.51%
cases:4.33%
controls:0.54%
cases:2.39%
controls:0.07%
cases:1.33%
controls:0.01%
cases:3.08%
controls:0.08%
cases:6.11%
controls:0.63%
cases:7.67%
controls:2.37%
144
643
4120
41927
185
232
4085
42382
102
28
4168
42586
57
5
4213
42609
131
32
4129
42506
253
261
3890
41328
288
889
3469
36695
Rash and other nonspecific skin eruption
R21 [45553721]
1.6e+00
1.9e+00
3.9e+00
1.0e+50
—
5.8e+00
3.1e+00
cases:0.68%
controls:0.14%
cases:0.47%
controls:0.07%
cases:0.84%
controls:0.02%
cases:98.95%
controls:0.00%
—
—
cases:17.72%
controls:0.06%
cases:5.19%
controls:0.24%
29
59
4235
42511
20
31
4250
42583
36
7
4234
42607
4225
0
45
42614
—
734
27
3409
41562
195
89
3562
37495
Skin Pathology biopsy report
65754-4 [40768443]
7.0e-01
2.0e+00
3.3e+00
1.0e+50
4.4e+00
2.2e+00
1.4e+00
cases:0.82%
controls:0.41%
cases:0.89%
controls:0.12%
cases:0.33%
controls:0.01%
cases:2.58%
controls:0.00%
cases:1.08%
controls:0.01%
cases:0.94%
controls:0.11%
cases:2.05%
controls:0.49%
35
174
4229
42396
38
50
4232
42564
14
5
4256
42609
110
0
4160
42614
46
6
4214
42532
39
45
4104
41544
77
186
3680
37398
Hypersensitivity skin testing
268377001 [4147813]
6.3e-01
1.5e+00
3.3e+00
1.0e+50
4.4e+00
2.9e+00
1.1e+00
cases:1.69%
controls:0.90%
cases:1.01%
controls:0.23%
cases:0.61%
controls:0.02%
cases:1.69%
controls:0.00%
cases:1.34%
controls:0.02%
cases:3.11%
controls:0.18%
cases:2.24%
controls:0.74%
72
384
4192
42186
43
97
4227
42517
26
10
4244
42604
72
0
4198
42614
57
7
4203
42531
129
76
4014
41513
84
280
3673
37304
combinations of corticosteroids
D07XB30 [21602188]
7.1e-01
1.3e+00
2.1e+00
5.3e+00
2.3e+00
1.1e+00
8.4e-01
cases:18.32%
controls:9.97%
cases:11.71%
controls:3.42%
cases:3.56%
controls:0.44%
cases:2.79%
controls:0.01%
cases:4.13%
controls:0.41%
cases:9.82%
controls:3.40%
cases:20.28%
controls:9.93%
781
4246
3483
38324
500
1457
3770
41157
152
187
4118
42427
119
6
4151
42608
176
176
4084
42362
407
1414
3736
40175
762
3733
2995
33851
combinations of corticosteroids
D07AB30 [21602118]
7.1e-01
1.3e+00
2.1e+00
5.3e+00
2.3e+00
1.1e+00
8.4e-01
cases:18.32%
controls:9.97%
cases:11.71%
controls:3.42%
cases:3.56%
controls:0.44%
cases:2.79%
controls:0.01%
cases:4.13%
controls:0.41%
cases:9.82%
controls:3.40%
cases:20.28%
controls:9.93%
781
4246
3483
38324
500
1457
3770
41157
152
187
4118
42427
119
6
4151
42608
176
176
4084
42362
407
1414
3736
40175
762
3733
2995
33851
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
7.9e-01
1.9e+00
3.0e+00
1.0e+50
4.0e+00
1.9e+00
1.4e+00
cases:0.82%
controls:0.37%
cases:0.82%
controls:0.12%
cases:0.23%
controls:0.01%
cases:0.30%
controls:0.00%
cases:0.61%
controls:0.01%
cases:0.72%
controls:0.11%
cases:2.05%
controls:0.51%
35
159
4229
42411
35
53
4235
42561
10
5
4260
42609
13
0
4257
42614
26
5
4234
42533
30
44
4113
41545
77
192
3680
37392
prednisolone; oral, parenteral
H02AB06 [21602734]
7.2e-01
1.2e+00
1.7e+00
5.0e+00
2.2e+00
1.2e+00
9.1e-01
cases:16.44%
controls:8.72%
cases:11.90%
controls:3.98%
cases:3.63%
controls:0.69%
cases:2.41%
controls:0.02%
cases:5.68%
controls:0.66%
cases:12.19%
controls:4.01%
cases:22.17%
controls:10.30%
701
3713
3563
38857
508
1695
3762
40919
155
292
4115
42322
103
7
4167
42607
242
282
4018
42256
505
1666
3638
39923
833
3871
2924
33713
prednisolone
A07EA01 [21600653]
7.2e-01
1.2e+00
1.7e+00
5.0e+00
2.2e+00
1.2e+00
9.1e-01
cases:16.53%
controls:8.76%
cases:11.90%
controls:3.99%
cases:3.63%
controls:0.69%
cases:2.41%
controls:0.02%
cases:5.70%
controls:0.67%
cases:12.26%
controls:4.01%
cases:22.23%
controls:10.34%
705
3729
3559
38841
508
1702
3762
40912
155
293
4115
42321
103
7
4167
42607
243
283
4017
42255
508
1669
3635
39920
835
3887
2922
33697
Systemic lupus erythematosus, unspecified
M32.9 [45553167]
1.5e+00
1.7e+00
2.4e+00
—
2.6e+00
2.5e+00
2.2e+00
cases:0.40%
controls:0.09%
cases:0.37%
controls:0.07%
cases:0.23%
controls:0.02%
—
—
cases:0.26%
controls:0.02%
cases:0.65%
controls:0.06%
cases:0.93%
controls:0.10%
17
38
4247
42532
16
29
4254
42585
10
9
4260
42605
—
11
8
4249
42530
27
23
4116
41566
35
39
3722
37545
Diffuse lymphoma with large B cells
C83.31 [2000501224]
1.7e+00
2.0e+00
2.6e+00
—
2.5e+00
2.1e+00
1.8e+00
cases:0.30%
controls:0.06%
cases:0.42%
controls:0.06%
cases:0.26%
controls:0.02%
—
—
cases:0.26%
controls:0.02%
cases:0.58%
controls:0.07%
cases:0.67%
controls:0.11%
13
24
4251
42546
18
24
4252
42590
11
8
4259
42606
—
11
9
4249
42529
24
31
4119
41558
25
40
3732
37544
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
1.1e+00
1.7e+00
2.7e+00
1.0e+50
3.7e+00
1.8e+00
1.7e+00
cases:0.91%
controls:0.31%
cases:0.68%
controls:0.12%
cases:0.21%
controls:0.01%
cases:0.14%
controls:0.00%
cases:0.68%
controls:0.02%
cases:0.80%
controls:0.13%
cases:1.86%
controls:0.36%
39
130
4225
42440
29
53
4241
42561
9
6
4261
42608
6
0
4264
42614
29
7
4231
42531
33
55
4110
41534
70
136
3687
37448
Rheumatology
66 [38004491]
1.1e+00
1.5e+00
2.1e+00
3.1e+00
1.9e+00
1.7e+00
1.4e+00
cases:7.01%
controls:2.55%
cases:6.23%
controls:1.48%
cases:2.44%
controls:0.30%
cases:0.37%
controls:0.02%
cases:2.04%
controls:0.32%
cases:7.27%
controls:1.46%
cases:10.54%
controls:2.89%
299
1085
3965
41485
266
632
4004
41982
104
129
4166
42485
16
7
4254
42607
87
136
4173
42402
301
606
3842
40983
396
1088
3361
36496
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
1.1e+00
1.6e+00
2.7e+00
1.0e+50
3.8e+00
1.8e+00
1.6e+00
cases:0.94%
controls:0.31%
cases:0.66%
controls:0.13%
cases:0.21%
controls:0.01%
cases:0.14%
controls:0.00%
cases:0.70%
controls:0.02%
cases:0.82%
controls:0.13%
cases:1.84%
controls:0.36%
40
134
4224
42436
28
54
4242
42560
9
6
4261
42608
6
0
4264
42614
30
7
4230
42531
34
56
4109
41533
69
137
3688
37447
desonide
D07AB08 [21602112]
9.2e-01
1.7e+00
2.8e+00
—
3.9e+00
2.0e+00
1.2e+00
cases:3.10%
controls:1.26%
cases:2.51%
controls:0.46%
cases:0.94%
controls:0.06%
—
—
cases:2.25%
controls:0.04%
cases:3.48%
controls:0.48%
cases:4.82%
controls:1.50%
132
537
4132
42033
107
197
4163
42417
40
25
4230
42589
—
96
19
4164
42519
144
198
3999
41391
181
564
3576
37020
Outpatient Visit
OP [9202]
6.5e-01
8.3e-01
1.0e+00
5.9e+00
1.7e+00
1.5e+00
8.8e-01
cases:77.72%
controls:64.63%
cases:63.72%
controls:43.45%
cases:23.49%
controls:9.76%
cases:62.44%
controls:0.46%
cases:37.72%
controls:9.88%
cases:77.50%
controls:43.90%
cases:86.96%
controls:73.46%
3314
27514
950
15056
2721
18515
1549
24099
1003
4157
3267
38457
2666
195
1604
42419
1607
4203
2653
38335
3211
18256
932
23333
3267
27610
490
9974
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
1.1e+00
1.7e+00
2.6e+00
1.0e+50
3.9e+00
1.7e+00
1.4e+00
cases:1.15%
controls:0.37%
cases:0.82%
controls:0.15%
cases:0.26%
controls:0.02%
cases:0.21%
controls:0.00%
cases:0.70%
controls:0.01%
cases:0.70%
controls:0.13%
cases:2.05%
controls:0.52%
49
158
4215
42412
35
65
4235
42549
11
8
4259
42606
9
0
4261
42614
30
6
4230
42532
29
55
4114
41534
77
197
3680
37387
Prick test
37968009 [4242723]
7.7e-01
1.6e+00
2.5e+00
1.0e+50
4.1e+00
2.5e+00
9.2e-01
cases:1.15%
controls:0.54%
cases:0.68%
controls:0.14%
cases:0.16%
controls:0.01%
cases:1.55%
controls:0.00%
cases:0.85%
controls:0.01%
cases:1.57%
controls:0.13%
cases:1.49%
controls:0.60%
49
228
4215
42342
29
61
4241
42553
7
6
4263
42608
66
0
4204
42614
36
6
4224
42532
65
52
4078
41537
56
225
3701
37359
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.8e+00
2.2e+00
1.9e+00
—
1.9e+00
2.2e+00
2.2e+00
cases:1.41%
controls:0.23%
cases:1.31%
controls:0.14%
cases:0.30%
controls:0.05%
—
—
cases:0.33%
controls:0.05%
cases:1.35%
controls:0.16%
cases:1.92%
controls:0.21%
60
96
4204
42474
56
60
4214
42554
13
20
4257
42594
—
14
22
4246
42516
56
66
4087
41523
72
79
3685
37505
Office Visit
OMOP4822458 [581477]
4.5e-01
9.3e-01
1.7e+00
5.7e+00
1.8e+00
9.3e-01
4.9e-01
cases:12.38%
controls:8.28%
cases:6.30%
controls:2.59%
cases:1.85%
controls:0.36%
cases:3.47%
controls:0.01%
cases:2.14%
controls:0.35%
cases:6.28%
controls:2.58%
cases:12.56%
controls:8.07%
528
3524
3736
39046
269
1102
4001
41512
79
152
4191
42462
148
5
4122
42609
91
149
4169
42389
260
1074
3883
40515
472
3034
3285
34550
hydrocortisone; local oral
A01AC03 [21600036]
1.0e+00
1.5e+00
3.0e+00
1.0e+50
3.4e+00
1.7e+00
1.2e+00
cases:2.91%
controls:1.05%
cases:1.66%
controls:0.38%
cases:0.87%
controls:0.04%
cases:0.80%
controls:0.00%
cases:1.20%
controls:0.04%
cases:1.96%
controls:0.37%
cases:3.19%
controls:1.02%
124
448
4140
42122
71
161
4199
42453
37
18
4233
42596
34
0
4236
42614
51
17
4209
42521
81
152
4062
41437
120
382
3637
37202
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
8.6e-01
1.1e+00
3.7e+00
1.0e+50
3.6e+00
1.6e+00
9.3e-01
cases:1.45%
controls:0.62%
cases:0.75%
controls:0.26%
cases:0.47%
controls:0.01%
cases:0.33%
controls:0.00%
cases:0.66%
controls:0.02%
cases:1.18%
controls:0.23%
cases:2.08%
controls:0.83%
62
263
4202
42307
32
112
4238
42502
20
5
4250
42609
14
0
4256
42614
28
8
4232
42530
49
97
4094
41492
78
311
3679
37273
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
8.9e-01
1.5e+00
2.7e+00
—
3.7e+00
1.7e+00
1.2e+00
cases:0.82%
controls:0.34%
cases:0.56%
controls:0.13%
cases:0.21%
controls:0.01%
—
—
cases:0.56%
controls:0.01%
cases:0.70%
controls:0.13%
cases:1.46%
controls:0.43%
35
144
4229
42426
24
56
4246
42558
9
6
4261
42608
—
24
6
4236
42532
29
52
4114
41537
55
163
3702
37421
Chronic lymphocytic leukaemia of B-cell type
C91.1 [45600564]
1.4e+00
1.7e+00
2.3e+00
—
2.8e+00
1.7e+00
1.6e+00
cases:0.40%
controls:0.09%
cases:0.37%
controls:0.07%
cases:0.26%
controls:0.03%
—
—
cases:0.28%
controls:0.02%
cases:0.43%
controls:0.08%
cases:0.48%
controls:0.09%
17
40
4247
42530
16
30
4254
42584
11
11
4259
42603
—
12
7
4248
42531
18
32
4125
41557
18
35
3739
37549
adalimumab; parenteral
L04AB04 [21603911]
1.8e+00
2.2e+00
2.2e+00
—
1.6e+00
1.7e+00
2.0e+00
cases:0.73%
controls:0.13%
cases:0.89%
controls:0.10%
cases:0.30%
controls:0.04%
—
—
cases:0.23%
controls:0.05%
cases:0.60%
controls:0.11%
cases:1.22%
controls:0.16%
31
54
4233
42516
38
43
4232
42571
13
15
4257
42599
—
10
20
4250
42518
25
44
4118
41545
46
60
3711
37524
HIV disease resulting in (persistent) generalized lymphadenopathy
B23.1 [45532868]
2.6e+00
3.0e+00
—
—
1.0e+50
2.9e+00
2.9e+00
cases:0.26%
controls:0.02%
cases:0.33%
controls:0.02%
—
—
—
—
cases:0.12%
controls:0.00%
cases:0.34%
controls:0.02%
cases:0.45%
controls:0.02%
11
8
4253
42562
14
7
4256
42607
—
—
5
0
4255
42538
14
8
4129
41581
17
9
3740
37575
Emergency Room Visit
ER [9203]
5.7e-01
9.1e-01
1.7e+00
5.6e+00
1.2e+00
7.5e-01
5.8e-01
cases:43.76%
controls:30.48%
cases:23.02%
controls:10.79%
cases:7.49%
controls:1.44%
cases:13.82%
controls:0.06%
cases:4.58%
controls:1.37%
cases:20.01%
controls:10.55%
cases:44.66%
controls:31.08%
1866
12976
2398
29594
983
4599
3287
38015
320
615
3950
41999
590
26
3680
42588
195
581
4065
41957
829
4387
3314
37202
1678
11682
2079
25902
Infectious Disease
44 [38004484]
8.2e-01
1.7e+00
2.9e+00
1.0e+50
2.9e+00
1.8e+00
1.3e+00
cases:2.49%
controls:1.11%
cases:2.06%
controls:0.39%
cases:1.10%
controls:0.06%
cases:0.52%
controls:0.00%
cases:1.13%
controls:0.06%
cases:2.58%
controls:0.44%
cases:4.15%
controls:1.21%
106
471
4158
42099
88
168
4182
42446
47
27
4223
42587
22
0
4248
42614
48
27
4212
42511
107
181
4036
41408
156
455
3601
37129
triamcinolone and antiseptics
D07BB03 [21602150]
9.6e-01
1.5e+00
3.0e+00
—
3.2e+00
1.6e+00
1.1e+00
cases:4.83%
controls:1.91%
cases:2.95%
controls:0.66%
cases:1.29%
controls:0.07%
—
—
cases:1.57%
controls:0.07%
cases:2.78%
controls:0.57%
cases:5.00%
controls:1.79%
206
814
4058
41756
126
283
4144
42331
55
28
4215
42586
—
67
29
4193
42509
115
238
4028
41351
188
674
3569
36910
hydrocortisone
D07XA01 [21602180]
9.4e-01
1.5e+00
3.0e+00
—
3.2e+00
1.6e+00
1.0e+00
cases:4.53%
controls:1.82%
cases:2.90%
controls:0.63%
cases:1.24%
controls:0.06%
—
—
cases:1.57%
controls:0.07%
cases:2.66%
controls:0.56%
cases:4.84%
controls:1.75%
193
776
4071
41794
124
270
4146
42344
53
27
4217
42587
—
67
29
4193
42509
110
231
4033
41358
182
659
3575
36925
hydrocortisone and antiseptics
D07BA04 [21602146]
9.4e-01
1.5e+00
3.0e+00
—
3.2e+00
1.6e+00
1.0e+00
cases:4.53%
controls:1.82%
cases:2.90%
controls:0.63%
cases:1.24%
controls:0.06%
—
—
cases:1.57%
controls:0.07%
cases:2.66%
controls:0.56%
cases:4.84%
controls:1.75%
193
776
4071
41794
124
270
4146
42344
53
27
4217
42587
—
67
29
4193
42509
110
231
4033
41358
182
659
3575
36925
chlorhexidine
D09AA12 [21602275]
9.3e-01
1.5e+00
3.0e+00
—
3.2e+00
1.6e+00
1.0e+00
cases:4.50%
controls:1.82%
cases:2.90%
controls:0.63%
cases:1.24%
controls:0.06%
—
—
cases:1.57%
controls:0.07%
cases:2.66%
controls:0.56%
cases:4.84%
controls:1.75%
192
776
4072
41794
124
270
4146
42344
53
27
4217
42587
—
67
29
4193
42509
110
231
4033
41358
182
659
3575
36925
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
9.3e-01
1.5e+00
3.0e+00
—
3.2e+00
1.6e+00
1.0e+00
cases:4.50%
controls:1.82%
cases:2.90%
controls:0.63%
cases:1.24%
controls:0.06%
—
—
cases:1.57%
controls:0.07%
cases:2.66%
controls:0.56%
cases:4.84%
controls:1.75%
192
776
4072
41794
124
270
4146
42344
53
27
4217
42587
—
67
29
4193
42509
110
231
4033
41358
182
659
3575
36925
chlorhexidine, combinations
D08AC52 [21602208]
9.3e-01
1.5e+00
3.0e+00
—
3.2e+00
1.6e+00
1.0e+00
cases:4.50%
controls:1.82%
cases:2.90%
controls:0.63%
cases:1.24%
controls:0.06%
—
—
cases:1.57%
controls:0.07%
cases:2.66%
controls:0.56%
cases:4.84%
controls:1.75%
192
776
4072
41794
124
270
4146
42344
53
27
4217
42587
—
67
29
4193
42509
110
231
4033
41358
182
659
3575
36925
chlorhexidine
S02AA09 [21605155]
9.3e-01
1.5e+00
3.0e+00
—
3.2e+00
1.6e+00
1.0e+00
cases:4.50%
controls:1.82%
cases:2.90%
controls:0.63%
cases:1.24%
controls:0.06%
—
—
cases:1.57%
controls:0.07%
cases:2.66%
controls:0.56%
cases:4.84%
controls:1.75%
192
776
4072
41794
124
270
4146
42344
53
27
4217
42587
—
67
29
4193
42509
110
231
4033
41358
182
659
3575
36925
chlorhexidine
S03AA04 [21605193]
9.3e-01
1.5e+00
3.0e+00
—
3.2e+00
1.6e+00
1.0e+00
cases:4.50%
controls:1.82%
cases:2.90%
controls:0.63%
cases:1.24%
controls:0.06%
—
—
cases:1.57%
controls:0.07%
cases:2.66%
controls:0.56%
cases:4.84%
controls:1.75%
192
776
4072
41794
124
270
4146
42344
53
27
4217
42587
—
67
29
4193
42509
110
231
4033
41358
182
659
3575
36925
Short blood count panel - Blood
55429-5 [40758558]
5.6e-01
8.7e-01
1.7e+00
4.3e+00
1.6e+00
1.1e+00
9.6e-01
cases:5.28%
controls:3.10%
cases:4.19%
controls:1.79%
cases:2.22%
controls:0.43%
cases:1.17%
controls:0.02%
cases:2.07%
controls:0.43%
cases:5.09%
controls:1.69%
cases:10.59%
controls:4.35%
225
1318
4039
41252
179
764
4091
41850
95
182
4175
42432
50
7
4220
42607
88
181
4172
42357
211
703
3932
40886
398
1634
3359
35950
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
7.5e-01
1.5e+00
2.8e+00
1.0e+50
3.7e+00
1.3e+00
9.0e-01
cases:1.41%
controls:0.67%
cases:0.91%
controls:0.20%
cases:0.37%
controls:0.02%
cases:0.26%
controls:0.00%
cases:0.47%
controls:0.01%
cases:0.60%
controls:0.17%
cases:1.92%
controls:0.79%
60
286
4204
42284
39
87
4231
42527
16
10
4254
42604
11
0
4259
42614
20
5
4240
42533
25
71
4118
41518
72
297
3685
37287
filgrastim; parenteral
L03AA02 [21603851]
1.5e+00
2.0e+00
1.8e+00
—
2.3e+00
1.9e+00
1.3e+00
cases:0.54%
controls:0.12%
cases:0.54%
controls:0.08%
cases:0.16%
controls:0.03%
—
—
cases:0.19%
controls:0.02%
cases:0.48%
controls:0.07%
cases:0.51%
controls:0.14%
23
50
4241
42520
23
32
4247
42582
7
11
4263
42603
—
8
8
4252
42530
20
31
4123
41558
19
54
3738
37530
hydrocortisone; oral, parenteral
H02AB09 [21602737]
1.0e+00
1.4e+00
2.4e+00
—
2.9e+00
1.7e+00
1.2e+00
cases:3.59%
controls:1.32%
cases:2.11%
controls:0.53%
cases:1.08%
controls:0.10%
—
—
cases:1.31%
controls:0.07%
cases:2.70%
controls:0.50%
cases:4.05%
controls:1.27%
153
560
4111
42010
90
227
4180
42387
46
41
4224
42573
—
56
31
4204
42507
112
209
4031
41380
152
479
3605
37105
cetirizine; oral
R06AE07 [21603497]
6.8e-01
1.0e+00
1.5e+00
4.4e+00
1.4e+00
9.2e-01
6.9e-01
cases:15.13%
controls:8.30%
cases:9.44%
controls:3.62%
cases:2.81%
controls:0.62%
cases:1.45%
controls:0.02%
cases:2.35%
controls:0.60%
cases:8.74%
controls:3.66%
cases:14.48%
controls:7.81%
645
3532
3619
39038
403
1542
3867
41072
120
265
4150
42349
62
8
4208
42606
100
255
4160
42283
362
1522
3781
40067
544
2935
3213
34649
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
6.7e-01
1.5e+00
2.6e+00
1.0e+50
3.4e+00
1.4e+00
1.0e+00
cases:2.74%
controls:1.42%
cases:1.92%
controls:0.45%
cases:0.52%
controls:0.04%
cases:0.52%
controls:0.00%
cases:1.08%
controls:0.04%
cases:1.76%
controls:0.44%
cases:5.06%
controls:1.84%
117
605
4147
41965
82
190
4188
42424
22
17
4248
42597
22
0
4248
42614
46
15
4214
42523
73
183
4070
41406
190
690
3567
36894
Basocellular carcinoma of the skin on another or unspecified part of the face
C44.31 [2000500792]
1.3e+00
1.8e+00
1.6e+00
—
2.4e+00
2.1e+00
1.4e+00
cases:1.41%
controls:0.39%
cases:1.08%
controls:0.17%
cases:0.21%
controls:0.04%
—
—
cases:0.45%
controls:0.04%
cases:1.54%
controls:0.20%
cases:2.32%
controls:0.57%
60
166
4204
42404
46
74
4224
42540
9
18
4261
42596
—
19
18
4241
42520
64
82
4079
41507
87
216
3670
37368
Basophils [#/volume] in Blood
26444-0 [3006315]
4.8e-01
8.2e-01
1.5e+00
4.0e+00
1.8e+00
1.1e+00
8.4e-01
cases:9.57%
controls:6.13%
cases:7.99%
controls:3.70%
cases:3.58%
controls:0.80%
cases:2.01%
controls:0.04%
cases:4.39%
controls:0.75%
cases:10.14%
controls:3.76%
cases:18.53%
controls:8.92%
408
2608
3856
39962
341
1576
3929
41038
153
341
4117
42273
86
16
4184
42598
187
321
4073
42217
420
1563
3723
40026
696
3351
3061
34233
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.8e-01
8.2e-01
1.5e+00
4.0e+00
1.8e+00
1.1e+00
8.5e-01
cases:9.50%
controls:6.11%
cases:8.01%
controls:3.69%
cases:3.58%
controls:0.81%
cases:2.01%
controls:0.04%
cases:4.39%
controls:0.76%
cases:10.11%
controls:3.74%
cases:18.50%
controls:8.87%
405
2600
3859
39970
342
1573
3928
41041
153
344
4117
42270
86
16
4184
42598
187
322
4073
42216
419
1557
3724
40032
695
3334
3062
34250
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.6e-01
8.0e-01
1.5e+00
4.0e+00
1.8e+00
1.0e+00
8.1e-01
cases:9.85%
controls:6.43%
cases:8.17%
controls:3.83%
cases:3.77%
controls:0.84%
cases:2.01%
controls:0.04%
cases:4.60%
controls:0.79%
cases:10.28%
controls:3.88%
cases:19.06%
controls:9.45%
420
2739
3844
39831
349
1631
3921
40983
161
358
4109
42256
86
16
4184
42598
196
338
4064
42200
426
1612
3717
39977
716
3552
3041
34032
Emergency Medicine
93 [38004510]
3.1e-01
6.6e-01
1.2e+00
6.0e+00
1.4e+00
5.5e-01
2.7e-01
cases:10.58%
controls:7.97%
cases:8.01%
controls:4.31%
cases:2.20%
controls:0.67%
cases:7.28%
controls:0.02%
cases:2.37%
controls:0.59%
cases:7.68%
controls:4.58%
cases:17.22%
controls:13.70%
451
3391
3813
39179
342
1835
3928
40779
94
286
4176
42328
311
8
3959
42606
101
253
4159
42285
318
1905
3825
39684
647
5150
3110
32434
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
4.7e-01
8.0e-01
1.5e+00
4.0e+00
1.8e+00
1.0e+00
8.1e-01
cases:9.87%
controls:6.39%
cases:8.13%
controls:3.82%
cases:3.65%
controls:0.83%
cases:2.04%
controls:0.04%
cases:4.41%
controls:0.77%
cases:10.16%
controls:3.90%
cases:18.61%
controls:9.24%
421
2722
3843
39848
347
1627
3923
40987
156
354
4114
42260
87
16
4183
42598
188
327
4072
42211
421
1624
3722
39965
699
3471
3058
34113
Actinic keratosis
L57.0 [45591640]
1.2e+00
1.6e+00
2.4e+00
—
1.8e+00
1.9e+00
1.4e+00
cases:2.63%
controls:0.78%
cases:1.78%
controls:0.38%
cases:0.59%
controls:0.05%
—
—
cases:0.23%
controls:0.04%
cases:2.68%
controls:0.40%
cases:4.87%
controls:1.20%
112
332
4152
42238
76
163
4194
42451
25
22
4245
42592
—
10
16
4250
42522
111
167
4032
41422
183
450
3574
37134
Other psoriatic arthropathies
M07.3*L40.5 [2000503010]
1.1e+00
2.0e+00
3.3e+00
—
—
2.0e+00
1.9e+00
cases:0.56%
controls:0.18%
cases:0.68%
controls:0.09%
cases:0.33%
controls:0.01%
—
—
—
—
cases:0.72%
controls:0.10%
cases:1.17%
controls:0.17%
24
78
4240
42492
29
38
4241
42576
14
5
4256
42609
—
—
30
42
4113
41547
44
64
3713
37520
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
1.2e+00
2.0e+00
2.6e+00
—
2.0e+00
1.8e+00
8.5e-01
cases:1.52%
controls:0.47%
cases:1.12%
controls:0.16%
cases:0.49%
controls:0.04%
—
—
cases:0.28%
controls:0.04%
cases:0.89%
controls:0.15%
cases:1.01%
controls:0.43%
65
201
4199
42369
48
67
4222
42547
21
15
4249
42599
—
12
17
4248
42521
37
64
4106
41525
38
163
3719
37421
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
1.2e+00
1.4e+00
2.3e+00
1.0e+50
2.7e+00
1.4e+00
1.3e+00
cases:0.77%
controls:0.22%
cases:0.40%
controls:0.10%
cases:0.16%
controls:0.02%
cases:0.16%
controls:0.00%
cases:0.28%
controls:0.02%
cases:0.39%
controls:0.10%
cases:0.98%
controls:0.28%
33
95
4231
42475
17
44
4253
42570
7
7
4263
42607
7
0
4263
42614
12
8
4248
42530
16
41
4127
41548
37
106
3720
37478
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
1.2e+00
1.3e+00
2.4e+00
1.0e+50
2.6e+00
1.4e+00
1.3e+00
cases:0.87%
controls:0.26%
cases:0.40%
controls:0.11%
cases:0.19%
controls:0.02%
cases:0.19%
controls:0.00%
cases:0.28%
controls:0.02%
cases:0.41%
controls:0.10%
cases:1.12%
controls:0.32%
37
111
4227
42459
17
48
4253
42566
8
7
4262
42607
8
0
4262
42614
12
9
4248
42529
17
43
4126
41546
42
119
3715
37465
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
6.5e-01
7.7e-01
1.5e+00
4.0e+00
1.6e+00
9.5e-01
7.5e-01
cases:6.40%
controls:3.45%
cases:3.93%
controls:1.86%
cases:1.19%
controls:0.28%
cases:0.63%
controls:0.01%
cases:1.27%
controls:0.27%
cases:4.56%
controls:1.82%
cases:10.54%
controls:5.26%
273
1468
3991
41102
168
794
4102
41820
51
118
4219
42496
27
5
4243
42609
54
115
4206
42423
189
758
3954
40831
396
1976
3361
35608
Intravenous
ZX120 [2001311495]
9.8e-01
1.7e+00
2.1e+00
—
2.2e+00
1.8e+00
1.3e+00
cases:2.09%
controls:0.79%
cases:1.76%
controls:0.34%
cases:0.66%
controls:0.08%
—
—
cases:0.68%
controls:0.08%
cases:1.67%
controls:0.28%
cases:2.95%
controls:0.79%
89
337
4175
42233
75
145
4195
42469
28
34
4242
42580
—
29
32
4231
42506
69
115
4074
41474
111
296
3646
37288
hydrocortisone and antiinfectives
S01CA03 [21603654]
7.9e-01
1.5e+00
2.9e+00
—
2.8e+00
1.4e+00
7.8e-01
cases:2.06%
controls:0.95%
cases:1.38%
controls:0.32%
cases:0.37%
controls:0.02%
—
—
cases:0.45%
controls:0.03%
cases:0.97%
controls:0.24%
cases:2.00%
controls:0.92%
88
404
4176
42166
59
138
4211
42476
16
9
4254
42605
—
19
12
4241
42526
40
99
4103
41490
75
347
3682
37237
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.7e-01
8.2e-01
1.5e+00
3.7e+00
1.8e+00
1.0e+00
8.1e-01
cases:9.15%
controls:5.89%
cases:7.54%
controls:3.46%
cases:3.28%
controls:0.76%
cases:1.71%
controls:0.04%
cases:4.13%
controls:0.72%
cases:9.20%
controls:3.51%
cases:16.93%
controls:8.27%
390
2509
3874
40061
322
1473
3948
41141
140
322
4130
42292
73
19
4197
42595
176
305
4084
42233
381
1459
3762
40130
636
3110
3121
34474
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.8e-01
8.1e-01
1.5e+00
3.7e+00
1.8e+00
1.0e+00
8.2e-01
cases:9.10%
controls:5.86%
cases:7.45%
controls:3.46%
cases:3.28%
controls:0.76%
cases:1.71%
controls:0.04%
cases:4.13%
controls:0.72%
cases:9.15%
controls:3.51%
cases:16.90%
controls:8.26%
388
2493
3876
40077
318
1474
3952
41140
140
324
4130
42290
73
19
4197
42595
176
307
4084
42231
379
1461
3764
40128
635
3104
3122
34480
Monocytes/Leukocytes in Blood
26485-3 [3019069]
4.8e-01
8.2e-01
1.5e+00
3.6e+00
1.8e+00
1.0e+00
8.1e-01
cases:9.19%
controls:5.91%
cases:7.54%
controls:3.47%
cases:3.30%
controls:0.76%
cases:1.71%
controls:0.05%
cases:4.15%
controls:0.71%
cases:9.20%
controls:3.50%
cases:16.88%
controls:8.29%
392
2518
3872
40052
322
1479
3948
41135
141
324
4129
42290
73
20
4197
42594
177
304
4083
42234
381
1456
3762
40133
634
3115
3123
34469
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
1.2e+00
1.3e+00
2.2e+00
1.0e+50
2.7e+00
1.3e+00
1.3e+00
cases:0.77%
controls:0.23%
cases:0.40%
controls:0.11%
cases:0.16%
controls:0.02%
cases:0.16%
controls:0.00%
cases:0.28%
controls:0.02%
cases:0.39%
controls:0.10%
cases:1.04%
controls:0.30%
33
97
4231
42473
17
48
4253
42566
7
8
4263
42606
7
0
4263
42614
12
8
4248
42530
16
42
4127
41547
39
112
3718
37472
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
4.7e-01
7.9e-01
1.5e+00
3.7e+00
1.7e+00
1.0e+00
7.9e-01
cases:9.12%
controls:5.92%
cases:7.40%
controls:3.50%
cases:3.19%
controls:0.76%
cases:1.69%
controls:0.04%
cases:3.97%
controls:0.71%
cases:9.20%
controls:3.55%
cases:16.82%
controls:8.43%
389
2521
3875
40049
316
1491
3954
41123
136
324
4134
42290
72
18
4198
42596
169
304
4091
42234
381
1476
3762
40113
632
3168
3125
34416
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.1e+00
1.3e+00
2.4e+00
—
2.2e+00
1.5e+00
1.4e+00
cases:0.54%
controls:0.17%
cases:0.47%
controls:0.13%
cases:0.23%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:0.46%
controls:0.10%
cases:0.90%
controls:0.22%
23
74
4241
42496
20
57
4250
42557
10
9
4260
42605
—
8
9
4252
42529
19
41
4124
41548
34
82
3723
37502
Internal Medicine
11 [38004456]
5.7e-01
8.5e-01
1.5e+00
4.1e+00
1.3e+00
8.8e-01
6.4e-01
cases:31.12%
controls:20.41%
cases:18.01%
controls:8.59%
cases:6.98%
controls:1.58%
cases:4.29%
controls:0.07%
cases:5.73%
controls:1.56%
cases:18.27%
controls:8.52%
cases:32.39%
controls:20.20%
1327
8689
2937
33881
769
3660
3501
38954
298
672
3972
41942
183
31
4087
42583
244
663
4016
41875
757
3543
3386
38046
1217
7593
2540
29991
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
4.8e-01
7.9e-01
1.5e+00
3.6e+00
1.8e+00
1.0e+00
7.9e-01
cases:9.45%
controls:6.06%
cases:7.61%
controls:3.60%
cases:3.37%
controls:0.79%
cases:1.73%
controls:0.05%
cases:4.18%
controls:0.74%
cases:9.29%
controls:3.63%
cases:17.14%
controls:8.58%
403
2581
3861
39989
325
1532
3945
41082
144
338
4126
42276
74
20
4196
42594
178
313
4082
42225
385
1510
3758
40079
644
3226
3113
34358
Juvenile polyarthritis (seronegative)
M08.3 [45596450]
1.8e+00
2.0e+00
1.8e+00
—
2.1e+00
2.0e+00
1.9e+00
cases:0.30%
controls:0.05%
cases:0.30%
controls:0.04%
cases:0.14%
controls:0.02%
—
—
cases:0.16%
controls:0.02%
cases:0.31%
controls:0.04%
cases:0.37%
controls:0.05%
13
21
4251
42549
13
17
4257
42597
6
10
4264
42604
—
7
9
4253
42529
13
17
4130
41572
14
20
3743
37564
Leukocytes [#/volume] in Urine
30405-5 [3018095]
6.1e-01
7.0e-01
1.4e+00
4.0e+00
1.6e+00
8.8e-01
7.1e-01
cases:6.89%
controls:3.86%
cases:4.38%
controls:2.22%
cases:1.38%
controls:0.34%
cases:0.66%
controls:0.01%
cases:1.48%
controls:0.31%
cases:5.31%
controls:2.27%
cases:12.19%
controls:6.41%
294
1645
3970
40925
187
946
4083
41668
59
147
4211
42467
28
5
4242
42609
63
133
4197
42405
220
943
3923
40646
458
2410
3299
35174
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
6.4e-01
6.9e-01
1.5e+00
3.8e+00
1.6e+00
9.2e-01
7.3e-01
cases:5.44%
controls:2.93%
cases:3.09%
controls:1.58%
cases:0.94%
controls:0.22%
cases:0.52%
controls:0.01%
cases:1.03%
controls:0.20%
cases:3.67%
controls:1.50%
cases:8.54%
controls:4.30%
232
1248
4032
41322
132
672
4138
41942
40
92
4230
42522
22
5
4248
42609
44
87
4216
42451
152
622
3991
40967
321
1617
3436
35967
cefalexin; oral
J01DB01 [21602870]
5.3e-01
8.8e-01
1.7e+00
3.7e+00
1.6e+00
8.1e-01
6.3e-01
cases:39.68%
controls:27.88%
cases:18.64%
controls:8.69%
cases:5.27%
controls:1.02%
cases:1.66%
controls:0.04%
cases:4.37%
controls:0.90%
cases:17.84%
controls:8.84%
cases:41.58%
controls:27.39%
1692
11870
2572
30700
796
3702
3474
38912
225
433
4045
42181
71
18
4199
42596
186
381
4074
42157
739
3676
3404
37913
1562
10295
2195
27289
Fever, unspecified
R50.9 [45582716]
7.7e-01
1.2e+00
2.8e+00
—
2.7e+00
1.4e+00
8.5e-01
cases:2.51%
controls:1.17%
cases:1.22%
controls:0.39%
cases:0.96%
controls:0.06%
—
—
cases:0.68%
controls:0.04%
cases:1.57%
controls:0.37%
cases:3.41%
controls:1.48%
107
499
4157
42071
52
165
4218
42449
41
24
4229
42590
—
29
19
4231
42519
65
155
4078
41434
128
556
3629
37028
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
9.5e-01
1.2e+00
2.2e+00
—
2.8e+00
1.6e+00
1.1e+00
cases:0.73%
controls:0.28%
cases:0.42%
controls:0.13%
cases:0.16%
controls:0.02%
—
—
cases:0.26%
controls:0.02%
cases:0.51%
controls:0.10%
cases:0.80%
controls:0.27%
31
120
4233
42450
18
54
4252
42560
7
8
4263
42606
—
11
7
4249
42531
21
42
4122
41547
30
102
3727
37482
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
4.6e-01
8.0e-01
1.4e+00
3.7e+00
1.6e+00
9.9e-01
7.9e-01
cases:11.02%
controls:7.24%
cases:9.56%
controls:4.55%
cases:4.54%
controls:1.13%
cases:2.41%
controls:0.06%
cases:5.23%
controls:1.11%
cases:11.32%
controls:4.54%
cases:20.12%
controls:10.25%
470
3082
3794
39488
408
1938
3862
40676
194
480
4076
42134
103
26
4167
42588
223
472
4037
42066
469
1887
3674
39702
756
3854
3001
33730
hydrocortisone aceponate
D07AC16 [21602135]
7.5e-01
1.5e+00
2.6e+00
—
2.8e+00
1.2e+00
8.3e-01
cases:13.46%
controls:6.82%
cases:9.23%
controls:2.22%
cases:3.14%
controls:0.24%
—
—
cases:3.97%
controls:0.24%
cases:7.14%
controls:2.24%
cases:14.40%
controls:6.84%
574
2902
3690
39668
394
945
3876
41669
134
104
4136
42510
—
169
102
4091
42436
296
930
3847
40659
541
2571
3216
35013
hydrocortisone
D07AA02 [21602102]
7.5e-01
1.5e+00
2.6e+00
—
2.8e+00
1.2e+00
8.3e-01
cases:13.46%
controls:6.82%
cases:9.23%
controls:2.22%
cases:3.14%
controls:0.24%
—
—
cases:3.97%
controls:0.24%
cases:7.14%
controls:2.24%
cases:14.40%
controls:6.84%
574
2902
3690
39668
394
945
3876
41669
134
104
4136
42510
—
169
102
4091
42436
296
930
3847
40659
541
2571
3216
35013
hydrocortisone butyrate
D07AB02 [21602106]
7.5e-01
1.5e+00
2.6e+00
—
2.8e+00
1.2e+00
8.3e-01
cases:13.46%
controls:6.82%
cases:9.23%
controls:2.22%
cases:3.14%
controls:0.24%
—
—
cases:3.97%
controls:0.24%
cases:7.14%
controls:2.24%
cases:14.40%
controls:6.84%
574
2902
3690
39668
394
945
3876
41669
134
104
4136
42510
—
169
102
4091
42436
296
930
3847
40659
541
2571
3216
35013
hydrocortisone buteprate
D07AB11 [21602115]
7.5e-01
1.5e+00
2.6e+00
—
2.8e+00
1.2e+00
8.3e-01
cases:13.46%
controls:6.82%
cases:9.23%
controls:2.22%
cases:3.14%
controls:0.24%
—
—
cases:3.97%
controls:0.24%
cases:7.14%
controls:2.24%
cases:14.40%
controls:6.84%
574
2902
3690
39668
394
945
3876
41669
134
104
4136
42510
—
169
102
4091
42436
296
930
3847
40659
541
2571
3216
35013
hydrocortisone
A07EA02 [21600654]
7.4e-01
1.5e+00
2.6e+00
—
2.8e+00
1.2e+00
8.3e-01
cases:13.63%
controls:6.97%
cases:9.25%
controls:2.24%
cases:3.14%
controls:0.24%
—
—
cases:3.97%
controls:0.24%
cases:7.17%
controls:2.26%
cases:14.40%
controls:6.85%
581
2969
3683
39601
395
955
3875
41659
134
104
4136
42510
—
169
103
4091
42435
297
938
3846
40651
541
2575
3216
35009
hydrocortisone
C05AA01 [21601608]
7.4e-01
1.5e+00
2.6e+00
—
2.8e+00
1.2e+00
8.3e-01
cases:13.63%
controls:6.97%
cases:9.25%
controls:2.24%
cases:3.14%
controls:0.24%
—
—
cases:3.97%
controls:0.24%
cases:7.17%
controls:2.26%
cases:14.40%
controls:6.85%
581
2969
3683
39601
395
955
3875
41659
134
104
4136
42510
—
169
103
4091
42435
297
938
3846
40651
541
2575
3216
35009
Nephrology
39 [38004479]
1.1e+00
1.1e+00
1.5e+00
2.2e+00
1.6e+00
1.2e+00
1.1e+00
cases:1.99%
controls:0.69%
cases:1.55%
controls:0.50%
cases:0.87%
controls:0.20%
cases:0.26%
controls:0.03%
cases:0.75%
controls:0.16%
cases:1.59%
controls:0.50%
cases:2.45%
controls:0.87%
85
293
4179
42277
66
213
4204
42401
37
87
4233
42527
11
12
4259
42602
32
68
4228
42470
66
210
4077
41379
92
326
3665
37258
Sicca syndrome [Sjögren]
M35.0 [45562711]
1.1e+00
1.5e+00
1.9e+00
—
1.8e+00
1.8e+00
1.5e+00
cases:0.70%
controls:0.23%
cases:0.49%
controls:0.11%
cases:0.21%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.72%
controls:0.12%
cases:1.14%
controls:0.26%
30
96
4234
42474
21
49
4249
42565
9
13
4261
42601
—
8
13
4252
42525
30
50
4113
41539
43
97
3714
37487
hydrocortisone
S02BA01 [21605166]
7.6e-01
1.5e+00
2.6e+00
—
2.8e+00
1.2e+00
8.2e-01
cases:11.87%
controls:5.92%
cases:7.85%
controls:1.91%
cases:2.79%
controls:0.21%
—
—
cases:3.47%
controls:0.22%
cases:5.84%
controls:1.90%
cases:12.38%
controls:5.88%
506
2521
3758
40049
335
815
3935
41799
119
89
4151
42525
—
148
92
4112
42446
242
792
3901
40797
465
2210
3292
35374
Psoriasis vulgaris
L40.0 [45543370]
1.2e+00
1.0e+00
1.8e+00
1.0e+50
2.5e+00
1.7e+00
1.4e+00
cases:1.22%
controls:0.39%
cases:0.63%
controls:0.22%
cases:0.35%
controls:0.06%
cases:0.33%
controls:0.00%
cases:0.47%
controls:0.04%
cases:1.30%
controls:0.23%
cases:1.86%
controls:0.46%
52
164
4212
42406
27
95
4243
42519
15
25
4255
42589
14
0
4256
42614
20
17
4240
42521
54
96
4089
41493
70
174
3687
37410
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
4.5e-01
7.8e-01
1.5e+00
3.8e+00
1.6e+00
8.6e-01
6.2e-01
cases:3.80%
controls:2.45%
cases:2.86%
controls:1.33%
cases:1.17%
controls:0.27%
cases:0.66%
controls:0.01%
cases:1.31%
controls:0.28%
cases:3.23%
controls:1.40%
cases:6.84%
controls:3.80%
162
1043
4102
41527
122
565
4148
42049
50
116
4220
42498
28
6
4242
42608
56
117
4204
42421
134
581
4009
41008
257
1427
3500
36157
Neoplasm of uncertain or unknown behaviour: Skin
D48.5 [45586113]
6.3e-01
1.4e+00
2.9e+00
—
2.6e+00
1.6e+00
1.1e+00
cases:0.70%
controls:0.38%
cases:0.66%
controls:0.16%
cases:0.30%
controls:0.02%
—
—
cases:0.21%
controls:0.02%
cases:0.68%
controls:0.14%
cases:1.76%
controls:0.57%
30
160
4234
42410
28
70
4242
42544
13
7
4257
42607
—
9
7
4251
42531
28
57
4115
41532
66
215
3691
37369
Gastroenterology
10 [38004455]
8.7e-01
9.7e-01
1.5e+00
2.8e+00
1.3e+00
1.2e+00
1.0e+00
cases:8.26%
controls:3.62%
cases:4.43%
controls:1.72%
cases:1.33%
controls:0.31%
cases:0.26%
controls:0.02%
cases:1.08%
controls:0.31%
cases:5.79%
controls:1.74%
cases:12.03%
controls:4.72%
352
1543
3912
41027
189
733
4081
41881
57
132
4213
42482
11
7
4259
42607
46
131
4214
42407
240
722
3903
40867
452
1773
3305
35811
hydroxyzine; oral, parenteral
N05BB01 [21604590]
7.7e-01
1.3e+00
2.7e+00
—
2.5e+00
1.4e+00
9.5e-01
cases:2.93%
controls:1.37%
cases:1.73%
controls:0.50%
cases:1.12%
controls:0.08%
—
—
cases:0.89%
controls:0.08%
cases:2.08%
controls:0.50%
cases:3.75%
controls:1.48%
125
585
4139
41985
74
211
4196
42403
48
34
4222
42580
—
38
32
4222
42506
86
206
4057
41383
141
556
3616
37028
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 [3027450]
8.2e-01
1.7e+00
—
1.0e+50
3.6e+00
2.1e+00
1.3e+00
cases:0.59%
controls:0.26%
cases:0.49%
controls:0.09%
—
—
cases:0.14%
controls:0.00%
cases:0.42%
controls:0.01%
cases:0.75%
controls:0.09%
cases:1.44%
controls:0.38%
25
110
4239
42460
21
38
4249
42576
—
6
0
4264
42614
18
5
4242
42533
31
38
4112
41551
54
142
3703
37442
clobetasol
D07AD01 [21602141]
8.7e-01
1.2e+00
1.9e+00
—
2.7e+00
1.7e+00
1.2e+00
cases:4.29%
controls:1.84%
cases:2.69%
controls:0.79%
cases:0.59%
controls:0.09%
—
—
cases:1.55%
controls:0.10%
cases:4.08%
controls:0.80%
cases:7.13%
controls:2.36%
183
783
4081
41787
115
338
4155
42276
25
39
4245
42575
—
66
43
4194
42495
169
333
3974
41256
268
888
3489
36696
antibiotics in combination with corticosteroids
D01AA20 [21601918]
8.6e-01
1.4e+00
2.4e+00
—
2.4e+00
1.5e+00
8.2e-01
cases:3.31%
controls:1.43%
cases:2.08%
controls:0.53%
cases:0.63%
controls:0.06%
—
—
cases:0.63%
controls:0.06%
cases:1.62%
controls:0.35%
cases:3.25%
controls:1.45%
141
608
4123
41962
89
224
4181
42390
27
24
4243
42590
—
27
25
4233
42513
67
146
4076
41443
122
546
3635
37038
azathioprine; oral, parenteral
L04AX01 [21603927]
1.4e+00
1.5e+00
1.6e+00
—
1.6e+00
1.7e+00
1.6e+00
cases:2.16%
controls:0.52%
cases:1.52%
controls:0.34%
cases:0.49%
controls:0.10%
—
—
cases:0.49%
controls:0.10%
cases:1.69%
controls:0.32%
cases:2.50%
controls:0.51%
92
221
4172
42349
65
147
4205
42467
21
41
4249
42573
—
21
44
4239
42494
70
135
4073
41454
94
191
3663
37393
General Practice
1 [38004446]
3.9e-01
5.5e-01
1.1e+00
5.3e+00
1.2e+00
4.7e-01
3.5e-01
cases:13.93%
controls:9.84%
cases:6.84%
controls:4.08%
cases:2.08%
controls:0.71%
cases:3.77%
controls:0.02%
cases:1.97%
controls:0.62%
cases:6.95%
controls:4.48%
cases:17.81%
controls:13.23%
594
4188
3670
38382
292
1738
3978
40876
89
304
4181
42310
161
8
4109
42606
84
262
4176
42276
288
1862
3855
39727
669
4974
3088
32610
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
1.2e+00
1.2e+00
2.0e+00
1.0e+50
2.6e+00
1.2e+00
1.2e+00
cases:0.89%
controls:0.28%
cases:0.44%
controls:0.14%
cases:0.19%
controls:0.03%
cases:0.19%
controls:0.00%
cases:0.28%
controls:0.02%
cases:0.41%
controls:0.12%
cases:1.25%
controls:0.37%
38
120
4226
42450
19
59
4251
42555
8
11
4262
42603
8
0
4262
42614
12
9
4248
42529
17
50
4126
41539
47
140
3710
37444
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
5.1e-01
6.7e-01
1.5e+00
3.6e+00
1.6e+00
8.5e-01
7.0e-01
cases:6.57%
controls:4.04%
cases:3.84%
controls:2.01%
cases:1.29%
controls:0.30%
cases:0.59%
controls:0.02%
cases:1.38%
controls:0.29%
cases:4.59%
controls:2.01%
cases:11.02%
controls:5.80%
280
1719
3984
40851
164
857
4106
41757
55
127
4215
42487
25
7
4245
42607
59
125
4201
42413
190
834
3953
40755
414
2179
3343
35405
Differential panel, method unspecified - Blood
69738-3 [42870588]
4.3e-01
6.9e-01
1.2e+00
3.5e+00
1.7e+00
9.5e-01
8.2e-01
cases:6.03%
controls:4.02%
cases:4.54%
controls:2.34%
cases:1.78%
controls:0.53%
cases:0.89%
controls:0.03%
cases:2.58%
controls:0.50%
cases:5.99%
controls:2.41%
cases:11.18%
controls:5.24%
257
1712
4007
40858
194
996
4076
41618
76
224
4194
42390
38
11
4232
42603
110
212
4150
42326
248
1002
3895
40587
420
1968
3337
35616
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
8.0e-01
1.3e+00
1.9e+00
—
2.7e+00
1.6e+00
1.0e+00
cases:0.96%
controls:0.43%
cases:0.63%
controls:0.18%
cases:0.16%
controls:0.02%
—
—
cases:0.38%
controls:0.03%
cases:0.75%
controls:0.16%
cases:1.28%
controls:0.45%
41
184
4223
42386
27
77
4243
42537
7
10
4263
42604
—
16
11
4244
42527
31
65
4112
41524
48
171
3709
37413
Allergy, unspecified
T78.4 [45580373]
8.7e-01
2.3e+00
3.0e+00
—
—
1.8e+00
1.3e+00
cases:0.77%
controls:0.32%
cases:0.98%
controls:0.10%
cases:0.23%
controls:0.01%
—
—
—
—
cases:0.51%
controls:0.09%
cases:1.12%
controls:0.31%
33
138
4231
42432
42
41
4228
42573
10
5
4260
42609
—
—
21
36
4122
41553
42
118
3715
37466
Crohn disease of small intestine
K50.0 [45596324]
1.6e+00
1.6e+00
2.4e+00
—
—
1.8e+00
1.8e+00
cases:0.68%
controls:0.13%
cases:0.47%
controls:0.09%
cases:0.30%
controls:0.03%
—
—
—
—
cases:0.51%
controls:0.09%
cases:0.69%
controls:0.11%
29
56
4235
42514
20
40
4250
42574
13
12
4257
42602
—
—
21
36
4122
41553
26
42
3731
37542
mometasone
D07AC13 [21602132]
5.7e-01
1.4e+00
2.1e+00
—
2.7e+00
1.5e+00
9.1e-01
cases:7.13%
controls:4.17%
cases:5.22%
controls:1.30%
cases:1.24%
controls:0.16%
—
—
cases:2.30%
controls:0.16%
cases:5.77%
controls:1.34%
cases:9.48%
controls:4.06%
304
1775
3960
40795
223
555
4047
42059
53
67
4217
42547
—
98
67
4162
42471
239
559
3904
41030
356
1526
3401
36058
Abdominal ultrasound examination
JN3AE [2001305555]
6.5e-01
9.1e-01
2.7e+00
—
2.8e+00
1.2e+00
9.5e-01
cases:2.13%
controls:1.13%
cases:0.87%
controls:0.35%
cases:0.40%
controls:0.03%
—
—
cases:0.54%
controls:0.03%
cases:1.18%
controls:0.35%
cases:3.38%
controls:1.34%
91
480
4173
42090
37
149
4233
42465
17
12
4253
42602
—
23
14
4237
42524
49
147
4094
41442
127
504
3630
37080
epinephrine; parenteral
C01CA24 [21600303]
9.9e-01
1.3e+00
2.2e+00
—
2.0e+00
1.5e+00
1.2e+00
cases:1.99%
controls:0.75%
cases:1.10%
controls:0.30%
cases:0.30%
controls:0.04%
—
—
cases:0.31%
controls:0.04%
cases:1.42%
controls:0.32%
cases:2.82%
controls:0.88%
85
320
4179
42250
47
129
4223
42485
13
15
4257
42599
—
13
17
4247
42521
59
135
4084
41454
106
330
3651
37254
epinephrine
S01EA01 [21603673]
9.9e-01
1.3e+00
2.2e+00
—
2.0e+00
1.5e+00
1.2e+00
cases:1.99%
controls:0.75%
cases:1.10%
controls:0.30%
cases:0.30%
controls:0.04%
—
—
cases:0.31%
controls:0.04%
cases:1.42%
controls:0.32%
cases:2.82%
controls:0.88%
85
320
4179
42250
47
129
4223
42485
13
15
4257
42599
—
13
17
4247
42521
59
135
4084
41454
106
330
3651
37254
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
1.1e+00
1.2e+00
1.9e+00
1.0e+50
2.6e+00
1.2e+00
1.2e+00
cases:0.91%
controls:0.31%
cases:0.47%
controls:0.15%
cases:0.21%
controls:0.03%
cases:0.19%
controls:0.00%
cases:0.31%
controls:0.02%
cases:0.46%
controls:0.13%
cases:1.28%
controls:0.40%
39
133
4225
42437
20
62
4250
42552
9
13
4261
42601
8
0
4262
42614
13
10
4247
42528
19
56
4124
41533
48
151
3709
37433
betamethasone
D07AC01 [21602120]
5.8e-01
1.3e+00
2.1e+00
—
2.9e+00
1.4e+00
8.4e-01
cases:9.66%
controls:5.64%
cases:7.19%
controls:2.12%
cases:2.22%
controls:0.28%
—
—
cases:4.88%
controls:0.27%
cases:8.33%
controls:2.20%
cases:13.55%
controls:6.34%
412
2401
3852
40169
307
902
3963
41712
95
119
4175
42495
—
208
116
4052
42422
345
917
3798
40672
509
2383
3248
35201
betamethasone
C05AA05 [21601610]
5.8e-01
1.3e+00
2.1e+00
—
2.9e+00
1.4e+00
8.4e-01
cases:9.66%
controls:5.64%
cases:7.19%
controls:2.12%
cases:2.22%
controls:0.28%
—
—
cases:4.88%
controls:0.27%
cases:8.33%
controls:2.20%
cases:13.55%
controls:6.34%
412
2401
3852
40169
307
902
3963
41712
95
119
4175
42495
—
208
116
4052
42422
345
917
3798
40672
509
2383
3248
35201
betamethasone
A07EA04 [21600656]
5.8e-01
1.3e+00
2.1e+00
—
2.9e+00
1.4e+00
8.4e-01
cases:9.66%
controls:5.64%
cases:7.19%
controls:2.12%
cases:2.22%
controls:0.28%
—
—
cases:4.88%
controls:0.27%
cases:8.33%
controls:2.20%
cases:13.55%
controls:6.34%
412
2401
3852
40169
307
902
3963
41712
95
119
4175
42495
—
208
116
4052
42422
345
917
3798
40672
509
2383
3248
35201
betamethasone
S02BA07 [21605169]
5.8e-01
1.3e+00
2.1e+00
—
2.9e+00
1.4e+00
8.4e-01
cases:9.66%
controls:5.64%
cases:7.19%
controls:2.12%
cases:2.22%
controls:0.28%
—
—
cases:4.88%
controls:0.27%
cases:8.33%
controls:2.20%
cases:13.55%
controls:6.34%
412
2401
3852
40169
307
902
3963
41712
95
119
4175
42495
—
208
116
4052
42422
345
917
3798
40672
509
2383
3248
35201
Emergency Room and Inpatient Visit
ERIP [262]
5.2e-01
7.8e-01
1.1e+00
4.3e+00
1.6e+00
5.0e-01
2.9e-01
cases:4.24%
controls:2.56%
cases:3.16%
controls:1.48%
cases:0.77%
controls:0.25%
cases:0.98%
controls:0.01%
cases:1.13%
controls:0.23%
cases:2.56%
controls:1.57%
cases:6.79%
controls:5.15%
181
1089
4083
41481
135
630
4135
41984
33
106
4237
42508
42
6
4228
42608
48
98
4212
42440
106
655
4037
40934
255
1935
3502
35649
Medical doctor
Z2221 [2001311556]
9.7e-01
1.3e+00
1.7e+00
—
1.8e+00
1.8e+00
1.4e+00
cases:9.57%
controls:3.85%
cases:5.43%
controls:1.47%
cases:1.15%
controls:0.20%
—
—
cases:1.41%
controls:0.23%
cases:7.68%
controls:1.41%
cases:13.47%
controls:3.57%
408
1637
3856
40933
232
628
4038
41986
49
87
4221
42527
—
60
99
4200
42439
318
585
3825
41004
506
1343
3251
36241
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
1.1e+00
1.2e+00
2.0e+00
1.0e+50
2.4e+00
1.3e+00
1.1e+00
cases:1.01%
controls:0.33%
cases:0.52%
controls:0.15%
cases:0.23%
controls:0.03%
cases:0.19%
controls:0.00%
cases:0.31%
controls:0.03%
cases:0.53%
controls:0.15%
cases:1.38%
controls:0.46%
43
142
4221
42428
22
65
4248
42549
10
14
4260
42600
8
0
4262
42614
13
12
4247
42526
22
62
4121
41527
52
174
3705
37410
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
1.1e+00
1.2e+00
2.0e+00
1.0e+50
2.4e+00
1.3e+00
1.1e+00
cases:1.01%
controls:0.33%
cases:0.52%
controls:0.15%
cases:0.23%
controls:0.03%
cases:0.19%
controls:0.00%
cases:0.31%
controls:0.03%
cases:0.53%
controls:0.15%
cases:1.38%
controls:0.47%
43
142
4221
42428
22
65
4248
42549
10
14
4260
42600
8
0
4262
42614
13
12
4247
42526
22
62
4121
41527
52
175
3705
37409
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
1.1e+00
1.2e+00
2.0e+00
1.0e+50
2.4e+00
1.3e+00
1.1e+00
cases:1.01%
controls:0.33%
cases:0.52%
controls:0.15%
cases:0.23%
controls:0.03%
cases:0.19%
controls:0.00%
cases:0.31%
controls:0.03%
cases:0.53%
controls:0.15%
cases:1.38%
controls:0.47%
43
142
4221
42428
22
65
4248
42549
10
14
4260
42600
8
0
4262
42614
13
12
4247
42526
22
62
4121
41527
52
175
3705
37409
Inpatient Hospital
21 [8717]
4.2e-01
6.8e-01
1.4e+00
4.0e+00
1.3e+00
6.8e-01
4.5e-01
cases:41.82%
controls:31.97%
cases:19.30%
controls:10.76%
cases:6.18%
controls:1.60%
cases:3.75%
controls:0.07%
cases:5.12%
controls:1.45%
cases:17.98%
controls:10.03%
cases:36.65%
controls:26.85%
1783
13611
2481
28959
824
4586
3446
38028
264
682
4006
41932
160
29
4110
42585
218
615
4042
41923
745
4173
3398
37416
1377
10092
2380
27492
Bacterial infection, unspecified
A49.9 [45590816]
8.2e-01
1.4e+00
2.4e+00
—
2.3e+00
1.1e+00
8.6e-01
cases:1.43%
controls:0.64%
cases:1.05%
controls:0.27%
cases:0.40%
controls:0.04%
—
—
cases:0.31%
controls:0.03%
cases:0.92%
controls:0.31%
cases:2.32%
controls:1.00%
61
271
4203
42299
45
115
4225
42499
17
15
4253
42599
—
13
13
4247
42525
38
127
4105
41462
87
375
3670
37209
clindamycin; oral, parenteral
J01FF01 [21602985]
7.3e-01
1.4e+00
2.5e+00
—
2.3e+00
1.1e+00
8.2e-01
cases:5.93%
controls:2.96%
cases:3.11%
controls:0.83%
cases:1.03%
controls:0.08%
—
—
cases:0.73%
controls:0.07%
cases:2.73%
controls:0.94%
cases:6.81%
controls:3.12%
253
1258
4011
41312
133
352
4137
42262
44
35
4226
42579
—
31
30
4229
42508
113
389
4030
41200
256
1173
3501
36411
prednisone; oral
H02AB07 [21602735]
1.1e+00
1.5e+00
1.7e+00
—
2.2e+00
1.2e+00
1.1e+00
cases:4.39%
controls:1.50%
cases:2.51%
controls:0.57%
cases:0.59%
controls:0.11%
—
—
cases:0.56%
controls:0.06%
cases:1.88%
controls:0.56%
cases:4.15%
controls:1.44%
187
640
4077
41930
107
243
4163
42371
25
46
4245
42568
—
24
26
4236
42512
78
231
4065
41358
156
542
3601
37042
prednisone
A07EA03 [21600655]
1.1e+00
1.5e+00
1.7e+00
—
2.2e+00
1.2e+00
1.1e+00
cases:4.39%
controls:1.50%
cases:2.51%
controls:0.57%
cases:0.59%
controls:0.11%
—
—
cases:0.56%
controls:0.06%
cases:1.88%
controls:0.56%
cases:4.15%
controls:1.44%
187
640
4077
41930
107
243
4163
42371
25
46
4245
42568
—
24
26
4236
42512
78
231
4065
41358
156
542
3601
37042
Crohn disease of large intestine
K50.1 [45601173]
1.9e+00
1.7e+00
—
—
2.3e+00
1.2e+00
1.7e+00
cases:0.54%
controls:0.08%
cases:0.35%
controls:0.06%
—
—
—
—
cases:0.16%
controls:0.02%
cases:0.29%
controls:0.08%
cases:0.56%
controls:0.11%
23
34
4241
42536
15
27
4255
42587
—
—
7
7
4253
42531
12
35
4131
41554
21
40
3736
37544
Paraesthesia of skin
R20.2 [45568120]
2.5e+00
2.4e+00
—
—
—
2.3e+00
1.6e+00
cases:1.38%
controls:0.12%
cases:0.56%
controls:0.05%
—
—
—
—
—
—
cases:0.29%
controls:0.03%
cases:1.33%
controls:0.27%
59
51
4205
42519
24
21
4246
42593
—
—
—
12
12
4131
41577
50
100
3707
37484
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.2e-01
6.2e-01
1.2e+00
3.9e+00
1.6e+00
6.8e-01
5.5e-01
cases:14.45%
controls:10.92%
cases:9.81%
controls:5.52%
cases:2.55%
controls:0.82%
cases:1.15%
controls:0.02%
cases:3.52%
controls:0.74%
cases:10.09%
controls:5.35%
cases:24.38%
controls:15.64%
616
4648
3648
37922
419
2351
3851
40263
109
348
4161
42266
49
10
4221
42604
150
316
4110
42222
418
2227
3725
39362
916
5880
2841
31704
Other dialysis
Z49.2 [45576160]
1.7e+00
2.4e+00
—
—
—
2.4e+00
2.3e+00
cases:0.21%
controls:0.04%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
cases:0.22%
controls:0.02%
cases:0.32%
controls:0.03%
9
17
4255
42553
9
8
4261
42606
—
—
—
9
8
4134
41581
12
12
3745
37572
Ankylosing spondylitis
M45 [45591841]
7.1e-01
1.6e+00
2.3e+00
—
2.3e+00
1.6e+00
1.0e+00
cases:0.54%
controls:0.27%
cases:0.54%
controls:0.11%
cases:0.23%
controls:0.02%
—
—
cases:0.26%
controls:0.03%
cases:0.60%
controls:0.13%
cases:0.67%
controls:0.24%
23
113
4241
42457
23
48
4247
42566
10
10
4260
42604
—
11
11
4249
42527
25
52
4118
41537
25
89
3732
37495
Besnier prurigo
L20.0 [45562534]
7.3e-01
1.4e+00
2.1e+00
—
2.2e+00
1.6e+00
7.9e-01
cases:1.36%
controls:0.66%
cases:1.08%
controls:0.28%
cases:0.33%
controls:0.04%
—
—
cases:0.52%
controls:0.06%
cases:1.38%
controls:0.28%
cases:1.76%
controls:0.81%
58
280
4206
42290
46
118
4224
42496
14
18
4256
42596
—
22
24
4238
42514
57
116
4086
41473
66
304
3691
37280
Physiotherapist
Z3226 [2001311560]
9.4e-01
1.1e+00
1.6e+00
—
2.1e+00
1.7e+00
1.3e+00
cases:4.67%
controls:1.87%
cases:1.78%
controls:0.58%
cases:0.40%
controls:0.08%
—
—
cases:0.61%
controls:0.08%
cases:2.73%
controls:0.52%
cases:6.76%
controls:2.02%
199
797
4065
41773
76
247
4194
42367
17
33
4253
42581
—
26
33
4234
42505
113
215
4030
41374
254
758
3503
36826
Asthma, unspecified
J45.9 [45562456]
7.4e-01
9.0e-01
8.9e-01
3.0e+00
1.5e+00
8.9e-01
8.0e-01
cases:4.95%
controls:2.42%
cases:2.65%
controls:1.09%
cases:0.59%
controls:0.24%
cases:0.23%
controls:0.01%
cases:0.77%
controls:0.17%
cases:2.75%
controls:1.15%
cases:7.11%
controls:3.31%
211
1032
4053
41538
113
466
4157
42148
25
103
4245
42511
10
5
4260
42609
33
73
4227
42465
114
478
4029
41111
267
1245
3490
36339
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
1.1e+00
1.2e+00
1.8e+00
1.0e+50
2.3e+00
1.2e+00
1.1e+00
cases:0.91%
controls:0.30%
cases:0.44%
controls:0.14%
cases:0.16%
controls:0.03%
cases:0.16%
controls:0.00%
cases:0.23%
controls:0.02%
cases:0.46%
controls:0.14%
cases:1.20%
controls:0.42%
39
129
4225
42441
19
59
4251
42555
7
11
4263
42603
7
0
4263
42614
10
10
4250
42528
19
57
4124
41532
45
156
3712
37428
fluconazole; oral, parenteral
J02AC01 [21603080]
6.0e-01
1.0e+00
1.3e+00
3.0e+00
1.1e+00
9.5e-01
7.5e-01
cases:12.85%
controls:7.49%
cases:6.28%
controls:2.37%
cases:1.10%
controls:0.29%
cases:0.23%
controls:0.01%
cases:0.85%
controls:0.29%
cases:5.84%
controls:2.35%
cases:13.28%
controls:6.74%
548
3188
3716
39382
268
1012
4002
41602
47
125
4223
42489
10
5
4260
42609
36
125
4224
42413
242
977
3901
40612
499
2532
3258
35052
Hematology
82 [38004501]
1.1e+00
1.3e+00
1.7e+00
—
1.9e+00
1.5e+00
1.2e+00
cases:2.27%
controls:0.79%
cases:2.01%
controls:0.54%
cases:1.29%
controls:0.23%
—
—
cases:1.27%
controls:0.20%
cases:2.56%
controls:0.58%
cases:3.09%
controls:0.95%
97
338
4167
42232
86
229
4184
42385
55
100
4215
42514
—
54
85
4206
42453
106
240
4037
41349
116
357
3641
37227
Rheumatism, unspecified
M79.0 [45567658]
1.3e+00
1.8e+00
2.5e+00
—
—
1.7e+00
1.4e+00
cases:1.08%
controls:0.29%
cases:0.56%
controls:0.10%
cases:0.14%
controls:0.01%
—
—
—
—
cases:0.56%
controls:0.10%
cases:1.22%
controls:0.32%
46
122
4218
42448
24
41
4246
42573
6
5
4264
42609
—
—
23
41
4120
41548
46
119
3711
37465
Other Crohn disease
K50.8 [45533599]
1.8e+00
1.5e+00
1.5e+00
—
1.9e+00
1.7e+00
1.7e+00
cases:0.82%
controls:0.14%
cases:0.59%
controls:0.13%
cases:0.16%
controls:0.04%
—
—
cases:0.26%
controls:0.04%
cases:0.72%
controls:0.13%
cases:0.90%
controls:0.16%
35
59
4229
42511
25
55
4245
42559
7
15
4263
42599
—
11
16
4249
42522
30
54
4113
41535
34
61
3723
37523
Skin texture symptom/complaint
S21 [2002000986]
6.1e-01
1.4e+00
3.4e+00
—
1.6e+00
9.7e-01
6.2e-01
cases:1.95%
controls:1.07%
cases:1.29%
controls:0.31%
cases:0.42%
controls:0.01%
—
—
cases:0.31%
controls:0.06%
cases:1.06%
controls:0.40%
cases:2.85%
controls:1.56%
83
456
4181
42114
55
134
4215
42480
18
6
4252
42608
—
13
25
4247
42513
44
168
4099
41421
107
586
3650
36998
Immunohistochemistry procedure
117617002 [4035726]
4.9e-01
1.1e+00
2.2e+00
1.0e+50
2.6e+00
1.0e+00
1.2e+00
cases:1.43%
controls:0.88%
cases:0.96%
controls:0.31%
cases:0.26%
controls:0.03%
cases:0.56%
controls:0.00%
cases:0.31%
controls:0.02%
cases:0.65%
controls:0.23%
cases:1.94%
controls:0.59%
61
374
4203
42196
41
132
4229
42482
11
12
4259
42602
24
0
4246
42614
13
10
4247
42528
27
96
4116
41493
73
223
3684
37361
Normoblasts [#/volume] in Blood
715-3 [3021589]
4.2e-01
6.3e-01
1.2e+00
3.5e+00
1.3e+00
8.3e-01
8.2e-01
cases:7.88%
controls:5.30%
cases:7.52%
controls:4.13%
cases:3.11%
controls:0.99%
cases:1.71%
controls:0.05%
cases:3.40%
controls:0.96%
cases:9.12%
controls:4.19%
cases:16.53%
controls:8.01%
336
2256
3928
40314
321
1761
3949
40853
133
424
4137
42190
73
23
4197
42591
145
409
4115
42129
378
1742
3765
39847
621
3009
3136
34575
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
8.7e-01
8.9e-01
2.6e+00
—
1.9e+00
1.4e+00
9.9e-01
cases:1.52%
controls:0.65%
cases:0.68%
controls:0.28%
cases:0.30%
controls:0.02%
—
—
cases:0.19%
controls:0.03%
cases:0.92%
controls:0.23%
cases:1.97%
controls:0.74%
65
275
4199
42295
29
119
4241
42495
13
10
4257
42604
—
8
12
4252
42526
38
96
4105
41493
74
279
3683
37305
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
9.0e-01
1.2e+00
2.4e+00
—
2.4e+00
9.8e-01
6.6e-01
cases:1.41%
controls:0.58%
cases:0.54%
controls:0.16%
cases:0.21%
controls:0.02%
—
—
cases:0.21%
controls:0.02%
cases:0.51%
controls:0.19%
cases:1.28%
controls:0.66%
60
245
4204
42325
23
69
4247
42545
9
8
4261
42606
—
9
8
4251
42530
21
79
4122
41510
48
249
3709
37335
Other specified dermatitis
L30.8 [45581941]
1.8e+00
2.6e+00
—
—
—
2.5e+00
1.6e+00
cases:0.63%
controls:0.11%
cases:0.49%
controls:0.04%
—
—
—
—
—
—
cases:0.77%
controls:0.06%
cases:0.85%
controls:0.17%
27
46
4237
42524
21
15
4249
42599
—
—
—
32
26
4111
41563
32
65
3725
37519
Pulmonary Disease
29 [38004472]
6.0e-01
7.8e-01
1.3e+00
2.9e+00
1.2e+00
9.3e-01
7.8e-01
cases:11.59%
controls:6.69%
cases:7.10%
controls:3.38%
cases:2.41%
controls:0.65%
cases:0.40%
controls:0.02%
cases:2.16%
controls:0.68%
cases:8.06%
controls:3.36%
cases:14.72%
controls:7.36%
494
2848
3770
39722
303
1442
3967
41172
103
279
4167
42335
17
9
4253
42605
92
289
4168
42249
334
1396
3809
40193
553
2767
3204
34817
Pharmacy visit
OMOP4822462 [581458]
9.1e-01
1.0e+00
7.4e-01
2.4e+00
9.3e-01
1.1e+00
1.4e+00
cases:97.19%
controls:93.31%
cases:92.69%
controls:82.17%
cases:60.42%
controls:42.18%
cases:19.91%
controls:2.15%
cases:64.69%
controls:41.97%
cases:93.51%
controls:82.65%
cases:98.70%
controls:95.09%
4144
39722
120
2848
3958
35014
312
7600
2580
17975
1690
24639
850
918
3420
41696
2756
17853
1504
24685
3874
34374
269
7215
3708
35739
49
1845
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.2e-01
7.3e-01
1.2e+00
3.2e+00
1.5e+00
8.0e-01
5.8e-01
cases:8.77%
controls:5.94%
cases:6.30%
controls:3.12%
cases:2.27%
controls:0.69%
cases:0.87%
controls:0.04%
cases:2.89%
controls:0.66%
cases:6.73%
controls:3.14%
cases:14.72%
controls:8.79%
374
2528
3890
40042
269
1331
4001
41283
97
295
4173
42319
37
15
4233
42599
123
279
4137
42259
279
1304
3864
40285
553
3302
3204
34282
hydrocortisone and antiinfectives
S03CA04 [21605208]
6.3e-01
1.2e+00
2.5e+00
—
2.4e+00
1.1e+00
5.6e-01
cases:2.67%
controls:1.44%
cases:1.62%
controls:0.50%
cases:0.42%
controls:0.04%
—
—
cases:0.54%
controls:0.05%
cases:1.30%
controls:0.45%
cases:3.09%
controls:1.79%
114
614
4150
41956
69
212
4201
42402
18
15
4252
42599
—
23
20
4237
42518
54
188
4089
41401
116
671
3641
36913
hydrocortisone and antiinfectives
S02CA03 [21605175]
6.3e-01
1.2e+00
2.5e+00
—
2.4e+00
1.1e+00
5.6e-01
cases:2.67%
controls:1.44%
cases:1.62%
controls:0.50%
cases:0.42%
controls:0.04%
—
—
cases:0.54%
controls:0.05%
cases:1.30%
controls:0.45%
cases:3.09%
controls:1.79%
114
614
4150
41956
69
212
4201
42402
18
15
4252
42599
—
23
20
4237
42518
54
188
4089
41401
116
671
3641
36913
Other seropositive rheumatoid arthritis
M05.8 [45538634]
8.0e-01
7.2e-01
1.3e+00
2.9e+00
9.8e-01
8.4e-01
8.0e-01
cases:2.16%
controls:0.98%
cases:1.57%
controls:0.77%
cases:0.70%
controls:0.19%
cases:0.21%
controls:0.01%
cases:0.56%
controls:0.21%
cases:1.81%
controls:0.79%
cases:2.56%
controls:1.17%
92
417
4172
42153
67
328
4203
42286
30
79
4240
42535
9
5
4261
42609
24
90
4236
42448
75
328
4068
41261
96
439
3661
37145
Generalized skin eruption due to drugs and medicaments
L27.0 [45538572]
8.0e-01
3.3e+00
—
1.0e+50
—
3.6e+00
1.5e+00
cases:0.19%
controls:0.08%
cases:0.30%
controls:0.01%
—
—
cases:0.30%
controls:0.00%
—
—
cases:0.53%
controls:0.01%
cases:0.29%
controls:0.07%
8
36
4256
42534
13
5
4257
42609
—
13
0
4257
42614
—
22
6
4121
41583
11
25
3746
37559
Outpatient Hospital
22 [8756]
4.3e-01
6.8e-01
1.3e+00
3.5e+00
1.3e+00
6.9e-01
5.4e-01
cases:32.97%
controls:24.31%
cases:13.33%
controls:7.23%
cases:3.14%
controls:0.92%
cases:1.12%
controls:0.04%
cases:3.00%
controls:0.85%
cases:12.72%
controls:6.80%
cases:30.48%
controls:20.35%
1406
10347
2858
32223
569
3081
3701
39533
134
391
4136
42223
48
15
4222
42599
128
362
4132
42176
527
2827
3616
38762
1145
7649
2612
29935
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
1.7e+00
1.5e+00
1.1e+00
—
1.6e+00
1.6e+00
1.9e+00
cases:0.82%
controls:0.15%
cases:0.70%
controls:0.15%
cases:0.16%
controls:0.06%
—
—
cases:0.23%
controls:0.05%
cases:0.89%
controls:0.18%
cases:1.44%
controls:0.21%
35
65
4229
42505
30
65
4240
42549
7
24
4263
42590
—
10
21
4250
42517
37
75
4106
41514
54
79
3703
37505
Other overlap syndromes
M35.1 [45553172]
1.6e+00
2.3e+00
—
—
—
2.4e+00
1.9e+00
cases:0.21%
controls:0.04%
cases:0.19%
controls:0.02%
—
—
—
—
—
—
cases:0.19%
controls:0.02%
cases:0.24%
controls:0.03%
9
18
4255
42552
8
8
4262
42606
—
—
—
8
7
4135
41582
9
13
3748
37571
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
3.5e-01
6.9e-01
1.3e+00
3.0e+00
1.5e+00
7.7e-01
6.6e-01
cases:7.22%
controls:5.22%
cases:5.20%
controls:2.68%
cases:1.59%
controls:0.44%
cases:0.42%
controls:0.02%
cases:1.88%
controls:0.43%
cases:5.74%
controls:2.74%
cases:13.26%
controls:7.32%
308
2221
3956
40349
222
1144
4048
41470
68
188
4202
42426
18
9
4252
42605
80
182
4180
42356
238
1138
3905
40451
498
2753
3259
34831
pegfilgrastim; parenteral
L03AA13 [21603856]
8.8e-01
1.7e+00
2.3e+00
—
2.2e+00
9.8e-01
1.2e+00
cases:0.56%
controls:0.23%
cases:0.56%
controls:0.10%
cases:0.26%
controls:0.03%
—
—
cases:0.16%
controls:0.02%
cases:0.31%
controls:0.12%
cases:0.85%
controls:0.26%
24
100
4240
42470
24
43
4246
42571
11
11
4259
42603
—
7
8
4253
42530
13
49
4130
41540
32
99
3725
37485
Crohn disease, unspecified
K50.9 [45562490]
1.7e+00
1.9e+00
—
—
—
2.6e+00
2.0e+00
cases:0.59%
controls:0.11%
cases:0.35%
controls:0.05%
—
—
—
—
—
—
cases:0.43%
controls:0.03%
cases:0.77%
controls:0.10%
25
47
4239
42523
15
22
4255
42592
—
—
—
18
13
4125
41576
29
39
3728
37545
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
5.2e-01
7.1e-01
1.2e+00
3.0e+00
1.3e+00
8.8e-01
5.7e-01
cases:6.43%
controls:3.94%
cases:3.63%
controls:1.81%
cases:0.91%
controls:0.27%
cases:0.23%
controls:0.01%
cases:0.96%
controls:0.25%
cases:4.15%
controls:1.77%
cases:9.90%
controls:5.82%
274
1676
3990
40894
155
773
4115
41841
39
116
4231
42498
10
5
4260
42609
41
107
4219
42431
172
735
3971
40854
372
2189
3385
35395
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
2.5e-01
5.0e-01
1.2e+00
4.1e+00
1.2e+00
5.9e-01
3.8e-01
cases:8.70%
controls:6.92%
cases:5.67%
controls:3.51%
cases:1.78%
controls:0.53%
cases:1.10%
controls:0.02%
cases:1.50%
controls:0.45%
cases:5.99%
controls:3.42%
cases:14.88%
controls:10.72%
371
2944
3893
39626
242
1494
4028
41120
76
226
4194
42388
47
8
4223
42606
64
192
4196
42346
248
1424
3895
40165
559
4029
3198
33555
triamcinolone and antiinfectives
S02CA04 [21605176]
9.4e-01
1.1e+00
1.9e+00
—
1.9e+00
1.6e+00
8.3e-01
cases:1.41%
controls:0.55%
cases:0.70%
controls:0.24%
cases:0.21%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.68%
controls:0.14%
cases:1.44%
controls:0.63%
60
235
4204
42335
30
102
4240
42512
9
14
4261
42600
—
8
12
4252
42526
28
57
4115
41532
54
237
3703
37347
methylprednisolone; oral, parenteral
H02AB04 [21602732]
7.8e-01
1.4e+00
1.9e+00
—
2.0e+00
1.2e+00
9.3e-01
cases:4.06%
controls:1.91%
cases:2.27%
controls:0.57%
cases:0.68%
controls:0.10%
—
—
cases:0.56%
controls:0.08%
cases:1.91%
controls:0.57%
cases:3.73%
controls:1.51%
173
812
4091
41758
97
245
4173
42369
29
42
4241
42572
—
24
34
4236
42504
79
236
4064
41353
140
567
3617
37017
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
3.9e-01
7.0e-01
1.2e+00
3.1e+00
1.4e+00
7.6e-01
5.9e-01
cases:8.35%
controls:5.82%
cases:6.18%
controls:3.16%
cases:1.76%
controls:0.53%
cases:0.47%
controls:0.02%
cases:2.11%
controls:0.51%
cases:6.52%
controls:3.16%
cases:14.56%
controls:8.65%
356
2479
3908
40091
264
1348
4006
41266
75
224
4195
42390
20
9
4250
42605
90
217
4170
42321
270
1316
3873
40273
547
3250
3210
34334
Medical Oncology
90 [38004507]
4.5e-01
8.5e-01
1.4e+00
2.6e+00
1.3e+00
8.5e-01
6.5e-01
cases:4.36%
controls:2.82%
cases:4.54%
controls:1.99%
cases:2.69%
controls:0.67%
cases:0.77%
controls:0.06%
cases:2.37%
controls:0.65%
cases:4.66%
controls:2.05%
cases:6.60%
controls:3.57%
186
1200
4078
41370
194
849
4076
41765
115
285
4155
42329
33
24
4237
42590
101
277
4159
42261
193
852
3950
40737
248
1340
3509
36244
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
5.8e-01
1.1e+00
2.1e+00
—
2.2e+00
1.3e+00
8.7e-01
cases:2.02%
controls:1.14%
cases:1.55%
controls:0.54%
cases:0.63%
controls:0.08%
—
—
cases:0.70%
controls:0.08%
cases:1.74%
controls:0.46%
cases:3.75%
controls:1.61%
86
486
4178
42084
66
229
4204
42385
27
32
4243
42582
—
30
35
4230
42503
72
193
4071
41396
141
606
3616
36978
Bone marrow biopsy
XW000 [2001310618]
1.0e+00
1.8e+00
2.1e+00
—
—
1.8e+00
1.3e+00
cases:0.70%
controls:0.25%
cases:0.59%
controls:0.10%
cases:0.14%
controls:0.02%
—
—
—
—
cases:0.46%
controls:0.08%
cases:0.90%
controls:0.24%
30
106
4234
42464
25
41
4245
42573
6
7
4264
42607
—
—
19
33
4124
41556
34
90
3723
37494
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.9e-01
4.6e-01
1.1e+00
3.9e+00
1.2e+00
5.4e-01
4.6e-01
cases:11.87%
controls:9.19%
cases:7.17%
controls:4.63%
cases:2.08%
controls:0.71%
cases:0.96%
controls:0.02%
cases:2.16%
controls:0.65%
cases:7.84%
controls:4.72%
cases:19.75%
controls:13.47%
506
3913
3758
38657
306
1974
3964
40640
89
303
4181
42311
41
8
4229
42606
92
276
4168
42262
325
1961
3818
39628
742
5064
3015
32520
Coeliac disease
K90.0 [45586745]
6.8e-01
9.2e-01
1.9e+00
—
1.9e+00
1.6e+00
1.1e+00
cases:0.70%
controls:0.36%
cases:0.47%
controls:0.19%
cases:0.19%
controls:0.03%
—
—
cases:0.16%
controls:0.03%
cases:0.84%
controls:0.18%
cases:1.30%
controls:0.45%
30
153
4234
42417
20
80
4250
42534
8
12
4262
42602
—
7
11
4253
42527
35
74
4108
41515
49
171
3708
37413
Skin symptom/complaint other
S29 [2002000993]
6.3e-01
1.5e+00
2.2e+00
—
2.0e+00
8.2e-01
7.9e-01
cases:2.77%
controls:1.49%
cases:2.13%
controls:0.50%
cases:0.73%
controls:0.08%
—
—
cases:0.54%
controls:0.07%
cases:1.40%
controls:0.62%
cases:4.58%
controls:2.12%
118
635
4146
41935
91
214
4179
42400
31
33
4239
42581
—
23
31
4237
42507
58
258
4085
41331
172
798
3585
36786
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
3.9e-01
6.3e-01
1.1e+00
3.1e+00
1.4e+00
7.3e-01
6.3e-01
cases:7.25%
controls:5.02%
cases:5.01%
controls:2.73%
cases:1.41%
controls:0.48%
cases:0.42%
controls:0.02%
cases:1.71%
controls:0.44%
cases:5.60%
controls:2.79%
cases:12.75%
controls:7.24%
309
2137
3955
40433
214
1163
4056
41451
60
204
4210
42410
18
8
4252
42606
73
189
4187
42349
232
1159
3911
40430
479
2721
3278
34863
Kidney transplant status
Z94.0 [45566477]
1.7e+00
1.6e+00
1.0e+00
—
1.5e+00
1.6e+00
1.6e+00
cases:0.59%
controls:0.11%
cases:0.56%
controls:0.12%
cases:0.19%
controls:0.07%
—
—
cases:0.23%
controls:0.05%
cases:0.60%
controls:0.13%
cases:0.75%
controls:0.15%
25
45
4239
42525
24
51
4246
42563
8
28
4262
42586
—
10
23
4250
42515
25
52
4118
41537
28
57
3729
37527
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.3e-01
5.2e-01
1.2e+00
3.7e+00
1.3e+00
5.6e-01
3.8e-01
cases:20.52%
controls:17.07%
cases:17.24%
controls:11.03%
cases:6.98%
controls:2.26%
cases:5.36%
controls:0.14%
cases:7.72%
controls:2.16%
cases:18.20%
controls:11.30%
cases:34.66%
controls:26.59%
875
7266
3389
35304
736
4700
3534
37914
298
962
3972
41652
229
59
4041
42555
329
919
3931
41619
754
4701
3389
36888
1302
9992
2455
27592
Erysipelas
A46 [45561706]
6.7e-01
1.3e+00
2.7e+00
1.0e+50
1.8e+00
7.5e-01
6.4e-01
cases:2.46%
controls:1.27%
cases:1.62%
controls:0.42%
cases:0.89%
controls:0.06%
cases:0.52%
controls:0.00%
cases:0.33%
controls:0.06%
cases:0.99%
controls:0.47%
cases:3.49%
controls:1.87%
105
541
4159
42029
69
181
4201
42433
38
25
4232
42589
22
0
4248
42614
14
24
4246
42514
41
196
4102
41393
131
703
3626
36881
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
8.2e-01
1.2e+00
1.5e+00
—
1.6e+00
1.5e+00
1.3e+00
cases:1.67%
controls:0.74%
cases:1.41%
controls:0.42%
cases:0.23%
controls:0.05%
—
—
cases:0.38%
controls:0.08%
cases:1.50%
controls:0.33%
cases:3.01%
controls:0.88%
71
314
4193
42256
60
180
4210
42434
10
22
4260
42592
—
16
33
4244
42505
62
138
4081
41451
113
330
3644
37254
Other extensive ultrasound examination of artery
PG1DE [2001309713]
1.3e+00
1.7e+00
2.2e+00
—
2.1e+00
1.7e+00
1.1e+00
cases:0.96%
controls:0.27%
cases:0.52%
controls:0.10%
cases:0.16%
controls:0.02%
—
—
cases:0.12%
controls:0.01%
cases:0.58%
controls:0.10%
cases:1.04%
controls:0.36%
41
117
4223
42453
22
42
4248
42572
7
8
4263
42606
—
5
6
4255
42532
24
43
4119
41546
39
134
3718
37450
Other and unspecified skin changes
R23.8 [45573020]
5.3e-01
1.3e+00
2.7e+00
—
1.8e+00
9.5e-01
5.9e-01
cases:1.97%
controls:1.17%
cases:1.59%
controls:0.44%
cases:0.61%
controls:0.04%
—
—
cases:0.31%
controls:0.05%
cases:1.23%
controls:0.48%
cases:3.70%
controls:2.09%
84
497
4180
42073
68
187
4202
42427
26
17
4244
42597
—
13
22
4247
42516
51
200
4092
41389
139
787
3618
36797
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
26975-3 [3025245]
6.8e-01
1.2e+00
—
—
3.4e+00
2.0e+00
1.2e+00
cases:0.33%
controls:0.17%
cases:0.28%
controls:0.08%
—
—
—
—
cases:0.35%
controls:0.01%
cases:0.53%
controls:0.07%
cases:0.96%
controls:0.29%
14
71
4250
42499
12
35
4258
42579
—
—
15
5
4245
42533
22
29
4121
41560
36
109
3721
37475
fusidic acid
D09AA02 [21602265]
7.7e-01
1.1e+00
2.0e+00
1.0e+50
1.9e+00
1.2e+00
8.2e-01
cases:4.78%
controls:2.28%
cases:2.01%
controls:0.65%
cases:0.59%
controls:0.08%
cases:0.26%
controls:0.00%
cases:0.52%
controls:0.08%
cases:2.24%
controls:0.68%
cases:5.96%
controls:2.72%
204
971
4060
41599
86
278
4184
42336
25
33
4245
42581
11
0
4259
42614
22
33
4238
42505
93
283
4050
41306
224
1021
3533
36563
fusidic acid; ointment
D06AX01 [21602062]
7.7e-01
1.1e+00
2.0e+00
1.0e+50
1.9e+00
1.2e+00
8.2e-01
cases:4.78%
controls:2.28%
cases:2.01%
controls:0.65%
cases:0.59%
controls:0.08%
cases:0.26%
controls:0.00%
cases:0.52%
controls:0.08%
cases:2.24%
controls:0.68%
cases:5.96%
controls:2.72%
204
971
4060
41599
86
278
4184
42336
25
33
4245
42581
11
0
4259
42614
22
33
4238
42505
93
283
4050
41306
224
1021
3533
36563
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
1.1e+00
1.4e+00
—
1.0e+50
2.3e+00
2.0e+00
1.1e+00
cases:1.59%
controls:0.55%
cases:0.68%
controls:0.17%
—
—
cases:0.21%
controls:0.00%
cases:0.19%
controls:0.02%
cases:1.18%
controls:0.16%
cases:1.89%
controls:0.65%
68
236
4196
42334
29
71
4241
42543
—
9
0
4261
42614
8
8
4252
42530
49
67
4094
41522
71
246
3686
37338
Hemodialysis
TK800 [2001305768]
8.1e-01
1.6e+00
1.6e+00
—
1.7e+00
1.6e+00
1.3e+00
cases:0.30%
controls:0.14%
cases:0.35%
controls:0.07%
cases:0.26%
controls:0.05%
—
—
cases:0.28%
controls:0.05%
cases:0.36%
controls:0.07%
cases:0.51%
controls:0.13%
13
58
4251
42512
15
31
4255
42583
11
22
4259
42592
—
12
21
4248
42517
15
31
4128
41558
19
50
3738
37534
imidazoles/triazoles in combination with corticosteroids
D01AC20 [21601936]
6.9e-01
1.4e+00
1.6e+00
—
2.2e+00
1.1e+00
8.5e-01
cases:6.33%
controls:3.27%
cases:4.54%
controls:1.18%
cases:0.82%
controls:0.16%
—
—
cases:1.36%
controls:0.15%
cases:3.23%
controls:1.13%
cases:7.67%
controls:3.44%
270
1391
3994
41179
194
503
4076
42111
35
70
4235
42544
—
58
62
4202
42476
134
472
4009
41117
288
1293
3469
36291
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
5.8e-01
9.1e-01
2.5e+00
—
2.1e+00
8.6e-01
8.3e-01
cases:1.43%
controls:0.80%
cases:0.54%
controls:0.22%
cases:0.23%
controls:0.02%
—
—
cases:0.21%
controls:0.03%
cases:0.58%
controls:0.25%
cases:1.89%
controls:0.84%
61
342
4203
42228
23
93
4247
42521
10
8
4260
42606
—
9
11
4251
42527
24
102
4119
41487
71
314
3686
37270
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.5e-01
6.3e-01
1.1e+00
3.2e+00
1.3e+00
6.6e-01
5.8e-01
cases:14.68%
controls:10.84%
cases:11.80%
controls:6.66%
cases:3.93%
controls:1.34%
cases:1.15%
controls:0.05%
cases:4.51%
controls:1.30%
cases:12.38%
controls:6.81%
cases:25.23%
controls:15.95%
626
4616
3638
37954
504
2840
3766
39774
168
572
4102
42042
49
20
4221
42594
192
551
4068
41987
513
2833
3630
38756
948
5994
2809
31590
tacrolimus
D11AH01 [21602338]
7.0e-01
1.4e+00
1.1e+00
1.0e+50
2.6e+00
1.8e+00
1.4e+00
cases:1.01%
controls:0.51%
cases:0.91%
controls:0.24%
cases:0.12%
controls:0.04%
cases:0.16%
controls:0.00%
cases:0.40%
controls:0.03%
cases:1.33%
controls:0.23%
cases:2.74%
controls:0.71%
43
215
4221
42355
39
101
4231
42513
5
16
4265
42598
7
0
4263
42614
17
13
4243
42525
55
95
4088
41494
103
266
3654
37318
Otolaryngology
4 [38004449]
6.2e-01
7.6e-01
8.8e-01
3.1e+00
1.1e+00
7.1e-01
6.3e-01
cases:17.07%
controls:9.97%
cases:7.35%
controls:3.57%
cases:1.38%
controls:0.58%
cases:0.35%
controls:0.02%
cases:1.55%
controls:0.52%
cases:7.34%
controls:3.73%
cases:17.62%
controls:10.24%
728
4244
3536
38326
314
1520
3956
41094
59
246
4211
42368
15
7
4255
42607
66
223
4194
42315
304
1551
3839
40038
662
3848
3095
33736
Arthritis, unspecified
M13.9 [45567463]
9.6e-01
1.2e+00
1.6e+00
—
1.9e+00
1.3e+00
8.6e-01
cases:1.59%
controls:0.62%
cases:0.84%
controls:0.27%
cases:0.30%
controls:0.06%
—
—
cases:0.38%
controls:0.06%
cases:0.92%
controls:0.25%
cases:1.76%
controls:0.75%
68
263
4196
42307
36
113
4234
42501
13
27
4257
42587
—
16
24
4244
42514
38
103
4105
41486
66
283
3691
37301
Nonallergic asthma
J45.1 [45557625]
8.9e-01
1.3e+00
1.7e+00
—
1.6e+00
1.3e+00
1.1e+00
cases:2.13%
controls:0.89%
cases:1.22%
controls:0.35%
cases:0.44%
controls:0.08%
—
—
cases:0.28%
controls:0.06%
cases:1.35%
controls:0.37%
cases:2.64%
controls:0.92%
91
378
4173
42192
52
148
4218
42466
19
36
4251
42578
—
12
25
4248
42513
56
155
4087
41434
99
345
3658
37239
Dermatographic urticaria
L50.3 [45596376]
9.8e-01
2.7e+00
—
1.0e+50
—
3.1e+00
2.0e+00
cases:0.28%
controls:0.11%
cases:0.40%
controls:0.03%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.63%
controls:0.03%
cases:0.85%
controls:0.12%
12
45
4252
42525
17
12
4253
42602
—
8
0
4262
42614
—
26
12
4117
41577
32
44
3725
37540
alfacalcidol; oral, parenteral
A11CC03 [21600818]
1.4e+00
1.6e+00
1.1e+00
—
2.2e+00
1.4e+00
1.1e+00
cases:0.80%
controls:0.20%
cases:0.75%
controls:0.15%
cases:0.12%
controls:0.04%
—
—
cases:0.28%
controls:0.03%
cases:0.65%
controls:0.16%
cases:0.83%
controls:0.27%
34
87
4230
42483
32
66
4238
42548
5
16
4265
42598
—
12
13
4248
42525
27
66
4116
41523
31
102
3726
37482
metronidazole
D06BX01 [21602096]
7.4e-01
1.3e+00
1.5e+00
1.0e+50
2.0e+00
1.3e+00
9.0e-01
cases:2.98%
controls:1.45%
cases:1.94%
controls:0.53%
cases:0.21%
controls:0.05%
cases:0.14%
controls:0.00%
cases:0.45%
controls:0.06%
cases:1.69%
controls:0.47%
cases:3.83%
controls:1.60%
127
617
4137
41953
83
227
4187
42387
9
20
4261
42594
6
0
4264
42614
19
27
4241
42511
70
194
4073
41395
144
600
3613
36984
Neurology
13 [38004458]
5.5e-01
6.4e-01
1.2e+00
2.6e+00
1.0e+00
8.7e-01
6.9e-01
cases:13.79%
controls:8.42%
cases:6.72%
controls:3.68%
cases:2.20%
controls:0.65%
cases:0.52%
controls:0.04%
cases:1.83%
controls:0.66%
cases:8.33%
controls:3.66%
cases:16.90%
controls:9.25%
588
3584
3676
38986
287
1567
3983
41047
94
279
4176
42335
22
16
4248
42598
78
280
4182
42258
345
1522
3798
40067
635
3476
3122
34108
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.2e-01
5.2e-01
1.1e+00
3.5e+00
1.2e+00
6.0e-01
4.3e-01
cases:18.36%
controls:14.10%
cases:17.87%
controls:11.43%
cases:7.63%
controls:2.66%
cases:4.68%
controls:0.15%
cases:7.68%
controls:2.53%
cases:19.62%
controls:11.84%
cases:31.43%
controls:22.94%
783
6001
3481
36569
763
4870
3507
37744
326
1133
3944
41481
200
64
4070
42550
327
1076
3933
41462
813
4923
3330
36666
1181
8622
2576
28962
General Surgery
2 [38004447]
4.7e-01
7.2e-01
8.1e-01
3.4e+00
1.1e+00
6.3e-01
4.7e-01
cases:26.92%
controls:18.70%
cases:11.36%
controls:5.87%
cases:1.85%
controls:0.83%
cases:0.66%
controls:0.02%
cases:2.30%
controls:0.82%
cases:9.90%
controls:5.51%
cases:22.76%
controls:15.51%
1148
7959
3116
34611
485
2500
3785
40114
79
353
4191
42261
28
9
4242
42605
98
347
4162
42191
410
2292
3733
39297
855
5829
2902
31755
Liver transplant status
Z94.4 [45566478]
1.9e+00
1.9e+00
—
—
2.0e+00
2.1e+00
1.7e+00
cases:0.19%
controls:0.03%
cases:0.16%
controls:0.02%
—
—
—
—
cases:0.12%
controls:0.02%
cases:0.19%
controls:0.02%
cases:0.21%
controls:0.04%
8
12
4256
42558
7
10
4263
42604
—
—
5
7
4255
42531
8
10
4135
41579
8
15
3749
37569
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
9.3e-01
1.2e+00
1.7e+00
—
1.7e+00
1.1e+00
9.3e-01
cases:1.10%
controls:0.44%
cases:0.66%
controls:0.20%
cases:0.21%
controls:0.04%
—
—
cases:0.21%
controls:0.04%
cases:0.70%
controls:0.23%
cases:1.57%
controls:0.63%
47
186
4217
42384
28
87
4242
42527
9
17
4261
42597
—
9
16
4251
42522
29
95
4114
41494
59
236
3698
37348
levocetirizine; oral
R06AE09 [21603498]
7.5e-01
1.1e+00
1.6e+00
—
2.0e+00
1.2e+00
8.6e-01
cases:3.99%
controls:1.91%
cases:2.97%
controls:0.98%
cases:0.82%
controls:0.17%
—
—
cases:1.24%
controls:0.18%
cases:3.26%
controls:0.97%
cases:5.22%
controls:2.27%
170
815
4094
41755
127
417
4143
42197
35
72
4235
42542
—
53
75
4207
42463
135
403
4008
41186
196
853
3561
36731
Other ultrasound examination
XX9XE [2001311056]
2.5e+00
—
—
—
—
2.3e+00
2.7e+00
cases:0.26%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.17%
controls:0.02%
cases:0.48%
controls:0.03%
11
9
4253
42561
—
—
—
—
7
7
4136
41582
18
12
3739
37572
pH of Urine
2756-5 [3015736]
4.7e-01
6.4e-01
1.1e+00
3.0e+00
1.3e+00
6.1e-01
3.7e-01
cases:7.25%
controls:4.64%
cases:4.61%
controls:2.49%
cases:1.22%
controls:0.40%
cases:0.42%
controls:0.02%
cases:1.41%
controls:0.38%
cases:4.85%
controls:2.69%
cases:12.19%
controls:8.73%
309
1975
3955
40595
197
1059
4073
41555
52
172
4218
42442
18
9
4252
42605
60
163
4200
42375
201
1120
3942
40469
458
3281
3299
34303
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
6.4e-01
8.1e-01
2.1e+00
—
1.8e+00
1.3e+00
8.7e-01
cases:1.71%
controls:0.91%
cases:0.89%
controls:0.40%
cases:0.26%
controls:0.03%
—
—
cases:0.23%
controls:0.04%
cases:1.35%
controls:0.37%
cases:3.17%
controls:1.35%
73
387
4191
42183
38
170
4232
42444
11
14
4259
42600
—
10
16
4250
42522
56
155
4087
41434
119
507
3638
37077
acitretin; oral
D05BB02 [21602051]
8.9e-01
1.2e+00
—
—
2.8e+00
2.1e+00
1.6e+00
cases:0.47%
controls:0.19%
cases:0.26%
controls:0.08%
—
—
—
—
cases:0.23%
controls:0.01%
cases:0.48%
controls:0.06%
cases:0.51%
controls:0.10%
20
82
4244
42488
11
34
4259
42580
—
—
10
6
4250
42532
20
24
4123
41565
19
38
3738
37546
Other lichen planus
L43.8 [45577038]
1.2e+00
1.6e+00
—
—
—
2.8e+00
1.9e+00
cases:0.38%
controls:0.12%
cases:0.19%
controls:0.04%
—
—
—
—
—
—
cases:0.60%
controls:0.04%
cases:0.83%
controls:0.13%
16
49
4248
42521
8
16
4262
42598
—
—
—
25
16
4118
41573
31
47
3726
37537
Physiotherapy
R4110 [2001310233]
9.4e-01
9.3e-01
1.5e+00
—
1.6e+00
1.3e+00
1.1e+00
cases:7.55%
controls:3.10%
cases:3.07%
controls:1.23%
cases:0.73%
controls:0.16%
—
—
cases:0.92%
controls:0.18%
cases:3.93%
controls:1.12%
cases:9.64%
controls:3.50%
322
1320
3942
41250
131
524
4139
42090
31
69
4239
42545
—
39
78
4221
42460
163
465
3980
41124
362
1314
3395
36270
other preparations, combinations; ointment
C05AX03 [21601631]
7.7e-01
1.2e+00
1.6e+00
—
1.9e+00
1.1e+00
8.7e-01
cases:4.83%
controls:2.30%
cases:2.62%
controls:0.84%
cases:0.61%
controls:0.12%
—
—
cases:0.70%
controls:0.11%
cases:2.10%
controls:0.73%
cases:5.06%
controls:2.18%
206
981
4058
41589
112
359
4158
42255
26
51
4244
42563
—
30
47
4230
42491
87
304
4056
41285
190
818
3567
36766
Oncology Clinic/Center
261QX0200X [38004268]
6.7e-01
1.1e+00
1.8e+00
—
2.8e+00
6.3e-01
3.9e-01
cases:7.39%
controls:3.93%
cases:3.47%
controls:1.22%
cases:0.75%
controls:0.12%
—
—
cases:1.41%
controls:0.09%
cases:1.91%
controls:1.02%
cases:5.80%
controls:4.02%
315
1674
3949
40896
148
518
4122
42096
32
52
4238
42562
—
60
38
4200
42500
79
426
4064
41163
218
1509
3539
36075
antibiotics in combination with other drugs
S01AA20 [21603571]
3.9e-01
6.0e-01
9.0e-01
3.3e+00
1.3e+00
4.3e-01
4.0e-01
cases:8.56%
controls:5.95%
cases:3.47%
controls:1.93%
cases:0.59%
controls:0.24%
cases:0.40%
controls:0.01%
cases:0.70%
controls:0.20%
cases:2.97%
controls:1.95%
cases:10.22%
controls:7.08%
365
2532
3899
40038
148
824
4122
41790
25
102
4245
42512
17
6
4253
42608
30
85
4230
42453
123
810
4020
40779
384
2661
3373
34923
Angioneurotic oedema
T78.3 [45551447]
9.5e-01
2.6e+00
—
—
—
2.9e+00
1.8e+00
cases:0.16%
controls:0.06%
cases:0.16%
controls:0.01%
—
—
—
—
—
—
cases:0.34%
controls:0.02%
cases:0.37%
controls:0.06%
7
27
4257
42543
7
5
4263
42609
—
—
—
14
8
4129
41581
14
24
3743
37560
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
7.3e-01
1.6e+00
2.9e+00
1.0e+50
—
1.1e+00
9.3e-01
cases:1.24%
controls:0.60%
cases:0.84%
controls:0.17%
cases:0.35%
controls:0.02%
cases:0.19%
controls:0.00%
—
—
cases:0.46%
controls:0.16%
cases:1.73%
controls:0.69%
53
256
4211
42314
36
74
4234
42540
15
8
4255
42606
8
0
4262
42614
—
19
65
4124
41524
65
260
3692
37324
Supplier / Service Provider
OMOP5117446 [33004]
-9.6e-01
-5.6e-01
-1.9e-01
1.4e+00
2.8e+00
2.8e+00
3.2e+00
cases:10.81%
controls:24.10%
cases:4.07%
controls:6.92%
cases:0.63%
controls:0.76%
cases:0.16%
controls:0.04%
cases:0.54%
controls:0.03%
cases:4.34%
controls:0.28%
cases:14.64%
controls:0.70%
461
10259
3803
32311
174
2951
4096
39663
27
325
4243
42289
7
17
4263
42597
23
14
4237
42524
180
118
3963
41471
550
264
3207
37320
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
4.3e-01
5.6e-01
1.3e+00
3.2e+00
1.1e+00
4.0e-01
2.5e-01
cases:7.43%
controls:4.96%
cases:4.61%
controls:2.68%
cases:1.45%
controls:0.40%
cases:0.49%
controls:0.02%
cases:1.17%
controls:0.38%
cases:4.25%
controls:2.89%
cases:11.21%
controls:8.95%
317
2110
3947
40460
197
1143
4073
41471
62
171
4208
42443
21
9
4249
42605
50
161
4210
42377
176
1201
3967
40388
421
3363
3336
34221
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.1e-01
4.7e-01
1.0e+00
3.2e+00
1.2e+00
5.1e-01
4.6e-01
cases:12.78%
controls:9.67%
cases:7.96%
controls:5.12%
cases:2.08%
controls:0.76%
cases:0.66%
controls:0.03%
cases:2.25%
controls:0.70%
cases:8.35%
controls:5.17%
cases:20.89%
controls:14.35%
545
4117
3719
38453
340
2181
3930
40433
89
324
4181
42290
28
11
4242
42603
96
297
4164
42241
346
2151
3797
39438
785
5393
2972
32191
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
4.7e-01
5.7e-01
1.2e+00
3.0e+00
1.2e+00
4.9e-01
3.0e-01
cases:8.77%
controls:5.69%
cases:5.88%
controls:3.40%
cases:1.73%
controls:0.54%
cases:0.56%
controls:0.03%
cases:1.67%
controls:0.51%
cases:6.01%
controls:3.78%
cases:14.64%
controls:11.23%
374
2421
3890
40149
251
1450
4019
41164
74
228
4196
42386
24
12
4246
42602
71
219
4189
42319
249
1570
3894
40019
550
4222
3207
33362
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
3.4e-01
1.1e+00
1.7e+00
—
2.1e+00
1.3e+00
9.7e-01
cases:1.55%
controls:1.10%
cases:1.64%
controls:0.56%
cases:0.75%
controls:0.13%
—
—
cases:0.94%
controls:0.12%
cases:2.00%
controls:0.55%
cases:3.67%
controls:1.43%
66
469
4198
42101
70
239
4200
42375
32
56
4238
42558
—
40
50
4220
42488
83
229
4060
41360
138
537
3619
37047
Extractable nuclear Ab [Presence] in Serum by Immunoblot
57431-9 [40760543]
8.6e-01
2.5e+00
—
—
—
2.7e+00
2.0e+00
cases:0.19%
controls:0.08%
cases:0.16%
controls:0.01%
—
—
—
—
—
—
cases:0.22%
controls:0.01%
cases:0.40%
controls:0.05%
8
34
4256
42536
7
6
4263
42608
—
—
—
9
6
4134
41583
15
20
3742
37564
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
4.5e-01
5.6e-01
1.2e+00
3.0e+00
1.2e+00
4.7e-01
2.9e-01
cases:8.79%
controls:5.82%
cases:5.95%
controls:3.48%
cases:1.76%
controls:0.54%
cases:0.59%
controls:0.03%
cases:1.67%
controls:0.52%
cases:5.99%
controls:3.84%
cases:14.85%
controls:11.50%
375
2476
3889
40094
254
1484
4016
41130
75
229
4195
42385
25
12
4245
42602
71
222
4189
42316
248
1599
3895
39990
558
4321
3199
33263
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
3.3e-01
5.7e-01
1.3e+00
3.2e+00
1.0e+00
4.0e-01
3.2e-01
cases:4.83%
controls:3.53%
cases:3.54%
controls:2.03%
cases:1.12%
controls:0.31%
cases:0.44%
controls:0.02%
cases:0.80%
controls:0.28%
cases:3.19%
controls:2.16%
cases:8.33%
controls:6.18%
206
1504
4058
41066
151
866
4119
41748
48
130
4222
42484
19
8
4251
42606
34
120
4226
42418
132
897
4011
40692
313
2324
3444
35260
Pustulosis palmaris et plantaris
L40.3 [45591634]
2.2e-01
1.7e+00
2.3e+00
—
2.3e+00
1.8e+00
1.4e+00
cases:0.12%
controls:0.09%
cases:0.23%
controls:0.04%
cases:0.16%
controls:0.02%
—
—
cases:0.12%
controls:0.01%
cases:0.27%
controls:0.04%
cases:0.43%
controls:0.11%
5
40
4259
42530
10
19
4260
42595
7
7
4263
42607
—
5
5
4255
42533
11
18
4132
41571
16
41
3741
37543
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
C50.41 [2000501002]
3.9e-01
7.5e-01
1.2e+00
2.5e+00
1.3e+00
8.1e-01
6.2e-01
cases:1.10%
controls:0.75%
cases:1.05%
controls:0.50%
cases:0.54%
controls:0.17%
cases:0.14%
controls:0.01%
cases:0.56%
controls:0.16%
cases:1.13%
controls:0.51%
cases:1.54%
controls:0.84%
47
320
4217
42250
45
214
4225
42400
23
71
4247
42543
6
5
4264
42609
24
66
4236
42472
47
211
4096
41378
58
315
3699
37269
Predominantly allergic asthma
J45.0 [45557624]
9.0e-01
1.2e+00
1.2e+00
1.0e+50
1.5e+00
1.2e+00
1.1e+00
cases:2.72%
controls:1.13%
cases:1.48%
controls:0.45%
cases:0.28%
controls:0.08%
cases:0.19%
controls:0.00%
cases:0.31%
controls:0.07%
cases:1.35%
controls:0.41%
cases:3.01%
controls:1.06%
116
479
4148
42091
63
193
4207
42421
12
35
4258
42579
8
0
4262
42614
13
28
4247
42510
56
170
4087
41419
113
400
3644
37184
Scheduled procedure
ZXD10 [2001311387]
9.6e-01
1.1e+00
1.2e+00
—
1.3e+00
1.4e+00
1.2e+00
cases:13.41%
controls:5.58%
cases:4.66%
controls:1.53%
cases:0.61%
controls:0.19%
—
—
cases:0.52%
controls:0.15%
cases:5.09%
controls:1.33%
cases:12.70%
controls:4.35%
572
2374
3692
40196
199
654
4071
41960
26
80
4244
42534
—
22
62
4238
42476
211
553
3932
41036
477
1635
3280
35949
Tryptase [Mass/volume] in Serum or Plasma
21582-2 [3019420]
1.7e+00
1.5e+00
—
—
—
3.0e+00
2.4e+00
cases:0.21%
controls:0.04%
cases:0.14%
controls:0.03%
—
—
—
—
—
—
cases:0.24%
controls:0.01%
cases:0.43%
controls:0.04%
9
16
4255
42554
6
13
4264
42601
—
—
—
10
5
4133
41584
16
15
3741
37569
dexamethasone and antiinfectives
S02CA06 [21605178]
7.1e-01
9.4e-01
1.7e+00
—
1.9e+00
1.1e+00
6.3e-01
cases:1.36%
controls:0.68%
cases:0.75%
controls:0.29%
cases:0.19%
controls:0.03%
—
—
cases:0.21%
controls:0.03%
cases:0.70%
controls:0.22%
cases:1.86%
controls:1.01%
58
288
4206
42282
32
125
4238
42489
8
14
4262
42600
—
9
13
4251
42525
29
93
4114
41496
70
378
3687
37206
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
2.4e-01
4.3e-01
1.1e+00
3.5e+00
1.1e+00
4.7e-01
2.5e-01
cases:20.08%
controls:16.48%
cases:18.20%
controls:12.68%
cases:7.73%
controls:2.82%
cases:4.66%
controls:0.15%
cases:7.82%
controls:2.62%
cases:19.70%
controls:13.33%
cases:32.55%
controls:27.32%
856
7014
3408
35556
777
5402
3493
37212
330
1202
3940
41412
199
63
4071
42551
333
1116
3927
41422
816
5544
3327
36045
1223
10269
2534
27315
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
4.3e-01
5.4e-01
1.2e+00
3.0e+00
1.2e+00
4.5e-01
2.9e-01
cases:8.84%
controls:5.94%
cases:5.88%
controls:3.51%
cases:1.73%
controls:0.54%
cases:0.56%
controls:0.03%
cases:1.67%
controls:0.52%
cases:5.96%
controls:3.87%
cases:14.93%
controls:11.57%
377
2529
3887
40041
251
1495
4019
41119
74
228
4196
42386
24
12
4246
42602
71
222
4189
42316
247
1610
3896
39979
561
4348
3196
33236
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
6.8e-01
8.0e-01
2.0e+00
—
1.5e+00
1.1e+00
1.0e+00
cases:2.09%
controls:1.07%
cases:1.10%
controls:0.50%
cases:0.44%
controls:0.06%
—
—
cases:0.33%
controls:0.07%
cases:1.38%
controls:0.46%
cases:3.83%
controls:1.44%
89
456
4175
42114
47
211
4223
42403
19
27
4251
42587
—
14
30
4246
42508
57
193
4086
41396
144
543
3613
37041
Heart transplant status
Z94.1 [45590779]
2.3e+00
2.5e+00
—
—
—
2.3e+00
2.3e+00
cases:0.12%
controls:0.01%
cases:0.16%
controls:0.01%
—
—
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.19%
controls:0.02%
5
5
4259
42565
7
6
4263
42608
—
—
—
6
6
4137
41583
7
7
3750
37577
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
7.1e-01
9.7e-01
1.4e+00
—
2.0e+00
1.1e+00
9.3e-01
cases:1.27%
controls:0.63%
cases:0.73%
controls:0.28%
cases:0.26%
controls:0.06%
—
—
cases:0.28%
controls:0.04%
cases:0.75%
controls:0.26%
cases:1.92%
controls:0.76%
54
267
4210
42303
31
118
4239
42496
11
26
4259
42588
—
12
17
4248
42521
31
109
4112
41480
72
287
3685
37297
Basocellular carcinoma of the skin on the torso
C44.51 [2000500800]
1.9e+00
1.7e+00
—
—
1.9e+00
2.0e+00
1.5e+00
cases:0.77%
controls:0.12%
cases:0.28%
controls:0.05%
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.46%
controls:0.06%
cases:0.83%
controls:0.18%
33
50
4231
42520
12
23
4258
42591
—
—
6
9
4254
42529
19
26
4124
41563
31
69
3726
37515
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
7.0e-01
8.5e-01
1.8e+00
—
2.0e+00
9.8e-01
7.7e-01
cases:2.18%
controls:1.09%
cases:1.08%
controls:0.46%
cases:0.33%
controls:0.06%
—
—
cases:0.35%
controls:0.05%
cases:1.16%
controls:0.44%
cases:3.70%
controls:1.75%
93
466
4171
42104
46
197
4224
42417
14
24
4256
42590
—
15
21
4245
42517
48
182
4095
41407
139
657
3618
36927
Centromere protein B Ab [Units/volume] in Serum
53982-5 [3039162]
1.3e+00
1.9e+00
—
—
—
2.4e+00
1.5e+00
cases:0.33%
controls:0.09%
cases:0.26%
controls:0.04%
—
—
—
—
—
—
cases:0.41%
controls:0.04%
cases:0.75%
controls:0.17%
14
40
4250
42530
11
16
4259
42598
—
—
—
17
16
4126
41573
28
64
3729
37520
Localized oedema
R60.0 [45597193]
6.5e-01
1.1e+00
2.0e+00
1.0e+50
1.7e+00
9.7e-01
5.8e-01
cases:1.55%
controls:0.82%
cases:0.96%
controls:0.31%
cases:0.23%
controls:0.03%
cases:0.19%
controls:0.00%
cases:0.19%
controls:0.03%
cases:0.89%
controls:0.34%
cases:2.29%
controls:1.30%
66
348
4198
42222
41
133
4229
42481
10
14
4260
42600
8
0
4262
42614
8
14
4252
42524
37
142
4106
41447
86
489
3671
37095
valaciclovir; oral
J05AB11 [21603137]
6.3e-01
1.0e+00
2.0e+00
—
1.5e+00
9.9e-01
8.7e-01
cases:2.63%
controls:1.41%
cases:1.71%
controls:0.61%
cases:0.68%
controls:0.09%
—
—
cases:0.54%
controls:0.13%
cases:1.81%
controls:0.68%
cases:4.10%
controls:1.76%
112
602
4152
41968
73
262
4197
42352
29
39
4241
42575
—
23
54
4237
42484
75
282
4068
41307
154
661
3603
36923
Urticaria, unspecified
L50.9 [45562541]
1.1e+00
2.2e+00
—
1.0e+50
—
2.6e+00
9.7e-01
cases:0.73%
controls:0.23%
cases:0.68%
controls:0.07%
—
—
cases:0.26%
controls:0.00%
—
—
cases:0.75%
controls:0.06%
cases:0.83%
controls:0.31%
31
100
4233
42470
29
31
4241
42583
—
11
0
4259
42614
—
31
23
4112
41566
31
118
3726
37466
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17792-3 [3023939]
1.0e+00
2.1e+00
—
1.0e+50
—
2.3e+00
1.5e+00
cases:0.54%
controls:0.19%
cases:0.47%
controls:0.06%
—
—
cases:0.12%
controls:0.00%
—
—
cases:0.72%
controls:0.07%
cases:1.30%
controls:0.30%
23
81
4241
42489
20
25
4250
42589
—
5
0
4265
42614
—
30
29
4113
41560
49
114
3708
37470
Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
71368-5 [42870308]
1.1e+00
2.4e+00
—
1.0e+50
1.0e+50
2.7e+00
1.8e+00
cases:0.16%
controls:0.06%
cases:0.19%
controls:0.02%
—
—
cases:0.33%
controls:0.00%
cases:0.12%
controls:0.00%
cases:0.31%
controls:0.02%
cases:0.43%
controls:0.07%
7
24
4257
42546
8
7
4262
42607
—
14
0
4256
42614
5
0
4255
42538
13
9
4130
41580
16
26
3741
37558
betamethasone
S03BA03 [21605203]
6.7e-01
1.1e+00
1.0e+00
—
2.1e+00
1.0e+00
9.5e-01
cases:3.54%
controls:1.84%
cases:2.18%
controls:0.73%
cases:0.33%
controls:0.12%
—
—
cases:0.73%
controls:0.09%
cases:2.12%
controls:0.76%
cases:4.84%
controls:1.93%
151
785
4113
41785
93
310
4177
42304
14
50
4256
42564
—
31
38
4229
42500
88
314
4055
41275
182
725
3575
36859
cyclophosphamide
L01AA01 [21601390]
1.5e+00
2.0e+00
—
—
2.3e+00
2.6e+00
1.6e+00
cases:0.16%
controls:0.04%
cases:0.14%
controls:0.02%
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.29%
controls:0.02%
cases:0.21%
controls:0.05%
7
16
4257
42554
6
8
4264
42606
—
—
6
6
4254
42532
12
9
4131
41580
8
17
3749
37567
Arthropathic psoriasis
L40.5 [45557703]
1.3e+00
1.4e+00
—
1.0e+50
—
2.1e+00
2.0e+00
cases:0.54%
controls:0.14%
cases:0.35%
controls:0.08%
—
—
cases:0.12%
controls:0.00%
—
—
cases:0.53%
controls:0.06%
cases:1.04%
controls:0.14%
23
60
4241
42510
15
36
4255
42578
—
5
0
4265
42614
—
22
27
4121
41562
39
52
3718
37532
Use of laser
ZXC10 [2001311360]
1.0e+00
2.1e+00
—
—
—
2.1e+00
1.7e+00
cases:0.35%
controls:0.13%
cases:0.19%
controls:0.02%
—
—
—
—
—
—
cases:0.27%
controls:0.03%
cases:0.59%
controls:0.10%
15
54
4249
42516
8
10
4262
42604
—
—
—
11
14
4132
41575
22
39
3735
37545
Bullous pemphigoid
L12.0 [45533635]
—
1.8e+00
—
—
—
3.2e+00
1.9e+00
—
—
cases:0.16%
controls:0.03%
—
—
—
—
—
—
cases:0.63%
controls:0.03%
cases:0.37%
controls:0.05%
—
7
12
4263
42602
—
—
—
26
11
4117
41578
14
20
3743
37564
Basement membrane Ab [Titer] in Serum by Immunofluorescence
57737-9 [40760847]
1.2e+00
2.3e+00
—
1.0e+50
1.0e+50
2.8e+00
1.8e+00
cases:0.19%
controls:0.06%
cases:0.19%
controls:0.02%
—
—
cases:0.33%
controls:0.00%
cases:0.12%
controls:0.00%
cases:0.34%
controls:0.02%
cases:0.45%
controls:0.07%
8
25
4256
42545
8
8
4262
42606
—
14
0
4256
42614
5
0
4255
42538
14
9
4129
41580
17
28
3740
37556
Specific gravity of Urine by Refractometry
5810-7 [3019150]
3.9e-01
6.4e-01
1.3e+00
2.9e+00
1.1e+00
4.7e-01
1.8e-01
cases:4.17%
controls:2.85%
cases:3.14%
controls:1.69%
cases:0.89%
controls:0.24%
cases:0.26%
controls:0.01%
cases:0.77%
controls:0.25%
cases:2.85%
controls:1.79%
cases:6.97%
controls:5.88%
178
1214
4086
41356
134
719
4136
41895
38
103
4232
42511
11
6
4259
42608
33
108
4227
42430
118
746
4025
40843
262
2211
3495
35373
Bacteria identified in Blood by Culture
600-7 [3023368]
4.9e-01
9.6e-01
2.0e+00
—
2.0e+00
8.4e-01
4.7e-01
cases:3.89%
controls:2.41%
cases:2.69%
controls:1.05%
cases:1.17%
controls:0.15%
—
—
cases:1.06%
controls:0.14%
cases:2.56%
controls:1.13%
cases:5.96%
controls:3.79%
166
1027
4098
41543
115
449
4155
42165
50
65
4220
42549
—
45
60
4215
42478
106
468
4037
41121
224
1426
3533
36158
C reactive protein [Mass/volume] in Capillary blood
48421-2 [3051387]
1.2e+00
1.5e+00
2.1e+00
—
1.7e+00
1.3e+00
8.1e-01
cases:0.98%
controls:0.29%
cases:0.56%
controls:0.13%
cases:0.16%
controls:0.02%
—
—
cases:0.12%
controls:0.02%
cases:0.58%
controls:0.16%
cases:1.76%
controls:0.79%
42
123
4222
42447
24
56
4246
42558
7
9
4263
42605
—
5
9
4255
42529
24
68
4119
41521
66
296
3691
37288
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
1.6e+00
1.6e+00
—
—
-1.0e+50
1.9e+00
1.7e+00
cases:0.80%
controls:0.16%
cases:0.73%
controls:0.14%
—
—
—
—
cases:0.00%
controls:0.02%
cases:0.70%
controls:0.11%
cases:0.93%
controls:0.17%
34
67
4230
42503
31
60
4239
42554
—
—
0
7
4260
42531
29
46
4114
41543
35
65
3722
37519
FISTULA - Fistula
FISTULA-1 [2002330212]
1.5e+00
1.8e+00
—
—
—
2.1e+00
1.4e+00
cases:0.30%
controls:0.07%
cases:0.30%
controls:0.05%
—
—
—
—
—
—
cases:0.34%
controls:0.04%
cases:0.35%
controls:0.09%
13
30
4251
42540
13
21
4257
42593
—
—
—
14
17
4129
41572
13
32
3744
37552
Gas panel - Venous blood
24339-4 [3000991]
7.1e-01
9.1e-01
1.4e+00
—
1.7e+00
1.1e+00
8.9e-01
cases:1.27%
controls:0.63%
cases:1.01%
controls:0.41%
cases:0.30%
controls:0.07%
—
—
cases:0.31%
controls:0.06%
cases:1.06%
controls:0.34%
cases:2.53%
controls:1.06%
54
267
4210
42303
43
174
4227
42440
13
31
4257
42583
—
13
24
4247
42514
44
142
4099
41447
95
397
3662
37187
aciclovir; oral, parenteral
J05AB01 [21603131]
7.1e-01
1.1e+00
2.0e+00
—
1.5e+00
8.7e-01
6.5e-01
cases:5.09%
controls:2.57%
cases:2.74%
controls:0.98%
cases:0.87%
controls:0.12%
—
—
cases:0.68%
controls:0.15%
cases:2.53%
controls:1.08%
cases:5.80%
controls:3.10%
217
1093
4047
41477
117
416
4153
42198
37
51
4233
42563
—
29
65
4231
42473
105
449
4038
41140
218
1166
3539
36418
glycerol; rectal
A06AG04 [21600587]
7.9e-01
1.4e+00
—
1.0e+50
—
2.6e+00
1.9e+00
cases:0.61%
controls:0.28%
cases:0.37%
controls:0.09%
—
—
cases:0.23%
controls:0.00%
—
—
cases:1.40%
controls:0.10%
cases:1.70%
controls:0.25%
26
118
4238
42452
16
40
4254
42574
—
10
0
4260
42614
—
58
42
4085
41547
64
93
3693
37491
glycerol
A06AX01 [21600597]
7.9e-01
1.4e+00
—
1.0e+50
—
2.6e+00
1.9e+00
cases:0.61%
controls:0.28%
cases:0.37%
controls:0.09%
—
—
cases:0.23%
controls:0.00%
—
—
cases:1.40%
controls:0.10%
cases:1.70%
controls:0.25%
26
118
4238
42452
16
40
4254
42574
—
10
0
4260
42614
—
58
42
4085
41547
64
93
3693
37491
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
9.7e-01
1.0e+00
1.5e+00
—
1.6e+00
9.7e-01
7.4e-01
cases:1.59%
controls:0.61%
cases:0.98%
controls:0.36%
cases:0.30%
controls:0.07%
—
—
cases:0.33%
controls:0.07%
cases:1.04%
controls:0.40%
cases:2.90%
controls:1.41%
68
260
4196
42310
42
153
4228
42461
13
29
4257
42585
—
14
29
4246
42509
43
165
4100
41424
109
530
3648
37054
Thorax X-ray examination
GD1AA [2001303617]
5.2e-01
9.1e-01
1.9e+00
—
1.5e+00
1.0e+00
9.0e-01
cases:8.61%
controls:5.30%
cases:5.36%
controls:2.24%
cases:1.66%
controls:0.25%
—
—
cases:1.29%
controls:0.28%
cases:5.26%
controls:1.98%
cases:14.91%
controls:6.65%
367
2257
3897
40313
229
953
4041
41661
71
108
4199
42506
—
55
121
4205
42417
218
824
3925
40765
560
2500
3197
35084
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
1.3e+00
2.1e+00
—
—
—
2.0e+00
1.3e+00
cases:0.47%
controls:0.12%
cases:0.37%
controls:0.04%
—
—
—
—
—
—
cases:0.39%
controls:0.05%
cases:0.53%
controls:0.15%
20
52
4244
42518
16
19
4254
42595
—
—
—
16
22
4127
41567
20
57
3737
37527
Upper gastrointestinal surgery
106 [44777669]
5.5e-01
6.7e-01
9.4e-01
2.2e+00
8.2e-01
8.9e-01
6.5e-01
cases:10.83%
controls:6.58%
cases:4.78%
controls:2.50%
cases:0.98%
controls:0.38%
cases:0.21%
controls:0.02%
cases:1.03%
controls:0.46%
cases:5.65%
controls:2.40%
cases:13.84%
controls:7.75%
462
2800
3802
39770
204
1066
4066
41548
42
164
4228
42450
9
10
4261
42604
44
195
4216
42343
234
999
3909
40590
520
2912
3237
34672
Allergic purpura
D69.0 [45576411]
1.7e+00
2.1e+00
—
1.0e+50
—
—
2.8e+00
cases:0.21%
controls:0.04%
cases:0.14%
controls:0.02%
—
—
cases:0.16%
controls:0.00%
—
—
—
—
cases:0.40%
controls:0.02%
9
16
4255
42554
6
7
4264
42607
—
7
0
4263
42614
—
—
15
9
3742
37575
infliximab; parenteral
L04AB02 [21603909]
1.4e+00
1.7e+00
—
—
—
1.8e+00
1.8e+00
cases:0.33%
controls:0.08%
cases:0.26%
controls:0.05%
—
—
—
—
—
—
cases:0.29%
controls:0.05%
cases:0.48%
controls:0.08%
14
35
4250
42535
11
20
4259
42594
—
—
—
12
20
4131
41569
18
30
3739
37554
pimecrolimus
D11AH02 [21602339]
6.9e-01
1.2e+00
—
1.0e+50
2.6e+00
1.8e+00
1.1e+00
cases:0.66%
controls:0.33%
cases:0.33%
controls:0.10%
—
—
cases:0.12%
controls:0.00%
cases:0.21%
controls:0.02%
cases:0.75%
controls:0.13%
cases:1.41%
controls:0.48%
28
140
4236
42430
14
41
4256
42573
—
5
0
4265
42614
9
7
4251
42531
31
52
4112
41537
53
180
3704
37404
Interstitial cystitis (chronic)
N30.1 [45596860]
1.4e+00
1.7e+00
—
—
—
1.8e+00
1.7e+00
cases:0.42%
controls:0.11%
cases:0.28%
controls:0.05%
—
—
—
—
—
—
cases:0.31%
controls:0.05%
cases:0.53%
controls:0.09%
18
45
4246
42525
12
22
4258
42592
—
—
—
13
21
4130
41568
20
35
3737
37549
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
4.3e-01
5.5e-01
1.1e+00
2.4e+00
1.3e+00
5.1e-01
2.9e-01
cases:3.61%
controls:2.38%
cases:2.62%
controls:1.54%
cases:0.68%
controls:0.23%
cases:0.19%
controls:0.02%
cases:0.89%
controls:0.24%
cases:2.75%
controls:1.66%
cases:6.68%
controls:5.09%
154
1012
4110
41558
112
655
4158
41959
29
97
4241
42517
8
7
4262
42607
38
100
4222
42438
114
692
4029
40897
251
1913
3506
35671
ebastine; oral
R06AX22 [21603521]
7.3e-01
9.8e-01
1.7e+00
—
1.4e+00
9.3e-01
9.1e-01
cases:4.85%
controls:2.39%
cases:2.93%
controls:1.12%
cases:0.82%
controls:0.15%
—
—
cases:0.66%
controls:0.16%
cases:2.73%
controls:1.09%
cases:5.00%
controls:2.08%
207
1019
4057
41551
125
479
4145
42135
35
64
4235
42550
—
28
70
4232
42468
113
455
4030
41134
188
781
3569
36803
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
6.3e-01
7.2e-01
1.7e+00
1.0e+50
2.3e+00
7.0e-01
5.8e-01
cases:1.34%
controls:0.72%
cases:0.82%
controls:0.40%
cases:0.37%
controls:0.07%
cases:0.21%
controls:0.00%
cases:0.52%
controls:0.05%
cases:0.99%
controls:0.49%
cases:2.64%
controls:1.50%
57
306
4207
42264
35
170
4235
42444
16
28
4254
42586
9
0
4261
42614
22
23
4238
42515
41
205
4102
41384
99
563
3658
37021
Atrial fibrillation and flutter
I48 [45596206]
3.8e-01
5.3e-01
1.2e+00
2.7e+00
9.2e-01
6.2e-01
3.1e-01
cases:5.35%
controls:3.74%
cases:3.40%
controls:2.03%
cases:1.33%
controls:0.42%
cases:0.42%
controls:0.03%
cases:1.01%
controls:0.41%
cases:3.86%
controls:2.12%
cases:6.49%
controls:4.86%
228
1590
4036
40980
145
866
4125
41748
57
178
4213
42436
18
12
4252
42602
43
173
4217
42365
160
880
3983
40709
244
1826
3513
35758
Destruction of lesion of skin, site unspecified
QXA25 [2001310041]
9.0e-01
2.1e+00
—
1.0e+50
—
2.8e+00
1.7e+00
cases:0.30%
controls:0.12%
cases:0.28%
controls:0.04%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.51%
controls:0.03%
cases:0.77%
controls:0.14%
13
53
4251
42517
12
15
4258
42599
—
8
0
4262
42614
—
21
13
4122
41576
29
51
3728
37533
Leukocytes other/Leukocytes in Blood
26471-3 [3013727]
1.6e+00
2.6e+00
—
—
—
2.4e+00
1.5e+00
cases:0.23%
controls:0.05%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
cases:0.19%
controls:0.02%
cases:0.21%
controls:0.05%
10
20
4254
42550
9
7
4261
42607
—
—
—
8
7
4135
41582
8
18
3749
37566
Monoclonal gammopathy of undetermined significance (MGUS)
D47.2 [45566693]
1.4e+00
2.1e+00
—
—
—
1.7e+00
1.4e+00
cases:0.26%
controls:0.06%
cases:0.26%
controls:0.03%
—
—
—
—
—
—
cases:0.19%
controls:0.03%
cases:0.27%
controls:0.07%
11
27
4253
42543
11
14
4259
42600
—
—
—
8
14
4135
41575
10
25
3747
37559
Capsular endoscopy
UJF92 [2001305032]
1.4e+00
1.9e+00
—
—
—
2.0e+00
1.3e+00
cases:0.45%
controls:0.11%
cases:0.23%
controls:0.04%
—
—
—
—
—
—
cases:0.27%
controls:0.04%
cases:0.40%
controls:0.11%
19
46
4245
42524
10
15
4260
42599
—
—
—
11
15
4132
41574
15
42
3742
37542
Other minor procedure on skin
TQW99 [2001310150]
1.3e+00
1.6e+00
—
1.0e+50
—
2.2e+00
1.5e+00
cases:1.03%
controls:0.27%
cases:0.44%
controls:0.09%
—
—
cases:0.26%
controls:0.00%
—
—
cases:0.82%
controls:0.09%
cases:1.33%
controls:0.31%
44
115
4220
42455
19
40
4251
42574
—
11
0
4259
42614
—
34
38
4109
41551
50
116
3707
37468
Essential (primary) hypertension
I10 [45591453]
2.4e-01
3.7e-01
1.0e+00
3.2e+00
8.8e-01
4.8e-01
3.6e-01
cases:15.36%
controls:12.46%
cases:8.74%
controls:6.19%
cases:2.67%
controls:0.99%
cases:1.76%
controls:0.07%
cases:2.35%
controls:0.99%
cases:10.21%
controls:6.60%
cases:23.00%
controls:17.25%
655
5303
3609
37267
373
2637
3897
39977
114
424
4156
42190
75
30
4195
42584
100
422
4160
42116
423
2743
3720
38846
864
6482
2893
31102
Nummular dermatitis
L30.0 [45562535]
1.0e+00
1.3e+00
—
1.0e+50
2.5e+00
2.2e+00
8.3e-01
cases:0.52%
controls:0.19%
cases:0.21%
controls:0.06%
—
—
cases:0.12%
controls:0.00%
cases:0.14%
controls:0.01%
cases:0.56%
controls:0.06%
cases:0.72%
controls:0.31%
22
80
4242
42490
9
24
4261
42590
—
5
0
4265
42614
6
5
4254
42533
23
25
4120
41564
27
118
3730
37466
Polyneuropathy, unspecified
G62.9 [45566898]
9.5e-01
1.1e+00
2.0e+00
—
—
1.3e+00
1.1e+00
cases:0.56%
controls:0.22%
cases:0.30%
controls:0.10%
cases:0.14%
controls:0.02%
—
—
—
—
cases:0.43%
controls:0.11%
cases:0.93%
controls:0.30%
24
93
4240
42477
13
43
4257
42571
6
8
4264
42606
—
—
18
47
4125
41542
35
113
3722
37471
Atherosclerotic heart disease
I25.1 [45596196]
3.2e-01
4.8e-01
8.1e-01
3.2e+00
9.5e-01
4.8e-01
3.3e-01
cases:4.17%
controls:3.08%
cases:2.53%
controls:1.58%
cases:0.75%
controls:0.33%
cases:0.40%
controls:0.02%
cases:0.77%
controls:0.30%
cases:2.70%
controls:1.70%
cases:5.75%
controls:4.21%
178
1310
4086
41260
108
675
4162
41939
32
142
4238
42472
17
7
4253
42607
33
128
4227
42410
112
706
4031
40883
216
1583
3541
36001
Exposure to unspecified factor
X59 [45756412]
5.8e-01
1.1e+00
1.5e+00
—
1.8e+00
9.4e-01
6.2e-01
cases:2.77%
controls:1.57%
cases:1.43%
controls:0.49%
cases:0.30%
controls:0.07%
—
—
cases:0.42%
controls:0.07%
cases:1.45%
controls:0.57%
cases:3.75%
controls:2.06%
118
667
4146
41903
61
210
4209
42404
13
29
4257
42585
—
18
29
4242
42509
60
237
4083
41352
141
773
3616
36811
Systemic sclerosis, unspecified
M34.9 [45533828]
2.0e+00
2.0e+00
—
—
—
2.3e+00
2.2e+00
cases:0.14%
controls:0.02%
cases:0.12%
controls:0.02%
—
—
—
—
—
—
cases:0.17%
controls:0.02%
cases:0.24%
controls:0.03%
6
8
4258
42562
5
7
4265
42607
—
—
—
7
7
4136
41582
9
10
3748
37574
Systemic involvement of connective tissue, unspecified
M35.9 [45553174]
1.2e+00
1.5e+00
—
—
—
2.6e+00
2.4e+00
cases:0.28%
controls:0.09%
cases:0.26%
controls:0.06%
—
—
—
—
—
—
cases:0.60%
controls:0.05%
cases:0.90%
controls:0.08%
12
38
4252
42532
11
24
4259
42590
—
—
—
25
19
4118
41570
34
31
3723
37553
Demanding antibody therapy of methastized malignancy
WD415 [2001310689]
1.0e+00
2.0e+00
2.1e+00
—
2.3e+00
2.2e+00
1.1e+00
cases:0.19%
controls:0.07%
cases:0.21%
controls:0.03%
cases:0.12%
controls:0.01%
—
—
cases:0.14%
controls:0.01%
cases:0.19%
controls:0.02%
cases:0.21%
controls:0.07%
8
29
4256
42541
9
12
4261
42602
5
6
4265
42608
—
6
6
4254
42532
8
9
4135
41580
8
27
3749
37557
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
1.0e+00
1.1e+00
2.2e+00
—
1.7e+00
1.3e+00
9.1e-01
cases:2.44%
controls:0.90%
cases:0.84%
controls:0.27%
cases:0.19%
controls:0.02%
—
—
cases:0.12%
controls:0.02%
cases:0.84%
controls:0.24%
cases:2.32%
controls:0.94%
104
384
4160
42186
36
115
4234
42499
8
9
4262
42605
—
5
9
4255
42529
35
101
4108
41488
87
354
3670
37230
methylprednisolone aceponate
D07AC14 [21602133]
8.6e-01
1.6e+00
—
—
2.5e+00
1.5e+00
7.2e-01
cases:0.63%
controls:0.27%
cases:0.40%
controls:0.08%
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.36%
controls:0.08%
cases:0.51%
controls:0.25%
27
114
4237
42456
17
34
4253
42580
—
—
6
5
4254
42533
15
33
4128
41556
19
93
3738
37491
methylprednisolone
D07AA01 [21602101]
8.6e-01
1.6e+00
—
—
2.5e+00
1.5e+00
7.2e-01
cases:0.63%
controls:0.27%
cases:0.40%
controls:0.08%
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.36%
controls:0.08%
cases:0.51%
controls:0.25%
27
114
4237
42456
17
34
4253
42580
—
—
6
5
4254
42533
15
33
4128
41556
19
93
3738
37491
Excision of other lesion extending through all layers of skin in lower limb
QDE10 [2001309980]
1.0e+00
1.9e+00
—
—
—
2.5e+00
1.0e+00
cases:0.40%
controls:0.14%
cases:0.23%
controls:0.04%
—
—
—
—
—
—
cases:0.29%
controls:0.02%
cases:0.40%
controls:0.14%
17
61
4247
42509
10
15
4260
42599
—
—
—
12
10
4131
41579
15
53
3742
37531
rituximab
L01FA01 [955167]
1.1e+00
1.7e+00
—
—
—
2.4e+00
2.3e+00
cases:0.19%
controls:0.06%
cases:0.23%
controls:0.04%
—
—
—
—
—
—
cases:0.34%
controls:0.03%
cases:0.67%
controls:0.07%
8
27
4256
42543
10
18
4260
42596
—
—
—
14
13
4129
41576
25
25
3732
37559
Tinea pedis
B35.3 [45581158]
5.2e-01
1.7e+00
—
1.0e+50
2.7e+00
2.0e+00
5.9e-01
cases:0.38%
controls:0.22%
cases:0.33%
controls:0.06%
—
—
cases:0.21%
controls:0.00%
cases:0.21%
controls:0.01%
cases:0.56%
controls:0.07%
cases:0.72%
controls:0.40%
16
95
4248
42475
14
26
4256
42588
—
9
0
4261
42614
9
6
4251
42532
23
31
4120
41558
27
150
3730
37434
Ribosomal P Ab [Presence] in Serum
31592-9 [3018333]
9.7e-01
2.1e+00
—
—
1.0e+50
2.8e+00
1.5e+00
cases:0.23%
controls:0.09%
cases:0.28%
controls:0.03%
—
—
—
—
cases:0.12%
controls:0.00%
cases:0.34%
controls:0.02%
cases:0.43%
controls:0.10%
10
38
4254
42532
12
14
4258
42600
—
—
5
0
4255
42538
14
9
4129
41580
16
36
3741
37548
Fungus identified in Specimen by Culture
580-1 [3000494]
4.0e-01
1.2e+00
1.6e+00
1.0e+50
2.1e+00
1.0e+00
5.4e-01
cases:1.71%
controls:1.15%
cases:1.33%
controls:0.39%
cases:0.21%
controls:0.04%
cases:0.42%
controls:0.00%
cases:0.33%
controls:0.04%
cases:1.11%
controls:0.41%
cases:2.58%
controls:1.52%
73
491
4191
42079
57
166
4213
42448
9
19
4261
42595
18
0
4252
42614
14
18
4246
42520
46
171
4097
41418
97
570
3660
37014
Orthopedic Surgery
20 [38004465]
4.7e-01
6.5e-01
8.2e-01
2.6e+00
7.3e-01
6.4e-01
4.7e-01
cases:17.42%
controls:11.64%
cases:8.29%
controls:4.51%
cases:1.52%
controls:0.68%
cases:0.19%
controls:0.01%
cases:1.41%
controls:0.68%
cases:8.54%
controls:4.71%
cases:20.84%
controls:14.11%
743
4954
3521
37616
354
1922
3916
40692
65
289
4205
42325
8
6
4262
42608
60
290
4200
42248
354
1959
3789
39630
783
5303
2974
32281
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.2e-01
3.4e-01
9.5e-01
3.3e+00
1.0e+00
3.9e-01
3.4e-01
cases:15.57%
controls:14.08%
cases:15.13%
controls:11.31%
cases:6.14%
controls:2.48%
cases:3.19%
controls:0.12%
cases:6.29%
controls:2.36%
cases:16.65%
controls:11.96%
cases:28.64%
controls:22.21%
664
5992
3600
36578
646
4818
3624
37796
262
1055
4008
41559
136
50
4134
42564
268
1002
3992
41536
690
4976
3453
36613
1076
8348
2681
29236
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
56723-0 [40759842]
9.7e-01
2.1e+00
—
—
1.0e+50
2.6e+00
1.6e+00
cases:0.23%
controls:0.09%
cases:0.28%
controls:0.03%
—
—
—
—
cases:0.12%
controls:0.00%
cases:0.34%
controls:0.02%
cases:0.45%
controls:0.10%
10
38
4254
42532
12
14
4258
42600
—
—
5
0
4255
42538
14
10
4129
41579
17
36
3740
37548
Cathetrisation of vein
TPH04 [2001309597]
5.9e-01
7.7e-01
1.5e+00
—
1.7e+00
1.0e+00
8.0e-01
cases:3.52%
controls:1.98%
cases:1.62%
controls:0.75%
cases:0.35%
controls:0.08%
—
—
cases:0.49%
controls:0.09%
cases:1.88%
controls:0.67%
cases:4.71%
controls:2.18%
150
843
4114
41727
69
321
4201
42293
15
35
4255
42579
—
21
39
4239
42499
78
278
4065
41311
177
820
3580
36764
hydroxychloroquine; oral
P01BA02 [21604889]
8.3e-01
8.1e-01
1.0e+00
—
8.8e-01
1.4e+00
1.3e+00
cases:2.88%
controls:1.28%
cases:2.13%
controls:0.96%
cases:0.63%
controls:0.22%
—
—
cases:0.63%
controls:0.26%
cases:3.84%
controls:0.94%
cases:4.92%
controls:1.36%
123
547
4141
42023
91
407
4179
42207
27
95
4243
42519
—
27
112
4233
42426
159
389
3984
41200
185
511
3572
37073
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
8.2e-01
8.5e-01
1.5e+00
—
1.4e+00
1.0e+00
7.3e-01
cases:3.68%
controls:1.66%
cases:1.38%
controls:0.59%
cases:0.30%
controls:0.07%
—
—
cases:0.33%
controls:0.08%
cases:1.71%
controls:0.62%
cases:4.60%
controls:2.28%
157
708
4107
41862
59
253
4211
42361
13
28
4257
42586
—
14
36
4246
42502
71
257
4072
41332
173
856
3584
36728
More than one and less than three hours
ZXE10 [2001311401]
7.6e-01
8.9e-01
1.2e+00
—
1.2e+00
1.2e+00
1.1e+00
cases:9.55%
controls:4.71%
cases:3.16%
controls:1.32%
cases:0.37%
controls:0.12%
—
—
cases:0.38%
controls:0.11%
cases:3.48%
controls:1.07%
cases:10.73%
controls:4.00%
407
2007
3857
40563
135
563
4135
42051
16
50
4254
42564
—
16
46
4244
42492
144
447
3999
41142
403
1503
3354
36081
Cardiology
6 [38004451]
4.6e-01
4.8e-01
6.6e-01
2.8e+00
8.7e-01
5.4e-01
4.9e-01
cases:10.79%
controls:7.10%
cases:5.57%
controls:3.52%
cases:1.08%
controls:0.56%
cases:0.23%
controls:0.01%
cases:1.20%
controls:0.51%
cases:5.65%
controls:3.37%
cases:13.57%
controls:8.74%
460
3022
3804
39548
238
1498
4032
41116
46
239
4224
42375
10
6
4260
42608
51
215
4209
42323
234
1402
3909
40187
510
3286
3247
34298
lymecycline; oral, parenteral
J01AA04 [21602802]
7.8e-01
1.2e+00
1.3e+00
—
2.0e+00
1.4e+00
8.5e-01
cases:2.51%
controls:1.16%
cases:0.98%
controls:0.29%
cases:0.12%
controls:0.03%
—
—
cases:0.26%
controls:0.04%
cases:1.26%
controls:0.30%
cases:2.37%
controls:1.02%
107
494
4157
42076
42
122
4228
42492
5
13
4265
42601
—
11
15
4249
42523
52
125
4091
41464
89
385
3668
37199
Pruritus, unspecified
L29.9 [45548195]
4.8e-01
2.3e+00
—
—
—
2.6e+00
1.4e+00
cases:0.23%
controls:0.15%
cases:0.42%
controls:0.04%
—
—
—
—
—
—
cases:0.75%
controls:0.06%
cases:0.88%
controls:0.21%
10
62
4254
42508
18
18
4252
42596
—
—
—
31
24
4112
41565
33
79
3724
37505
Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
56730-5 [40759849]
9.7e-01
2.1e+00
—
—
1.0e+50
2.7e+00
1.4e+00
cases:0.23%
controls:0.09%
cases:0.28%
controls:0.03%
—
—
—
—
cases:0.12%
controls:0.00%
cases:0.36%
controls:0.02%
cases:0.43%
controls:0.10%
10
38
4254
42532
12
14
4258
42600
—
—
5
0
4255
42538
15
10
4128
41579
16
38
3741
37546
moxifloxacin; oral, parenteral
J01MA14 [21603021]
7.7e-01
7.6e-01
2.0e+00
—
2.6e+00
8.2e-01
9.0e-01
cases:1.50%
controls:0.70%
cases:0.44%
controls:0.21%
cases:0.19%
controls:0.03%
—
—
cases:0.16%
controls:0.01%
cases:0.48%
controls:0.21%
cases:2.34%
controls:0.96%
64
298
4200
42272
19
89
4251
42525
8
11
4262
42603
—
7
5
4253
42533
20
89
4123
41500
88
362
3669
37222
End-stage renal disease
N18.0 [45601717]
1.3e+00
2.3e+00
—
—
—
2.2e+00
1.8e+00
cases:0.23%
controls:0.07%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
cases:0.17%
controls:0.02%
cases:0.37%
controls:0.06%
10
28
4254
42542
9
9
4261
42605
—
—
—
7
8
4136
41581
14
23
3743
37561
Erythematous condition, unspecified
L53.9 [45577042]
9.2e-01
2.3e+00
—
—
—
2.1e+00
1.9e+00
cases:0.12%
controls:0.05%
cases:0.14%
controls:0.01%
—
—
—
—
—
—
cases:0.17%
controls:0.02%
cases:0.40%
controls:0.06%
5
20
4259
42550
6
6
4264
42608
—
—
—
7
9
4136
41580
15
22
3742
37562
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
8.5e-01
1.0e+00
1.5e+00
—
1.7e+00
1.4e+00
1.4e+00
cases:1.34%
controls:0.57%
cases:0.77%
controls:0.28%
cases:0.14%
controls:0.03%
—
—
cases:0.26%
controls:0.05%
cases:0.80%
controls:0.20%
cases:2.45%
controls:0.63%
57
244
4207
42326
33
121
4237
42493
6
13
4264
42601
—
11
21
4249
42517
33
84
4110
41505
92
235
3665
37349
Drill biopsy of bone marrow, pelvis
TNE25 [2001307884]
2.2e+00
—
—
—
—
2.4e+00
1.6e+00
cases:0.28%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.19%
controls:0.02%
cases:0.21%
controls:0.04%
12
13
4252
42557
—
—
—
—
8
7
4135
41582
8
16
3749
37568
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot
56731-3 [40759850]
9.7e-01
2.1e+00
—
—
1.0e+50
2.6e+00
1.5e+00
cases:0.23%
controls:0.09%
cases:0.28%
controls:0.03%
—
—
—
—
cases:0.12%
controls:0.00%
cases:0.36%
controls:0.03%
cases:0.45%
controls:0.10%
10
38
4254
42532
12
14
4258
42600
—
—
5
0
4255
42538
15
11
4128
41578
17
38
3740
37546
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
56724-8 [40759843]
9.7e-01
2.1e+00
—
—
1.0e+50
2.6e+00
1.5e+00
cases:0.23%
controls:0.09%
cases:0.28%
controls:0.03%
—
—
—
—
cases:0.12%
controls:0.00%
cases:0.36%
controls:0.03%
cases:0.45%
controls:0.10%
10
38
4254
42532
12
14
4258
42600
—
—
5
0
4255
42538
15
11
4128
41578
17
38
3740
37546
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
56725-5 [40759844]
9.7e-01
2.1e+00
—
—
1.0e+50
2.6e+00
1.5e+00
cases:0.23%
controls:0.09%
cases:0.28%
controls:0.03%
—
—
—
—
cases:0.12%
controls:0.00%
cases:0.36%
controls:0.03%
cases:0.45%
controls:0.10%
10
38
4254
42532
12
14
4258
42600
—
—
5
0
4255
42538
15
11
4128
41578
17
38
3740
37546
Histone Ab [Presence] in Serum by Immunoblot
56717-2 [40759836]
9.7e-01
2.1e+00
—
—
1.0e+50
2.6e+00
1.5e+00
cases:0.23%
controls:0.09%
cases:0.28%
controls:0.03%
—
—
—
—
cases:0.12%
controls:0.00%
cases:0.36%
controls:0.03%
cases:0.45%
controls:0.10%
10
38
4254
42532
12
14
4258
42600
—
—
5
0
4255
42538
15
11
4128
41578
17
38
3740
37546
pH of Venous blood
2746-6 [3012544]
6.5e-01
9.6e-01
1.4e+00
—
1.6e+00
1.0e+00
5.7e-01
cases:1.62%
controls:0.85%
cases:1.33%
controls:0.52%
cases:0.42%
controls:0.10%
—
—
cases:0.45%
controls:0.09%
cases:1.18%
controls:0.43%
cases:2.77%
controls:1.58%
69
363
4195
42207
57
220
4213
42394
18
43
4252
42571
—
19
38
4241
42500
49
180
4094
41409
104
593
3653
36991
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
6.0e-01
6.8e-01
1.6e+00
1.0e+50
2.2e+00
6.7e-01
5.5e-01
cases:1.29%
controls:0.71%
cases:0.80%
controls:0.41%
cases:0.33%
controls:0.07%
cases:0.16%
controls:0.00%
cases:0.47%
controls:0.05%
cases:0.99%
controls:0.51%
cases:2.69%
controls:1.57%
55
304
4209
42266
34
173
4236
42441
14
29
4256
42585
7
0
4263
42614
20
23
4240
42515
41
211
4102
41378
101
591
3656
36993
erythropoietin; parenteral
B03XA01 [21601133]
1.1e+00
1.8e+00
—
—
2.3e+00
2.6e+00
1.8e+00
cases:0.19%
controls:0.06%
cases:0.26%
controls:0.04%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.31%
controls:0.02%
cases:0.32%
controls:0.05%
8
26
4256
42544
11
18
4259
42596
—
—
5
5
4255
42533
13
10
4130
41579
12
19
3745
37565
Osmolality of Urine
2695-5 [3026782]
6.6e-01
6.9e-01
1.6e+00
—
1.6e+00
9.5e-01
8.0e-01
cases:4.64%
controls:2.47%
cases:2.11%
controls:1.07%
cases:0.66%
controls:0.14%
—
—
cases:0.63%
controls:0.13%
cases:2.37%
controls:0.93%
cases:6.25%
controls:2.91%
198
1050
4066
41520
90
457
4180
42157
28
59
4242
42555
—
27
57
4233
42481
98
387
4045
41202
235
1094
3522
36490
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
8.4e-01
8.6e-01
1.3e+00
—
1.6e+00
9.0e-01
7.2e-01
cases:3.05%
controls:1.35%
cases:1.87%
controls:0.80%
cases:0.40%
controls:0.11%
—
—
cases:0.61%
controls:0.13%
cases:2.08%
controls:0.85%
cases:4.84%
controls:2.42%
130
573
4134
41997
80
341
4190
42273
17
46
4253
42568
—
26
54
4234
42484
86
354
4057
41235
182
911
3575
36673
nystatin
D01AA01 [21601911]
8.3e-01
1.1e+00
1.7e+00
—
1.9e+00
1.5e+00
7.9e-01
cases:1.06%
controls:0.47%
cases:0.66%
controls:0.21%
cases:0.16%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:0.56%
controls:0.12%
cases:1.30%
controls:0.60%
45
198
4219
42372
28
89
4242
42525
7
13
4263
42601
—
8
12
4252
42526
23
50
4120
41539
49
224
3708
37360

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
537
1590
3.71
153.79
1.4
1.2
—
—
—
0
0
2746
19512
2.12
117.25
10.1
6.4
0.58
0.58
e9/l
0.02
2428
16662
2494
17125
2.08
116.45
15.8
11.5
0.00
0.00
e9/l
0.74
2066
13884
2748
19560
2.11
116.41
10.2
6.4
0.04
0.04
e9/l
0.15
2430
16701
2768
19951
2.08
110.72
10.2
6.5
1.88
1.92
e9/l
0.88
2478
17491
2568
18024
2.05
110.39
10.5
6.6
2.96
2.82
%
2.03
2480
16891
1862
11668
2.05
109.73
9.7
6.3
—
—
—
0
0
2164
14321
2.02
109.34
5.9
4.0
100.28
100.72
e6/l
0.00
1592
9921
2788
20201
2.07
109.21
10.5
6.6
0.23
0.19
e9/l
0.80
2494
17563
2568
18068
2.04
109.08
10.6
6.7
8.81
8.77
%
0.28
2486
16938
2571
18133
2.03
108.01
10.2
6.5
57.30
57.12
%
0.35
2513
17322
2560
18030
2.03
107.95
10.6
6.7
0.68
0.68
%
0.14
2475
16878
2598
18498
2.02
104.93
10.5
6.6
27.77
28.04
%
0.65
2523
17531
2943
21964
2.07
103.43
13.9
9.7
4.04
4.09
e9/l
0.53
2600
18984
1923
12402
1.99
102.45
4.7
3.4
49.80
81.75
e6/l
0.82
1524
9401
1823
11593
1.99
100.62
5.6
4.2
7.40
7.40
ph
0.26
1347
8317
1685
10716
1.94
90.40
4.5
3.3
0.36
0.43
e6/l
0.53
1276
7819
1626
10234
1.94
89.85
4.4
3.2
0.83
64.99
estimate
—
6
41
1018
5416
2.15
89.80
1.7
1.4
630.73
562.53
titre
0.51
246
1187
1560
9700
1.95
89.22
5.3
4.1
90.93
90.48
%
0.30
1529
9479
1952
13075
1.90
89.05
9.4
6.5
—
—
—
0
0
1101
6115
2.07
86.22
3.9
3.1
3.19
2.86
e6/l
0.44
592
2926
1375
8566
1.89
75.44
3.6
2.7
5.23
6.17
e6/l
2.09
1258
7804
2111
15062
1.79
73.66
2.6
2.1
—
—
—
0
0
3644
30897
2.15
71.98
31.1
19.5
13.76
13.61
%
8.83
3619
30491
2314
17069
1.77
70.97
6.5
5.0
35.67
35.66
g/l
0.01
2209
16006
395
1520
2.76
70.81
1.4
1.3
0.30
1.28
u/ml
2.05
22
119
341
1217
2.96
70.31
2.2
1.8
1.17
1.19
g/l
0.45
328
1160
1113
6646
1.91
68.43
3.7
2.9
0.99
1.20
e6/l
0.67
614
3472
617
2982
2.25
67.46
3.8
2.9
10.54
10.56
g/l
0.04
586
2760
330
1187
2.93
67.01
2.4
1.8
0.23
0.23
g/l
0.65
318
1130
721
3725
2.12
66.57
2.7
2.4
36.44
52.10
u/l
0.62
620
3124
2322
17333
1.73
66.52
8.5
6.8
1.21
1.21
mmol/l
0.52
2226
16039
1190
7323
1.86
66.28
3.9
2.9
516.51
524.10
mosm/kgh2o
0.60
1052
6437
273
894
3.19
65.25
1.5
1.2
46.21
40.88
u/ml
0.17
30
89
401
1636
2.60
63.81
2.4
1.9
23.27
7.30
iu/ml
0.67
100
387
814
4491
2.00
62.49
3.6
2.8
7.02
8.09
umol/l
0.72
713
3921
1823
12886
1.72
62.26
4.2
3.3
38.81
32.83
u/l
0.31
1748
12167
2500
19316
1.70
60.67
9.2
7.4
1.22
1.21
mmol/l
0.25
2258
16686
3411
28800
1.88
60.23
11.6
8.2
79.75
80.11
u/l
0.17
3308
27355
3325
27964
1.82
57.99
6.7
4.4
13.03
12.24
mm/h
2.48
3202
26213
2542
19882
1.68
57.44
7.9
6.6
11.12
11.39
umol/l
0.40
2465
18922
530
2588
2.19
55.90
1.6
1.3
383.25
210.18
u/ml
1.74
500
2398
2140
16116
1.65
55.12
4.2
3.5
6.25
6.24
ph
0.06
1179
8989
1240
8140
1.73
53.50
1.7
1.5
2.39
2.38
g/l
0.02
762
5001
2541
20086
1.64
53.12
5.0
3.9
0.00
0.00
estimate
1.08
567
4273
1375
9316
1.70
52.69
4.2
3.8
0.17
0.13
—
6
101
2318
17951
1.63
52.27
3.1
2.5
78.24
77.74
nmol/l
0.37
2186
16323
1495
10377
1.67
52.15
5.8
4.4
—
—
—
0
0
1553
10911
1.66
51.55
3.6
3.0
0.00
0.03
1.28
20
258
2567
20439
1.63
51.25
5.0
4.0
1.82
0.08
estimate
0.47
551
4151
2547
20303
1.62
50.05
5.0
3.9
7.10
3.26
estimate
0.44
580
4388
920
5648
1.80
49.53
3.2
2.7
22.22
22.53
%
0.28
880
5258
297
1191
2.60
48.65
1.5
1.3
44.27
46.26
u/ml
0.04
16
65
1033
6599
1.74
48.32
3.2
2.6
12.92
13.00
umol/l
0.13
986
6165
284
1118
2.65
48.29
1.5
1.3
14.46
8.15
u/ml
0.37
29
165
761
4446
1.86
47.99
2.1
1.8
—
—
—
0
0
283
1116
2.64
47.95
1.5
1.3
23.15
5.92
u/ml
0.64
20
100
1389
9622
1.65
47.91
3.2
2.7
337.15
336.27
umol/l
0.12
1272
8510
977
6158
1.76
47.85
3.1
2.6
2.32
2.33
g/l
0.14
920
5703
909
5650
1.77
46.57
2.3
2.3
29.56
29.64
s
0.16
891
5503
473
2372
2.12
46.19
2.1
1.9
1.18
1.33
g/l
1.26
457
2192
999
6404
1.73
45.80
4.5
3.6
0.81
0.82
mmol/l
0.77
944
6017
164
490
3.44
45.35
1.4
1.3
61.75
64.52
u/ml
—
8
28
310
1328
2.44
44.09
1.4
1.3
—
—
—
0
0
2357
18788
1.56
43.47
3.9
3.1
119.13
114.70
ug/l
0.25
2231
17573
2969
25007
1.60
42.54
6.5
4.7
752.34
2022.04
e6/l
1.60
110
341
304
1314
2.41
42.37
2.3
2.3
10.53
10.27
g/l
0.40
283
1169
336
1518
2.32
42.35
2.4
2.3
4.20
4.22
g/l
0.16
318
1384
336
1519
2.31
42.28
2.4
2.3
7.22
7.46
g/l
1.88
317
1385
1799
13562
1.56
42.10
3.9
3.4
2.35
2.36
mmol/l
0.28
1686
12340
335
1517
2.31
41.98
2.4
2.3
3.64
3.70
g/l
0.31
316
1386
565
3122
1.93
41.86
2.4
2.7
66.81
66.37
g/l
0.74
530
2865
318
1420
2.34
41.15
2.4
2.4
2.96
2.96
g/l
0.03
300
1287
337
1546
2.28
40.94
1.7
1.6
8.22
18.68
iu/ml
—
6
42
1118
7640
1.63
39.20
3.2
2.9
2.46
2.45
mmol/l
0.46
1017
6849
117
309
3.86
38.86
1.3
1.2
—
—
—
0
0
3028
25852
1.57
38.72
6.3
4.6
1.02
2.83
—
6
32
811
5121
1.72
38.45
2.9
2.4
116.66
128.01
ug/g
0.48
670
4097
2123
16806
1.52
38.45
2.5
2.1
95.26
96.37
pmol/l
0.56
1171
8716
121
333
3.71
37.89
1.3
1.2
—
—
—
0
0
1054
7153
1.63
37.79
4.4
3.8
253.63
418.41
ng/l
1.99
816
5518
741
4585
1.74
37.72
1.8
1.5
—
—
—
0
0
100
244
4.17
37.02
1.3
1.4
78.00
577.00
titre
—
5
20
473
2561
1.95
37.00
2.5
2.4
24.51
22.03
au/ml
0.25
48
274
1546
11513
1.53
36.83
2.7
2.1
173.29
222.71
u/l
1.52
1477
10899
1413
10335
1.55
36.47
2.7
2.4
2.77
2.80
mg/l
0.22
1233
8952
1201
8470
1.58
36.43
1.9
1.8
1.11
1.23
mg/l
0.79
940
6538
2659
22261
1.51
35.46
6.5
5.0
6.59
6.65
mmol/l
0.74
2559
21030
821
5306
1.68
35.38
2.4
2.0
—
—
—
0
0
224
915
2.53
35.21
1.4
1.2
13.52
3.08
u/ml
0.48
12
57
706
4399
1.72
34.80
4.5
2.8
1.78
1.78
%
0.00
645
3922
821
5327
1.67
34.79
1.3
1.2
—
—
—
0
0
2118
16977
1.49
34.70
16.9
14.7
1.23
1.25
inr
0.62
1822
14162
527
3034
1.84
33.99
3.1
2.5
0.32
0.43
e6/l
0.66
508
2888
95
238
4.06
33.97
1.3
1.4
66.15
67.06
titre
0.01
13
17
1290
9373
1.54
33.75
1.4
1.3
2.22
1.87
u/ml
0.29
367
2516
622
3774
1.76
33.61
2.7
2.3
362.86
379.84
nmol/l
1.30
590
3485
574
3421
1.78
32.95
8.0
8.0
1.26
1.34
mmol/l
1.55
559
3353
568
3388
1.78
32.48
10.4
9.2
—
—
—
0
0
229
984
2.40
32.25
1.7
1.5
15.23
15.72
iu/ml
—
10
26
1009
7016
1.57
31.83
2.0
1.9
—
—
—
0
0
83
199
4.23
31.48
1.7
1.6
7.17
9.06
ug/l
0.73
76
176
789
5189
1.64
31.36
8.1
6.2
1.06
1.05
mmol/l
0.34
749
4820
3456
30938
1.59
31.08
30.9
20.1
330.99
331.82
g/l
6.39
3445
30752
220
944
2.40
31.08
2.2
2.0
11.13
11.93
mg/l
0.68
208
875
686
4379
1.67
30.57
1.8
1.6
—
—
—
0
0
758
4966
1.64
30.52
1.5
1.3
—
—
—
0
0
208
4463
0.44
30.31
5.2
4.9
32.85
32.82
%
0.02
144
2960
1452
11008
1.48
30.21
3.5
3.2
1460.28
1394.43
ng/l
0.15
1290
9507
1036
7323
1.55
30.13
1.4
1.3
30.07
30.91
iu/ml
0.06
321
2250
423
2365
1.87
29.77
1.3
1.3
53.11
53.07
au/ml
0.00
17
166
3946
36686
1.88
29.46
25.3
15.7
21.70
23.98
mg/l
5.06
3452
30130
673
4315
1.66
29.40
1.5
1.4
—
—
—
0
0
3325
29717
1.52
28.00
5.5
4.5
14.69
14.75
pmol/l
0.74
3166
27359
1164
8576
1.49
27.38
7.4
4.8
—
—
—
0
0
604
3850
1.66
26.81
5.2
4.3
1.73
1.81
mmol/l
0.24
538
3350
374
2078
1.88
26.76
1.2
1.1
0.93
1.24
u/ml
—
8
21
959
6815
1.52
26.75
1.4
1.3
13.36
11.42
u/ml
0.32
366
2654
543
3369
1.70
26.69
6.8
4.8
0.11
0.20
%
0.35
148
851
558
3492
1.69
26.56
6.5
4.6
0.70
0.88
%
1.29
175
1051
227
1056
2.21
26.54
3.6
3.3
3.01
2.09
index
0.80
124
537
486
2930
1.74
26.50
1.6
1.5
—
—
—
0
0
67
156
4.35
26.43
32.8
29.4
115.20
116.17
ug/l
0.04
59
131
618
3996
1.64
25.87
5.1
4.3
7.38
7.38
ph
0.55
384
2319
608
3944
1.63
25.07
5.2
4.3
5.79
5.83
kpa
0.48
594
3842
533
3346
1.68
24.98
6.6
4.6
0.05
0.11
%
2.74
152
905
96
299
3.26
24.94
2.9
2.3
75.34
72.54
%
1.16
91
285
1519
12031
1.41
23.40
3.8
3.2
—
—
—
0
0
55
121
4.59
23.32
3.3
2.7
0.16
0.17
e9/l
0.06
35
60
578
3775
1.61
23.06
2.5
2.3
0.22
0.21
g/l
1.67
543
3534
267
1403
1.96
22.55
2.3
2.4
20.60
21.11
s
0.77
242
1242
3729
34578
1.57
22.54
6.8
5.5
1.88
1.91
mu/l
0.62
3576
32156
74
211
3.55
22.10
1.6
1.5
7.31
5.95
u/l
0.27
61
182
487
3081
1.65
22.03
4.7
4.0
93.97
88.61
ng/l
0.57
439
2640
513
3336
1.61
20.72
5.7
4.4
0.63
0.66
%
0.10
144
991
229
1180
1.99
20.45
2.4
2.9
94.53
92.83
%
0.56
224
1143
509
3315
1.61
20.41
4.4
3.8
4.75
4.57
kpa
1.03
498
3223
3942
37204
1.68
20.33
26.7
18.4
139.51
139.67
mmol/l
3.48
3907
36484
3947
37276
1.68
20.14
27.1
18.6
3.96
3.96
mmol/l
0.76
3909
36480
525
3463
1.59
19.94
10.3
7.7
9.89
9.85
mmol/l
0.05
514
3320
100
365
2.78
19.76
3.0
2.4
1222.94
1195.92
e6/l
0.10
82
315
1370
10897
1.38
19.75
1.9
1.7
20.47
20.41
nmol/l
0.05
1231
9241
49
114
4.34
19.42
7.9
4.7
55.14
52.40
%
0.34
49
108
1811
15107
1.34
18.97
4.8
3.9
1.08
0.36
estimate
0.30
470
3505
821
6038
1.44
18.42
1.8
1.7
—
—
—
0
0
126
537
2.39
18.15
1.3
1.3
5.33
5.11
u/ml
0.05
69
254
216
1138
1.95
18.11
2.6
3.2
2.15
3.19
ratio
0.77
120
659
1679
13917
1.34
18.09
4.6
3.7
83.91
91.39
ng/l
0.05
1133
9479
51
132
3.90
17.57
1.1
1.3
0.31
0.30
g/l
0.70
38
107
221
1194
1.90
17.19
6.8
5.2
1.56
1.53
mg/l
0.22
205
1089
176
880
2.04
17.12
4.6
3.3
57.44
57.87
%
0.16
176
880
159
767
2.11
17.02
1.6
1.7
—
—
—
0
0
293
1734
1.74
16.90
1.8
1.8
1.55
1.54
g/l
0.09
258
1508
229
1263
1.86
16.71
2.6
3.5
40.11
53.76
mg/l
0.67
194
1071
229
1265
1.86
16.63
2.6
3.5
51.19
55.11
mg/l
0.19
194
1075
213
1160
1.88
16.18
2.7
2.9
3.45
3.58
g/l
0.64
204
1102
196
1044
1.92
15.93
1.2
1.2
—
—
—
0
0
82
304
2.73
15.80
1.2
1.2
293.53
193.57
titre
0.37
17
56
488
3340
1.52
15.54
1.6
1.4
—
—
—
0
0
156
775
2.05
15.47
1.6
1.5
—
—
—
0
0
1330
10851
1.33
15.33
4.6
3.4
0.55
0.19
estimate
0.29
463
3388
158
792
2.03
15.29
5.2
3.6
25.86
25.97
mg/l
0.01
117
557
665
4861
1.44
15.16
3.8
3.3
4.46
4.57
e9/l
0.13
621
4214
93
376
2.51
15.08
3.5
3.5
16.24
13.30
index
0.94
63
208
389
2552
1.58
14.98
3.2
3.4
4.45
4.48
pmol/l
0.23
352
2300
347
2219
1.61
14.88
10.7
9.9
24.15
24.24
mmol/l
0.19
340
2174
132
625
2.15
14.87
1.8
1.6
—
—
—
0
0
68
237
2.90
14.72
3.0
2.4
0.70
0.68
e9/l
0.06
63
226
1450
12034
1.31
14.62
3.2
2.7
60.29
67.34
u/l
0.49
1355
11165
1496
12501
1.30
14.24
3.0
2.4
—
—
—
0
0
4044
38840
1.65
14.22
30.2
20.2
77.85
75.48
umol/l
3.00
4023
38382
41
107
3.86
14.02
1.4
1.4
—
—
—
0
0
595
4324
1.44
13.92
8.7
7.9
0.66
0.97
mmol/l
0.99
506
3544
163
856
1.94
13.85
4.7
4.0
—
—
—
0
0
174
934
1.90
13.85
2.5
2.3
130.56
127.90
g/l
0.73
140
740
228
1334
1.75
13.70
2.2
2.2
214.12
740.26
ug/l
2.47
209
1252
134
661
2.06
13.59
1.6
1.6
0.53
0.74
g/l
2.78
107
524
101
445
2.30
13.58
14.6
5.1
7.37
7.21
mmol/l
0.19
89
377
187
1035
1.84
13.54
1.3
1.2
—
—
—
0
0
198
1116
1.81
13.51
1.3
1.2
336.67
961.21
titre
—
6
33
174
943
1.88
13.46
1.3
1.3
—
—
—
0
0
148
763
1.97
13.28
1.4
1.3
275.24
268.42
u/ml
0.07
96
443
473
3326
1.47
13.13
1.2
1.2
—
—
—
0
0
219
3592
0.59
13.06
4.6
4.3
7.33
7.35
ph
0.56
175
2541
139
707
2.00
12.97
1.7
1.5
137.99
142.87
au/ml
0.16
42
213
68
255
2.69
12.89
3.1
2.4
584.20
515.02
e6/l
0.38
45
200
4009
38536
1.56
12.68
17.6
12.0
25.43
25.35
u/l
0.13
3953
37473
195
1117
1.78
12.63
1.3
1.2
97.50
140.78
titre
0.36
12
102
206
1200
1.75
12.59
1.3
1.4
278.28
285.16
ug/g
0.18
125
696
294
1882
1.60
12.55
3.6
3.3
1.02
1.02
ratio
1.67
267
1695
213
1255
1.73
12.51
1.4
1.3
—
—
—
0
0
57
200
2.87
12.25
3.1
2.7
37.42
42.33
%
0.91
28
105
301
1949
1.59
12.25
1.2
1.1
222.86
119.85
titre
—
7
61
3694
35015
1.38
12.12
5.6
5.0
5.87
5.89
mmol/l
0.46
3508
32250
107
507
2.14
12.10
1.8
1.4
—
—
—
0
0
107
507
2.14
12.10
1.8
1.4
—
—
—
0
0
107
507
2.14
12.10
1.8
1.4
—
—
—
0
0
107
507
2.14
12.10
1.8
1.4
—
—
—
0
0
91
404
2.28
12.07
1.4
1.4
6.49
6.88
g/l
0.50
72
302
91
404
2.28
12.07
1.4
1.4
2.82
2.86
g/l
0.06
72
303
91
404
2.28
12.07
1.4
1.4
0.38
0.40
g/l
0.34
71
303
90
400
2.28
11.91
1.5
1.4
—
—
—
0
0
584
4356
1.39
11.68
8.8
8.0
7.42
7.42
ph
0.85
322
2400
127
654
1.97
11.49
1.1
1.1
—
—
—
0
0
89
400
2.25
11.48
1.3
1.1
—
—
—
0
0
467
3362
1.44
11.41
2.7
2.7
73.20
69.50
e9/l
1.13
284
2433
582
4358
1.39
11.35
8.9
8.0
12.53
12.48
kpa
0.09
567
4194
582
4358
1.39
11.35
8.9
8.0
5.02
5.10
kpa
1.38
568
4190
1078
8840
1.29
11.30
4.7
4.1
1.02
1.36
kg/l
0.80
804
5902
56
205
2.75
11.16
2.5
2.2
2.11
1.93
umol/l
0.78
50
188
48
162
2.99
11.08
35.5
40.1
6.80
7.10
ug/l
0.50
42
146
163
923
1.80
11.01
1.8
1.6
12821.70
12044.48
e6/l
0.10
115
622
2747
25162
1.25
10.94
3.9
3.3
45.14
46.03
u/l
0.23
2622
23650
1789
15638
1.25
10.87
2.1
1.9
1.35
1.34
mmol/l
0.05
1573
13231
64
256
2.52
10.72
3.2
2.6
248.04
212.03
e6/l
0.70
48
213
85
389
2.21
10.53
2.4
2.4
—
—
—
0
0
38
116
3.30
10.38
2.9
2.7
0.61
0.61
mmol/l
0.26
38
116
52
191
2.74
10.33
2.6
2.2
29.54
28.67
umol/l
0.26
46
178
150
846
1.80
10.29
1.9
1.6
584.82
1199.89
e6/l
0.64
120
661
148
834
1.80
10.19
1.9
1.5
12.65
28.20
e6/l
0.94
111
609
487
3602
1.40
10.18
9.8
8.8
118.86
120.51
g/l
1.05
481
3521
516
3860
1.38
10.08
9.4
8.4
95.86
95.62
%
0.43
506
3732
791
6315
1.31
10.00
1.8
1.8
1183.11
1163.27
nmol/l
0.25
612
4805
177
1056
1.71
9.99
1.5
1.4
10.91
11.20
u/l
0.10
135
839
376
2665
1.45
9.97
1.3
1.3
—
—
—
0
0
1995
17766
1.23
9.84
3.3
2.8
—
—
estimate
—
0
0
101
512
2.00
9.61
6.6
6.7
12.11
12.12
mg/l
0.00
95
482
305
2099
1.49
9.41
1.4
1.2
—
—
—
0
0
3594
34249
1.29
8.90
7.2
6.2
39.20
39.07
mmol/mol
0.39
3460
32100
35
113
3.11
8.78
1.5
1.7
9.43
8.54
ug/l
0.61
35
113
101
532
1.92
8.65
1.7
1.6
19.68
27.10
ng/l
1.95
101
532
87
436
2.02
8.59
1.6
1.4
—
—
—
0
0
41
147
2.81
8.57
2.2
2.1
32.37
29.46
%
0.59
41
147
29
85
3.43
8.48
2.1
1.6
100.26
179.26
au/ml
—
5
9
276
1904
1.48
8.43
2.3
2.4
—
—
—
0
0
46
177
2.62
8.41
2.0
1.7
—
—
—
0
0
78
380
2.07
8.33
2.5
1.8
—
—
—
0
0
194
1246
1.58
8.25
2.6
2.5
—
—
—
0
0
4094
39884
1.51
8.21
36.4
24.1
255.45
255.06
e9/l
0.14
4039
39076
4094
39890
1.51
8.13
36.2
23.9
30.25
30.25
pg
0.06
4077
39467
4094
39891
1.50
8.12
36.3
24.0
91.18
90.99
fl
1.74
4076
39469
4094
39893
1.50
8.09
37.2
24.5
39.87
40.47
%
2.18
4075
39450
4094
39895
1.50
8.07
36.4
24.0
4.42
4.46
e12/l
4.62
4026
38971
4094
39899
1.50
8.02
36.4
24.1
6.85
6.73
e9/l
1.44
4030
38967
4094
39904
1.50
7.96
36.6
24.2
132.56
133.96
g/l
8.64
4076
39494
109
608
1.81
7.85
4.8
3.7
1.42
1.51
%
0.09
98
540
382
2833
1.38
7.84
1.3
1.2
105.17
148.23
u/ml
1.80
143
1073
327
2363
1.42
7.82
3.8
3.5
128.13
128.61
g/l
0.15
319
2294
1283
11114
1.22
7.80
5.5
4.1
0.00
0.00
estimate
2.14
540
3999
87
452
1.94
7.80
2.1
2.3
0.76
1.30
g/24h
1.59
53
269
95
510
1.88
7.72
1.1
1.2
—
—
—
0
0
477
3679
1.33
7.60
2.4
2.1
0.01
0.01
estimate
0.10
131
784
409
3084
1.36
7.57
5.4
3.8
1.23
1.23
mmol/l
0.05
373
2666
1480
13032
1.21
7.55
4.1
3.4
7.39
7.32
mmol/l
0.23
1292
11062
139
841
1.67
7.54
1.6
1.4
3.69
3.72
mmol/l
0.12
133
797
217
1465
1.51
7.40
1.6
1.6
13.31
14.98
u/ml
0.24
48
331
35
126
2.79
7.31
2.8
2.1
8.78
10.00
mg/l
0.56
30
108
117
682
1.74
7.28
1.9
2.0
4.54
5.01
mmol/24h
1.04
106
598
333
2448
1.39
7.22
12.2
9.9
94.41
93.94
%
0.72
333
2439
153
962
1.61
7.15
1.6
1.4
468.64
538.44
mg/l
1.57
146
915
205
1378
1.51
7.15
2.0
1.7
334.33
293.61
mu/l
0.91
187
1247
132
803
1.66
7.04
1.9
1.5
—
—
—
0
0
291
2107
1.41
6.90
1.4
1.4
30.46
28.82
iu/l
0.33
251
1793
113
664
1.72
6.86
1.1
1.1
—
—
—
0
0
322
2375
1.38
6.85
2.4
2.3
12.13
12.31
nmol/l
0.14
287
2135
62
300
2.08
6.81
1.2
1.4
9.24
8.80
mmol/l
0.32
54
289
20
53
3.79
6.80
1.2
1.0
—
—
—
0
0
93
520
1.81
6.70
1.2
1.2
—
—
—
0
0
398
3048
1.34
6.66
2.8
2.6
6.09
6.09
ph
0.05
287
2059
64
319
2.02
6.51
1.9
1.4
27.54
33.08
%
0.68
45
194
476
3751
1.30
6.50
1.8
1.8
—
—
—
0
0
48
217
2.23
6.28
2.3
2.1
8.65
8.44
mmol/l
0.11
48
217
155
1012
1.55
6.22
2.1
1.9
—
—
—
0
0
402
3115
1.32
6.21
5.6
4.0
—
—
—
0
0
30
109
2.76
6.20
1.1
1.1
—
—
—
0
0
127
792
1.62
6.19
5.2
4.3
2.60
2.72
mmol/l
0.20
96
527
87
492
1.78
6.07
3.2
2.7
—
—
—
0
0
61
308
1.99
6.02
1.7
1.2
2.19
1.81
u/ml
0.13
34
169
105
629
1.69
5.99
3.5
2.8
—
—
—
0
0
3768
36469
1.26
5.92
6.4
5.6
2.65
2.73
mmol/l
6.29
3615
34034
240
1731
1.41
5.86
1.1
1.1
—
—
—
0
0
29
107
2.72
5.84
1.3
1.1
—
—
—
0
0
30
113
2.67
5.81
5.1
4.7
—
—
—
0
0
251
1829
1.40
5.78
2.4
1.9
—
—
—
0
0
55
274
2.02
5.65
1.1
1.1
58.03
40.52
mg/l
0.39
43
229
44
202
2.19
5.58
1.3
1.2
0.52
0.57
ratio
0.97
21
115
215
1535
1.42
5.57
1.6
1.6
0.38
0.31
mg/l
0.59
94
711
67
360
1.87
5.54
1.4
2.0
—
—
—
0
0
97
584
1.68
5.47
1.4
1.3
0.23
0.35
nmol/l
—
7
27
29
111
2.62
5.47
1.0
1.0
—
—
—
0
0
194
1366
1.44
5.43
1.1
1.1
—
—
—
0
0
124
796
1.57
5.41
2.7
2.9
41.11
34.27
umol/l
0.47
113
724
86
503
1.72
5.39
1.4
1.3
0.19
0.22
nmol/l
0.34
59
396
39
173
2.27
5.38
1.2
1.1
29.67
10.43
u/ml
—
6
21
53
267
2.00
5.31
1.1
1.1
218.57
272.96
mg/l
2.14
42
237
165
1135
1.47
5.23
1.9
2.0
4.19
8.54
iu/l
0.43
63
486
3526
33985
1.20
5.21
4.7
4.2
1.29
1.27
mmol/l
0.68
3335
31355
15
31
4.85
5.11
1.1
1.1
0.03
0.03
u/ml
0.09
15
31
195
1395
1.42
5.03
3.4
3.4
1789.00
3268.96
u/ml
0.28
161
1172
98
607
1.63
4.99
1.2
1.2
—
—
—
0
0
85
508
1.69
4.96
3.0
2.5
5.63
8.06
umol/l
0.91
69
370
27
105
2.58
4.96
1.6
1.3
56.76
53.52
%
0.15
22
88
114
736
1.56
4.89
1.4
1.4
58.77
64.07
mmol/l
0.77
91
590
212
1548
1.39
4.87
2.3
1.9
2.21
2.00
ug/l
0.11
193
1376
124
818
1.53
4.84
3.7
4.2
—
—
—
0
0
487
3992
1.25
4.83
3.8
4.2
8.87
22.96
ug/l
2.04
400
3217
15
42
3.58
4.76
1.2
1.2
1.53
1.53
iu/ml
—
9
19
365
2898
1.28
4.73
2.7
3.1
217.96
200.69
ng/l
0.28
332
2645
3704
35942
1.21
4.70
5.7
5.0
4.56
4.67
mmol/l
10.10
3554
33685
61
338
1.82
4.64
1.3
1.2
—
—
—
0
0
3682
35722
1.21
4.60
5.5
4.9
1.47
1.49
mmol/l
2.71
3513
33273
1336
12060
1.16
4.52
3.8
3.5
59.35
45.57
mg/l
1.17
875
7582
42
210
2.01
4.36
1.3
1.2
—
—
—
0
0
1353
12256
1.15
4.33
4.6
4.2
11.12
10.13
mg/mmol
0.19
881
7530
14
33
4.25
4.31
1.1
1.3
0.44
0.50
iu/ml
—
8
17
12
24
5.01
4.31
3.8
2.9
3.02
3.69
mg/l
0.38
12
24
24
95
2.53
4.29
1.3
1.2
—
—
—
0
0
363
2921
1.26
4.24
2.2
2.3
7.04
7.12
ug/l
0.03
325
2563
56
312
1.81
4.22
3.4
3.0
57.71
28.95
mg/l
0.60
40
227
20
73
2.75
4.18
1.8
1.8
—
—
—
0
0
86
543
1.60
4.11
2.6
2.0
0.91
0.89
%
0.13
66
365
197
1464
1.36
4.11
2.4
2.2
5497.64
6409.31
u/l
0.19
89
580
145
1025
1.43
4.07
4.3
2.9
—
—
—
0
0
196
1460
1.36
4.04
2.8
2.1
—
—
—
0
0
53
295
1.81
4.03
1.5
1.8
3.43
4.40
mg/l
1.55
53
286
55
310
1.78
4.01
3.4
2.7
30.74
29.73
mg/l
0.05
42
216
27
117
2.32
4.00
1.2
1.2
27.67
28.89
s
0.65
27
117
193
1437
1.36
3.99
2.6
2.1
—
—
—
0
0
194
1446
1.36
3.98
2.8
2.1
—
—
—
0
0
9
14
6.44
3.98
1.0
1.0
—
—
—
0
0
9
14
6.44
3.98
1.0
1.0
—
—
—
0
0
9
14
6.44
3.98
1.0
1.0
—
—
—
0
0
194
1452
1.35
3.89
2.8
2.0
—
—
—
0
0
71
434
1.65
3.89
2.3
2.4
9.80
36.07
iu/ml
—
6
39
36
178
2.03
3.88
1.7
2.1
11.33
157.13
ug/min
—
9
46
25
107
2.34
3.82
1.2
1.4
124.15
118.82
nmol/l
0.05
13
80
158
1155
1.38
3.69
3.0
2.1
—
—
—
0
0
69
427
1.63
3.62
2.8
1.8
5333.33
1347.69
titre
—
6
13
11
25
4.41
3.62
1.4
1.0
—
—
—
0
0
599
5160
1.19
3.61
3.2
3.3
0.72
0.78
ug/l
0.66
413
3374
41
219
1.88
3.58
1.4
1.3
—
—
—
0
0
81
523
1.56
3.57
1.1
1.1
1.48
1.50
g/l
0.16
76
480
56
330
1.71
3.54
1.1
1.1
9.26
7.35
iu/ml
0.20
17
88
29
137
2.12
3.54
1.2
1.5
54.45
334.32
nmol/24h
0.75
29
137
75
477
1.58
3.53
1.3
1.3
—
—
nmol/l
—
0
0
35
178
1.97
3.52
1.6
1.6
—
—
—
0
0
49
279
1.76
3.50
1.7
1.2
—
—
—
0
0
80
518
1.55
3.49
4.0
1.9
14.40
6.89
titre
—
5
9
8
14
5.72
3.34
1.0
1.0
—
—
—
0
0
8
14
5.72
3.34
1.0
1.0
—
—
—
0
0
72
463
1.56
3.26
2.3
1.8
89.93
89.61
%
0.17
72
455
9
19
4.74
3.23
1.1
2.9
—
—
—
0
0
11
29
3.80
3.18
1.7
1.4
—
—
—
0
0
108
761
1.43
3.16
1.7
2.1
0.87
0.82
nmol/l
0.36
98
644
1193
10915
1.13
3.11
1.6
1.5
—
—
—
0
0
86
582
1.49
3.10
1.2
1.2
—
—
—
0
0
62
391
1.59
3.07
1.1
1.1
—
—
—
0
0
94
650
1.46
3.05
1.7
1.8
—
—
—
0
0
15
56
2.68
3.05
2.3
3.9
23.07
22.36
mg/l
—
7
14
175
1342
1.32
3.05
2.9
2.2
—
—
—
0
0
57
354
1.62
3.01
1.2
1.2
—
—
—
0
0
73
482
1.52
2.97
3.0
2.9
—
—
—
0
0
39
219
1.79
2.96
2.1
2.4
16.26
16.04
%
0.20
39
219
30
155
1.94
2.94
1.7
1.7
—
—
—
0
0
57
357
1.60
2.92
1.2
1.3
1.63
1.52
nmol/l
0.21
47
323
99
698
1.43
2.92
1.2
1.1
—
—
—
0
0
26
128
2.04
2.91
4.3
4.2
7.91
8.36
mg/l
0.16
21
104
279
2283
1.24
2.89
3.5
3.7
59.94
57.92
u/ml
0.04
267
2205
52
321
1.63
2.83
1.2
1.2
103.37
107.51
pmol/l
0.38
52
321
315
2621
1.22
2.79
5.8
4.4
5.01
5.17
kpa
3.33
306
2510
98
696
1.42
2.79
1.2
1.1
—
—
—
0
0
79
540
1.47
2.75
1.7
1.5
68.96
54.81
mu/l
0.22
70
482
44
263
1.68
2.72
1.3
1.1
3.89
3.17
u/ml
0.07
27
98
45
271
1.67
2.71
1.6
1.3
34.63
34.19
mmol/l
0.05
39
238
306
2550
1.22
2.68
5.8
4.5
7.42
7.42
ph
0.48
273
2117
52
326
1.60
2.68
1.5
1.4
105500.17
84451.12
e6/l
0.11
42
213
121
899
1.36
2.65
1.2
1.1
1.51
2.34
u/ml
0.77
77
504
342
4035
0.83
2.65
1.9
1.9
3.35
3.41
ratio
0.40
258
3046
25
126
1.99
2.65
1.0
1.1
4.44
2.72
u/ml
0.31
18
73
50
312
1.61
2.63
1.0
1.1
—
—
—
0
0
96
688
1.40
2.62
1.2
1.1
19.04
20.05
au/ml
0.04
14
155
57
370
1.55
2.55
4.5
5.2
108.47
67.18
u/ml
0.21
21
116
12
44
2.73
2.54
2.3
1.6
—
—
—
0
0
134
1021
1.32
2.50
1.1
1.1
—
—
—
0
0
951
8686
1.12
2.50
5.4
5.5
2.26
3.50
ug/l
1.61
869
7798
65
439
1.49
2.44
1.3
1.5
282.14
278.38
mosm/kgh2o
0.58
43
330
34
196
1.74
2.42
1.0
1.1
1440.71
1412.59
miu/ml
0.06
34
196
5
8
6.26
2.37
1.4
1.4
22.42
39.56
mg/l
—
5
8
8
22
3.64
2.36
1.1
1.0
—
—
—
0
0
39
237
1.65
2.31
1.1
1.1
4.96
6.72
nmol/l
0.20
14
47
16
72
2.23
2.27
1.1
1.1
0.68
0.69
umol/24h
—
9
38
6
13
4.62
2.27
1.2
1.1
0.04
0.06
u/ml
—
6
13
72
505
1.43
2.26
1.3
1.3
308.81
304.22
pmol/l
0.04
62
427
86
1172
0.73
2.25
7.7
9.8
—
—
—
0
0
81
581
1.40
2.25
1.6
1.4
26.70
29.37
u/l
0.34
69
486
38
232
1.64
2.23
1.1
1.1
1.70
3.98
u/ml
0.36
19
67
14
60
2.34
2.21
1.4
1.5
10.66
554173.91
nmol/l
—
8
48
104
780
1.34
2.20
2.6
2.5
143.35
100.89
ug/min
0.44
63
474
43
272
1.59
2.19
1.0
1.0
—
—
—
0
0
74
525
1.42
2.19
1.1
1.1
7.11
3.29
eliau/ml
0.61
32
242
26
143
1.82
2.18
1.9
3.2
—
—
—
0
0
26
143
1.82
2.18
1.2
1.2
810.00
1025.81
titre
—
10
31
282
3319
0.84
2.17
1.4
1.3
—
—
—
0
0
204
1673
1.23
2.15
4.5
3.3
25.31
25.30
mmol/l
0.01
197
1614
21
108
1.95
2.15
1.0
1.2
—
—
—
0
0
98
732
1.35
2.14
1.4
1.3
—
—
—
0
0
44
282
1.57
2.13
1.1
1.0
—
—
—
0
0
85
622
1.37
2.11
1.2
1.1
38.73
984.40
iu/ml
0.53
15
138
22
395
0.55
2.08
2.5
2.7
—
—
—
0
0
18
89
2.03
2.05
1.4
1.4
—
—
—
0
0
24
132
1.82
2.03
1.1
1.0
—
—
—
0
0
37
232
1.60
1.98
1.4
1.8
90.18
108.19
ng/l
0.85
37
232
41
264
1.56
1.97
1.3
1.1
5.05
2.32
u/ml
0.27
20
83
59
411
1.44
1.96
1.8
1.6
61.50
58.07
%
0.31
43
253
47
313
1.51
1.95
1.2
1.2
—
—
—
0
0
31
495
0.62
1.89
2.2
2.7
13.66
13.18
%
1.60
31
490
8
28
2.86
1.86
1.5
1.1
—
—
—
0
0
8
28
2.86
1.86
1.1
1.1
—
—
—
0
0
29
174
1.67
1.85
1.2
1.1
—
—
—
0
0
95
725
1.32
1.84
1.1
1.1
2.27
1.50
u/ml
0.39
59
384
6
17
3.53
1.83
3.7
3.1
—
—
—
0
0
62
445
1.40
1.78
1.1
1.1
—
—
—
0
0
22
124
1.78
1.75
1.8
1.4
7.94
8.37
mmol/l
0.13
22
124
32
201
1.60
1.73
1.2
1.4
7.41
7.41
ph
0.03
21
134
8
30
2.67
1.72
3.5
1.9
—
—
—
0
0
5
13
3.85
1.71
2.0
4.4
—
—
—
0
0
1518
14414
1.08
1.71
3.5
3.1
—
—
—
0
0
268
2310
1.17
1.71
7.8
6.9
24.83
24.50
mmol/l
0.84
262
2214
70
517
1.36
1.70
1.6
1.5
31.44
32.23
g/l
0.21
64
471
8
31
2.58
1.66
1.1
1.0
—
—
—
0
0
12
56
2.15
1.61
1.8
1.5
—
—
—
0
0
155
1280
1.22
1.60
1.3
1.3
222.04
230.68
miu/ml
0.10
68
631
51
362
1.41
1.59
1.4
1.2
—
—
—
0
0
54
388
1.40
1.57
1.7
1.6
—
—
—
0
0
30
191
1.57
1.56
1.2
1.4
949.38
889.16
pmol/l
—
6
20
468
4222
1.12
1.56
1.6
1.5
—
—
—
0
0
261
2997
0.86
1.54
1.7
1.7
3.36
3.47
mmol/l
0.77
176
2022
11
51
2.16
1.50
8.7
14.1
4.87
5.49
mmol/l
0.50
11
51
852
7944
1.09
1.48
1.9
1.7
30458658.00
32240049.81
pmol/l
0.03
742
6644
30
195
1.54
1.45
2.5
2.5
516.30
493.15
min
0.40
20
150
98
782
1.26
1.42
1.1
1.1
5.97
4.61
u/ml
0.32
61
438
9
40
2.25
1.40
1.0
1.2
1.76
1.80
umol/24h
—
9
40
76
589
1.30
1.39
1.1
1.1
6.46
4.94
u/ml
0.27
50
281
95
758
1.26
1.38
1.1
1.1
0.65
1.24
u/ml
0.89
56
355
12
60
2.00
1.38
1.5
1.6
—
—
—
0
0
26
167
1.56
1.34
1.7
1.4
12.00
2.87
%
—
7
30
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
6
24
2.50
1.30
2.5
1.5
359.33
332.33
umol/24h
—
6
24
105
1282
0.81
1.29
1.1
1.1
0.63
0.63
ratio
0.04
11
170
27
179
1.51
1.23
1.9
2.5
94.08
153.29
umol/l
0.98
13
99
83
666
1.25
1.19
1.6
1.4
0.46
0.37
nmol/l
0.25
60
508
17
102
1.67
1.16
1.1
1.1
—
—
—
0
0
17
102
1.67
1.16
1.1
1.1
—
—
—
0
0
17
102
1.67
1.16
1.1
1.1
—
—
—
0
0
5
20
2.50
1.15
1.0
1.5
0.15
0.16
umol/l
—
5
20
41
303
1.36
1.08
1.7
1.4
—
—
—
0
0
29
202
1.44
1.07
2.1
1.7
7.40
6.91
nmol/l
0.03
21
161
91
749
1.22
1.06
3.8
3.3
0.79
0.82
nmol/l
0.35
80
597
40
297
1.35
1.04
2.0
2.2
1.71
1.72
u/field
0.01
28
159
127
1082
1.18
1.03
1.3
1.4
—
—
—
0
0
83
679
1.23
1.03
2.4
1.9
181.59
196.02
pmol/l
0.71
76
639
9
46
1.96
1.03
1.0
1.1
—
—
—
0
0
38
282
1.35
1.00
1.0
1.1
23.39
16.27
u/ml
—
9
113
149
1292
1.16
0.99
5.2
3.7
657.75
414.18
mg/l
0.24
104
568
7
36
1.95
0.97
1.1
1.1
—
—
—
0
0
9
50
1.80
0.96
4.9
2.7
—
—
—
0
0
16
100
1.60
0.96
1.0
1.0
21.84
32.15
iu/ml
0.52
16
100
16
100
1.60
0.96
1.2
1.2
39.30
40.30
g/l
0.16
11
51
6
27
2.22
0.93
1.3
1.4
—
—
—
0
0
64
516
1.24
0.93
1.6
1.5
4.69
3.89
ug/l
0.27
55
456
35
260
1.35
0.93
2.6
2.6
686.48
619.93
ml
0.32
21
180
6
28
2.14
0.91
1.0
1.1
—
—
—
0
0
11
63
1.75
0.90
1.5
1.3
—
—
—
0
0
8
42
1.91
0.88
1.6
1.7
49.13
43.93
umol/l
—
8
42
76
629
1.21
0.88
1.1
1.1
6.42
4.03
u/ml
0.46
51
323
31
231
1.34
0.82
26.3
18.9
1294.26
1470.21
nmol/l
0.74
31
225
6
32
1.88
0.81
1.0
1.1
—
—
—
0
0
6
33
1.82
0.79
1.0
1.2
—
—
—
0
0
0
27
0.00
0.77
0.0
3.0
—
0.62
—
0
27
15
99
1.52
0.75
1.0
1.0
—
—
—
0
0
190
1714
1.11
0.74
4.8
4.4
36.90
36.93
°c
0.46
185
1695
5
26
1.92
0.70
1.6
1.3
—
—
—
0
0
114
1001
1.14
0.70
1.6
1.5
56.68
59.08
ug/l
0.24
96
833
12
77
1.56
0.68
2.6
2.2
—
—
—
0
0
90
779
1.16
0.68
1.5
1.5
—
—
—
0
0
11
168
0.65
0.67
3.5
3.1
—
—
—
0
0
19
261
0.73
0.67
1.8
1.6
8.50
7.79
mmol/l
1.00
19
251
48
394
1.22
0.65
1.5
1.5
—
—
—
0
0
102
1156
0.88
0.62
4.6
6.5
1.27
1.28
mmol/l
0.07
89
1023
8
49
1.63
0.62
1.0
1.0
0.81
6.57
u/ml
—
8
49
186
1698
1.10
0.61
4.6
5.4
1.49
1.60
%
1.02
181
1604
91
796
1.15
0.61
1.6
1.6
—
—
—
0
0
172
1565
1.10
0.61
4.8
5.7
0.83
0.89
%
0.64
167
1479
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
28
356
0.79
0.60
1.1
1.2
—
—
—
0
0
12
80
1.50
0.59
1.8
2.5
8.25
36.20
ug/l
0.42
12
80
133
1473
0.90
0.57
7.5
4.6
24.20
24.79
mmol/l
2.01
126
1363
18
132
1.37
0.57
1.3
1.6
63.69
65.49
%
0.06
13
105
6
36
1.67
0.56
3.8
2.4
1.00
0.72
u/field
—
6
36
6
36
1.67
0.56
1.3
1.4
—
—
—
0
0
6
37
1.62
0.55
1.3
1.3
5.82
5.63
mmol/l
—
6
19
87
766
1.14
0.55
1.5
1.5
1.26
1.28
mm
0.19
64
542
112
1004
1.12
0.54
1.1
1.1
25.07
6.06
eliau/ml
0.67
17
122
36
438
0.82
0.54
2.9
2.2
18.00
22.39
mg/l
0.55
15
168
6
40
1.50
0.51
1.0
1.1
101.33
90.40
titre
—
6
40
22
171
1.29
0.49
1.2
1.3
159.59
156.64
mmol/24h
0.06
22
171
23
181
1.27
0.48
1.2
1.2
12.00
9.64
mm/h
0.31
23
181
16
120
1.33
0.46
1.7
1.9
9525.00
23207.43
e6/l
—
8
63
16
120
1.33
0.46
1.8
2.0
—
—
—
0
0
10
69
1.45
0.44
1.1
1.1
—
—
—
0
0
10
69
1.45
0.44
1.1
1.1
—
—
—
0
0
10
69
1.45
0.44
1.1
1.1
—
—
—
0
0
5
31
1.61
0.43
1.4
1.1
—
4.90
—
0
5
51
444
1.15
0.41
2.9
2.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
0.02
—
0
8
0
17
0.00
0.40
0.0
1.0
—
0.10
—
0
7
29
241
1.20
0.40
6.3
6.9
15.50
92.54
ug/l
0.54
22
149
12
158
0.76
0.37
1.9
3.3
—
—
—
0
0
198
1865
1.06
0.36
2.4
2.2
0.01
0.42
estimate
0.50
108
602
14
178
0.79
0.34
1.8
3.2
—
—
—
0
0
50
563
0.89
0.34
1.2
1.2
—
—
—
0
0
61
550
1.11
0.32
1.1
1.1
0.25
0.27
u/ml
0.05
29
197
14
110
1.27
0.31
5.4
6.5
25.19
24.56
mmol/l
0.30
14
98
7
52
1.35
0.31
1.1
1.3
53.57
68.04
ug/l
—
7
52
21
175
1.20
0.30
1.1
1.4
195.62
207.36
pmol/l
0.08
21
175
43
382
1.13
0.29
1.7
1.5
—
—
—
0
0
14
112
1.25
0.28
1.2
1.1
—
—
—
0
0
9
74
1.22
0.25
2.0
2.3
22.46
17.64
umol/l
—
9
74
7
91
0.77
0.22
3.4
7.4
6.06
5.95
kpa
—
7
80
5
40
1.25
0.22
1.0
1.2
12.62
8.43
mg/l
—
5
35
47
429
1.10
0.22
2.1
1.6
550.28
347.30
mu/l
0.97
39
342
69
642
1.08
0.21
1.3
1.2
64.52
37.70
u/l
0.62
64
552
5
42
1.19
0.21
1.2
1.0
7.54
7.33
kpa
—
5
31
5
42
1.19
0.21
1.2
1.0
—
—
—
0
0
5
42
1.19
0.21
1.2
1.0
3.20
3.23
kpa
—
5
31
0
10
0.00
0.21
0.0
1.0
—
7.02
—
0
10
205
1972
1.04
0.21
1.7
1.7
—
—
—
0
0
16
135
1.19
0.21
1.7
2.2
3143.11
735.47
e6/l
—
9
97
5
43
1.16
0.21
1.0
1.2
14.68
16.49
g/l
—
5
36
0
14
0.00
0.20
0.0
1.1
—
0.18
—
0
6
22
193
1.14
0.19
1.4
1.3
136.55
134.55
nmol/l
0.09
22
193
22
249
0.88
0.19
1.0
1.0
752.69
717.05
ng/l
0.12
16
167
10
81
1.24
0.18
1.2
1.2
—
—
—
0
0
22
247
0.89
0.17
1.0
1.0
338.65
320.78
ng/l
0.15
17
168
20
226
0.88
0.17
1.2
1.1
—
—
—
0
0
15
129
1.16
0.17
1.7
1.8
0.07
0.05
estimate
0.10
15
129
21
236
0.89
0.16
1.4
1.5
77.52
78.86
umol/l
0.07
21
236
8
72
1.11
0.16
1.6
1.3
—
—
—
0
0
49
458
1.07
0.15
1.7
1.5
2241.88
3784.87
e6/l
0.36
32
319
9
110
0.82
0.13
1.2
1.4
3.21
3.37
mmol/l
—
9
98
183
1783
1.03
0.12
1.7
1.6
967.47
1022.51
mu/l
0.34
150
1497
18
199
0.90
0.11
1.2
1.6
—
—
—
0
0
16
144
1.11
0.10
2.2
1.7
15.20
14.65
pmol/l
—
10
122
84
810
1.04
0.10
4.9
3.6
53.88
765.49
u/ml
1.46
78
739
5
44
1.14
0.10
5.0
3.2
40.80
41.91
%
—
5
44
5
44
1.14
0.10
10.0
6.4
5.20
8.66
%
—
5
44
5
47
1.06
0.09
1.0
1.0
6.34
9.60
mu/l
—
5
38
52
497
1.05
0.09
1.3
1.3
—
—
—
0
0
42
402
1.05
0.07
1.6
1.4
138329.21
72165.91
e6/l
0.36
24
221
7
80
0.87
0.07
3.4
7.7
4.86
5.43
kpa
—
7
80
42
436
0.96
0.06
1.8
1.7
—
—
—
0
0
13
120
1.08
0.04
1.5
1.5
0.55
0.49
e9/l
0.30
13
120
183
1812
1.01
0.03
6.5
4.6
—
—
—
0
0
46
451
1.02
0.02
1.4
1.3
6.38
7.31
mmol/l
2.24
41
407
16
154
1.04
0.00
3.5
1.7
39.84
39.96
g/l
0.03
16
154
30
295
1.02
0.00
1.5
1.4
1.50
1.16
promille
0.76
25
226
39
391
1.00
0.00
1.6
3.3
57.98
57.66
%
0.03
31
335
5
56
0.89
0.00
1.0
1.2
19.84
19.75
mmol/l
—
5
48
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
-0.00
1.7
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
7.2
—
138.40
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
38.60
—
0
5
8
83
0.96
-0.00
1.1
1.2
—
—
—
0
0
9
93
0.97
-0.00
2.8
3.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.26
—
0
5
5
59
0.85
-0.00
1.2
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
65
0.92
-0.00
2.0
1.8
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_RASH_OTHER_NONSPECIFIC_SKIN_ERUPT – Rash and other nonspecific skin eruption

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).